6/20/2024 | 462 | Costs Taxed as to 461 USCA Mandate, USCA Case Number 23-410(L), 23-418(Con), 23-420(Con), 23-423(Con). IT IS HEREBY ORDERED that costs are taxed in the amount of $252.20 in favor of the Defendants-Appellees.(km) (Entered: 06/20/2024) |
6/5/2024 | | Transmission of USCA Mandate/Order to the District Judge re: [461] USCA Mandate.(km) (Entered: 06/05/2024) |
6/5/2024 | | Transmission of USCA Mandate/Order to the District Judge re: [460] USCA Order.(km) (Entered: 06/05/2024) |
6/4/2024 | 460 | TRUE COPY OPINION of USCA as to 445 Notice of Appeal, filed by Rite Aid Hdqtrs. Corp.,, CVS Pharmacy, Inc., Rite Aid Corporation, 448 Notice of Appeal, filed by J M Smith Corporation, KPH Healthcare Services, Inc., 450 Notice of Appeal,, filed by Teamsters Local No. 1150 Prescription Drug Benefit Plan, Mayor and City Council of Baltimore, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., UFCW Local 1500 Welfare Fund, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Western Region & Local 177 Health Care Plan, 449 Notice of Appeal, filed by The Kroger Co., Walgreen Co., H-E-B L.P., ALBERTSONS COMPANIES, INC. USCA Case Number 23-410(L), 23-418(Con), 23-420(Con), 23-423(Con). USCA Case Number 23-410(L), 23-418(Con), 23-420(Con), 23-423(Con). For the foregoing reasons, we AFFIRM the district court's judgment dismissing Plaintiffs' claims with prejudice Catherine O'Hagan Wolfe, Clerk USCA for the Second Circuit. Certified: 6/4/2024.(km) (Entered: 06/05/2024) |
6/4/2024 | 461 | MANDATE of USCA (Certified Copy) as to 445 Notice of Appeal, filed by Rite Aid Hdqtrs. Corp.,, CVS Pharmacy, Inc., Rite Aid Corporation, 448 Notice of Appeal, filed by J M Smith Corporation, KPH Healthcare Services, Inc., 450 Notice of Appeal,, filed by Teamsters Local No. 1150 Prescription Drug Benefit Plan, Mayor and City Council of Baltimore, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., UFCW Local 1500 Welfare Fund, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Western Region & Local 177 Health Care Plan, 449 Notice of Appeal, filed by The Kroger Co., Walgreen Co., H-E-B L.P., ALBERTSONS COMPANIES, INC. USCA Case Number 23-410(L), 23-418(Con), 23-420(Con), 23-423(Con). The appeal in the above captioned case from an order of the United States District Court for the Southern District of New York was argued on the district court's record and the parties' briefs. IT IS HEREBY ORDERED, ADJUDGED and DECREED that the district court's judgment dismissing Plaintiff's claims with prejudice is AFFIRMED. Catherine O'Hagan Wolfe, Clerk USCA for the Second Circuit. Issued As Mandate: 6/4/2024.(km) (Entered: 06/05/2024) |
8/18/2023 | 459 | ORDER. For the reasons stated in the Opinion and Order at Dkt. No. 438, the Clerk of Court is respectfully directed to close this case, its member cases, and its related cases: 20-cv-5735, 20-cv-07110, 20-cv-08754, 20-cv-08756, 20-cv-05538, 20-cv-09793, 20-cv-10087, 20-cv-05813, 20-cv-07580, 20-cv-07352, 20-cv-05837, 20-cv-07492, 20-cv-05826, 20-cv-07309, 20-cv-05901, 20-cv-06769, 20-cv-07177, 20-cv-06647, 20-cv-07296, 20-cv-07304, 20-cv-06223. SO ORDERED. (Signed by Judge Lewis J. Liman on 8/18/23) (yv) (Entered: 08/21/2023) |
7/20/2023 | 458 | ORDER granting 456 Motion to Withdraw as Attorney. Attorney James Tierney terminated. (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (bhk) (Entered: 07/20/2023) |
7/19/2023 | 457 | DECLARATION of James Tierney in Support re: (54 in 1:20-cv-08756-LJL) MOTION for James Tierney to Withdraw as Attorney .. Document filed by ANI Pharmaceuticals, Inc.. Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(Tierney, James) (Entered: 07/19/2023) |
7/19/2023 | 456 | MOTION for James Tierney to Withdraw as Attorney . Document filed by ANI Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit Certificate of Service)Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(Tierney, James) (Entered: 07/19/2023) |
3/30/2023 | 455 | REPLY MEMORANDUM OF LAW in Support re: 393 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Third Amended Complaint. . Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 03/30/2023) |
3/30/2023 | 454 | MEMORANDUM OF LAW in Support re: 393 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Third Amended Complaint. . Document filed by ANI Pharmaceuticals, Inc., Abbvie, Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Appendix to Defendants' Memorandum of Law in Support of Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Third Amended Complaints).(Gidley, John) (Entered: 03/30/2023) |
3/29/2023 | 453 | MEMORANDUM OF LAW in Opposition re: 386 MOTION to Dismiss for Lack of Personal Jurisdiction Under Rule 12(b)(2). [Public Version]. Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund. (Attachments: # 1 Affidavit of Donna M. Evans, # 2 Exhibit A - Filed Under Seal, # 3 Exhibit B - Filed Under Seal, # 4 Exhibit C - Filed Under Seal, # 5 Exhibit D - Filed Under Seal, # 6 Exhibit E - Filed Under Seal, # 7 Exhibit F - Filed Under Seal, # 8 Exhibit G - Filed Under Seal, # 9 Exhibit H, # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M).(Robertson, Sharon) (Entered: 03/29/2023) |
3/29/2023 | 452 | MEMORANDUM OF LAW in Opposition re: 393 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Third Amended Complaint. . Document filed by ALBERTSONS COMPANIES, INC., CVS Pharmacy, Inc., H-E-B L.P., J M Smith Corporation, KPH Healthcare Services, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, The Kroger Co., Walgreen Co...(Hennings, Kimberly) (Entered: 03/29/2023) |
3/24/2023 | 451 | ORDER granting 391 Letter Motion to Seal; granting in part and denying in part 394 Letter Motion to Seal; granting in part and denying in part 401 Letter Motion to Seal; granting in part and denying in part 410 Letter Motion to Seal; granting in part and denying in part 415 Letter Motion to Seal; granting 417 Letter Motion to Seal; granting in part and denying in part 421 Letter Motion to Seal; granting in part and denying in part 423 Letter Motion to Seal. This order addresses several pending motions to seal in this case. The motion at Dkt. No. 391 is GRANTED. The motions at Dkt. Nos. 394 and 401 are GRANTED IN PART and DENIED in PART. The proposed redactions at Dkt. No. 402-1 are granted for the highlighted selections on page 8, line 67 (excluding the term "nebivolol"); page 15, lines 23 (excluding "nebivolol API"), line 5; page 21; page 22, line 14; page 35; and page 36 (excluding the phrase "select new products of equal value if Amerigen discontinued any product"). The remainder of the proposed redactions are denied. The proposed redactions for Dkt. No. 402-2 are granted for the highlighted selections on page 53, lines 25-26 (excluding the term "API"); page 54, line 1 (excluding $37.5), lines 15-16 (following "nebivolol API"); page 57, lines 11-17; page 58, lines 2, 9, footnote 96; page 60, lines 21-23; page 61, lines 68; page 62, line 6 (excluding "for 'Development Work'"), lines 16-18; page 63, lines 22-23, 25-27; page 64, line 23; page 67, lines 25-27; page 68, lines 1, 27; page 69, line 1, footnote 95 line 3 (excluding "Forest's"); page 71; page 72; page 74, lines 19-21; page 75; and page 76 (excluding "$4"). The remainder of the proposed redactions are denied. The motion at Dkt. No. 407 is GRANTED IN PART and DENIED IN PART. The motion at Dkt. No. 417 is GRANTED. End-Payor Plaintiffs are directed to publicly file their Opposition to Nonresident Defendants Rule 12(b)(2) Motion to Dismiss End-Payor Plaintiffs Non-New York Claims for Lack of Personal Jurisdiction and the accompanying Evans Declaration. Dkt. Nos. 412-2 through 412-8, or Exhibits A through G of the Evans Declaration, shall remain under seal. The motions at Dkt. Nos. 410 and 415 are GRANTED IN PART and DENIED IN PART. The proposed redactions at Dkt. No. 416-1 are granted for the highlighted sections on page 13, line 14 (excluding "requirements contract"); page 16 (excluding "API" and "nebivolol"); and page 23, lines 19-20 (excluding "in milestones for 'Development Work'"). The remainder of the proposed redactions are denied. The motions at Dkt. Nos. 421 and 423 are GRANTED IN PART and DENIED IN PART. The proposed redactions at Dkt. No. 424-1 are granted for the highlighted sections on page 8, lines 67, 16; and page 19. The remainder of the proposed redactions are denied. The parties are directed to file public versions of the filings at issue, in the form directed by this order, on the public docket by March 31, 2023. The Clerk of Court is respectfully directed to close the motions at Dkt. Nos. 391, 394, 401, 407, 410, 415, 417, 421, 423. The Clerk of Court is also respectfully directed to unseal Dkt. No. 438. SO ORDERED. (Signed by Judge Lewis J. Liman on 3/24/23) (yv) (Entered: 03/24/2023) |
3/20/2023 | | Appeal Record Sent to USCA (Electronic File). Certified Indexed record on Appeal Electronic Files for 450 Notice of Appeal, filed by Teamsters Local No. 1150 Prescription Drug Benefit Plan, Mayor and City Council of Baltimore, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., UFCW Local 1500 Welfare Fund, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Western Region & Local 177 Health Care Plan were transmitted to the U.S. Court of Appeals..(tp) (Entered: 03/20/2023) |
3/20/2023 | | Transmission of Notice of Appeal and Certified Copy of Docket Sheet to US Court of Appeals re: 450 Notice of Appeal. (tp) (Entered: 03/20/2023) |
3/20/2023 | 450 | NOTICE OF APPEAL from 439 Order,,,,, 438 Memorandum & Opinion,,,,,,,,,. Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund. Filing fee $ 505.00, receipt number BNYSDC-27491656. Form C and Form D are due within 14 days to the Court of Appeals, Second Circuit..(Van Der Meulen, Robin) (Entered: 03/20/2023) |
3/20/2023 | | Appeal Record Sent to USCA (Electronic File). Certified Indexed record on Appeal Electronic Files for 449 Notice of Appeal, filed by The Kroger Co., Walgreen Co., H-E-B L.P., ALBERTSONS COMPANIES, INC. were transmitted to the U.S. Court of Appeals. (tp) (Entered: 03/20/2023) |
3/20/2023 | | Transmission of Notice of Appeal and Certified Copy of Docket Sheet to US Court of Appeals re: 449 Notice of Appeal. (tp) (Entered: 03/20/2023) |
3/20/2023 | | Appeal Fee Paid electronically via Pay.gov: for 449 Notice of Appeal,. Filing fee $ 505.00. Pay.gov receipt number NYSDC-27489894, paid on 3/20/2023. (tp) (Entered: 03/20/2023) |
3/20/2023 | | Appeal Record Sent to USCA (Electronic File). Certified Indexed record on Appeal Electronic Files for 448 Notice of Appeal, filed by J M Smith Corporation, KPH Healthcare Services, Inc. were transmitted to the U.S. Court of Appeals. (tp) (Entered: 03/20/2023) |
3/20/2023 | | Transmission of Notice of Appeal and Certified Copy of Docket Sheet to US Court of Appeals re: 448 Notice of Appeal. (tp) (Entered: 03/20/2023) |
3/20/2023 | | Appeal Fee Paid electronically via Pay.gov: for 448 Notice of Appeal. Filing fee $ 505.00. Pay.gov receipt number NYSDC-27490777, paid on 3/20/2023. (tp) (Entered: 03/20/2023) |
3/20/2023 | 449 | NOTICE OF APPEAL from 439 Order,,,,, 438 Memorandum & Opinion,,,,,,,,,,. Document filed by ALBERTSONS COMPANIES, INC., H-E-B L.P., The Kroger Co., Walgreen Co.. Form C and Form D are due within 14 days to the Court of Appeals, Second Circuit..(Perwin, Scott) (Entered: 03/20/2023) |
3/20/2023 | | Appeal Record Sent to USCA (Electronic File). Certified Indexed record on Appeal Electronic Files for 445 Notice of Appeal, filed by Rite Aid Hdqtrs. Corp., CVS Pharmacy, Inc., Rite Aid Corporation were transmitted to the U.S. Court of Appeals. (tp) (Entered: 03/20/2023) |
3/20/2023 | | Transmission of Notice of Appeal and Certified Copy of Docket Sheet to US Court of Appeals re: 445 Notice of Appeal. (tp) (Entered: 03/20/2023) |
3/20/2023 | | ***NOTICE TO ATTORNEY REGARDING DEFICIENT APPEAL. Notice to attorney Scott Perwin to RE-FILE Document No. (444 in 1:20-cv-05735-LJL, 52 in 1:20-cv-08756-LJL, 137 in 1:20-cv-07110-LJL, 51 in 1:20-cv-08754-LJL) Notice of Appeal. The filing is deficient for the following reason(s): (1) the order/judgment being appealed was not selected; (2) the PDF does not list the member cases being appealed. Re-file the appeal using the event type Notice of Appeal found under the event list Appeal Documents - attach the correct signed PDF - select the correct named filer/filers - select the correct order/judgment being appealed - Do Not Pay the Appeal Fee Again. Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL. (tp) (Entered: 03/20/2023) |
3/20/2023 | | ***NOTICE TO ATTORNEY REGARDING DEFICIENT APPEAL. Notice to attorney Kimberly Hennings to RE-FILE Document No. (53 in 1:20-cv-08756-LJL, 447 in 1:20-cv-05735-LJL, 52 in 1:20-cv-08754-LJL, 138 in 1:20-cv-07110-LJL) Notice of Appeal,,.. The filing is deficient for the following reason(s): the order/judgment being appealed was not selected;. Re-file the appeal using the event type Notice of Appeal found under the event list Appeal Documents - attach the correct signed PDF - select the correct named filer/filers - select the correct order/judgment being appealed. Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL(nd) (Entered: 03/20/2023) |
3/20/2023 | 448 | NOTICE OF APPEAL from 350 Order, Set Deadlines/Hearings,,,,,,, 439 Order,,,,, 349 Memorandum & Opinion,,,,,,,,, 438 Memorandum & Opinion,,,,,,,,,,. Document filed by J M Smith Corporation, KPH Healthcare Services, Inc.. Form C and Form D are due within 14 days to the Court of Appeals, Second Circuit..(Hennings, Kimberly) (Entered: 03/20/2023) |
3/20/2023 | 447 | FILING ERROR - NO ORDER/JUDGMENT SELECTED FOR APPEAL - NOTICE OF APPEAL. Document filed by J M Smith Corporation, KPH Healthcare Services, Inc., J M Smith Corporation d/b/a Smith Drug Company, KPH Healthcare Services, Inc.. Filing fee $ 505.00, receipt number NYSDC-27490777. Form C and Form D are due within 14 days to the Court of Appeals, Second Circuit. Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(Hennings, Kimberly) Modified on 3/20/2023 (nd). (Entered: 03/20/2023) |
3/20/2023 | 446 | FILING ERROR - WRONG EVENT TYPE SELECTED FROM MENU - NOTICE of Notice of Appeal filed in 1:20-cv-5735-LJL. Document filed by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,..(Refsin, Barry) Modified on 3/20/2023 (nd). (Entered: 03/20/2023) |
3/20/2023 | 445 | NOTICE OF APPEAL from 439 Order,,,,, 438 Memorandum & Opinion,,,,,,,,. Document filed by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,. Filing fee $ 505.00, receipt number ANYSDC-27490121. Form C and Form D are due within 14 days to the Court of Appeals, Second Circuit..(Refsin, Barry) (Entered: 03/20/2023) |
3/20/2023 | 444 | FILING ERROR - NO ORDER SELECTED FOR APPEAL - NOTICE OF APPEAL. Document filed by ALBERTSONS COMPANIES, INC., H-E-B L.P., The Kroger Co., Walgreen Co.. Filing fee $ 505.00, receipt number NYSDC-27489894. Form C and Form D are due within 14 days to the Court of Appeals, Second Circuit. Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(Perwin, Scott) Modified on 3/20/2023 (tp). (Entered: 03/20/2023) |
3/10/2023 | 443 | ORDER granting 441 Motion to Withdraw as Attorney. Attorney John A. Jurata terminated. (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (bhk) (Entered: 03/10/2023) |
3/3/2023 | 442 | DECLARATION of Eileen Cole in Support re: (50 in 1:20-cv-08756-LJL) MOTION for John Jurata, Jr. to Withdraw as Attorney .. Document filed by ANI Pharmaceuticals, Inc.. Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(Cole, Eileen) (Entered: 03/03/2023) |
3/3/2023 | 441 | MOTION for John Jurata, Jr. to Withdraw as Attorney . Document filed by ANI Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit Certificate of Service)Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(Cole, Eileen) (Entered: 03/03/2023) |
2/28/2023 | 440 | LETTER addressed to Judge Lewis J. Liman from J. Mark Gidley dated February, 28 2023 re: Redactions from Opinion and Order on Defendants' Motions to Dismiss. Document filed by AbbVie Inc., Actavis, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 02/28/2023) |
2/21/2023 | 439 | ORDER: For the reasons stated in the Opinion and Order filed by the Court today: Defendants' motion to dismiss the Direct Purchaser and Retailer Plaintiffs' Complaints for failure to state a claim is GRANTED, and the Direct Purchaser and Retailer Plaintiffs' Complaints are DISMISSED with prejudice. Defendants' motion to dismiss the End-Payor Plaintiffs' Complaint for failure to state a claim is GRANTED, and the End-Payor Plaintiffs' Complaint is DISMISSED with prejudice. Nonresident Defendants' motion to dismiss the End-Payor Plaintiffs' Complaint's non-New York, state-law claims for lack of personal jurisdiction and Teva Israel's motion to dismiss for lack of personal jurisdiction are DENIED as moot. In order to preserve the ability of the parties to move the Court for redactions from the Opinion and Order, the Opinion and Order is temporarily filed under seal. The parties shall meet and confer with respect to potential redactions and, by February 28, 2023, the parties shall file any proposed redactions pursuant to the Court's Individual Practices. In addition, the parties are invited to inform the Court of any errors in citation, typography, or similar errors they discover in their review. The Court will rule on any outstanding motions to seal at the same time it rules on any proposed redactions to the Opinion and Order. SO ORDERED. (Signed by Judge Lewis J. Liman on 2/21/2023) (va) (Entered: 02/21/2023) |
2/21/2023 | 438 | ***SELECTED PARTIES*** OPINION AND ORDER re: 388 MOTION to Dismiss the February 2022 Complaints Under Rule 12(b)(2) filed by Teva Pharmaceutical Industries Ltd., 403 MOTION to File Amicus Brief filed by International Center for Law & Economics, New Civil Liberties Alliance, 397 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the End-Payor Plaintiffs' Second Consolidated Amended Complaint filed by Watson Pharma, Inc., Allergan, Inc., Allergan USA, Inc., Torrent Pharma Inc., Glenmark Generics Inc., Indchemie Health Specialties Private Ltd., Glenmark Generics Inc., USA, Amerigen Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals S.A., Actavis, Inc., Glenmark Generics Ltd., Teva Pharmaceuticals USA, Inc., AbbVie Inc., Forest Laboratories, LLC, Watson Laboratories, Inc. (NV), Hetero USA Inc., Glenmark Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Hetero Drugs LTD., ANI Pharmaceuticals, Inc., Watson Laboratories, Inc. (DE), Allergan Sales LLC, Forest Laboratories Ireland, Ltd., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Inc., Alkem Laboratories Ltd., Hetero Labs Ltd, Forest Laboratories Holdings, Ltd., Watson Pharmaceuticals Inc., 393 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Third Amended Complaint. filed by Watson Pharma, Inc., Allergan, Inc., Allergan USA, Inc., Torrent Pharma Inc., Glenmark Generics Inc., Indchemie Health Specialties Private Ltd., Glenmark Generics Inc., USA, Amerigen Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals S.A., Actavis, Inc., Glenmark Generics Ltd., Forest Laboratories, LLC, Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NV), Hetero USA Inc., Glenmark Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Hetero Drugs LTD., ANI Pharmaceuticals, Inc., Watson Laboratories, Inc. (DE), Allergan Sales, LLC, Amerigen Pharmaceuticals Ltd., Forest Laboratories Ireland, Ltd., Ascend Laboratories, LLC, Abbvie, Inc., Forest Laboratories Inc., Alkem Laboratories Ltd., Hetero Labs Ltd, Forest Laboratories Holdings, Ltd., Watson Pharmaceuticals Inc., 386 MOTION to Dismiss for Lack of Personal Jurisdiction Under Rule 12(b)(2) filed by Watson Pharma, Inc., Forest Laboratories Holdings Ltd., Allergan, Inc., Allergan USA, Inc., Torrent Pharma Inc., Indchemie Health Specialties Private Ltd., Glenmark Generics Inc., USA, Amerigen Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals S.A., Glenmark Generics Ltd., AbbVie Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NV), Hetero USA Inc., Glenmark Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Hetero Drugs LTD., ANI Pharmaceuticals, Inc., Watson Laboratories, Inc. (DE), Actavis Inc., Amerigen Pharmaceuticals Ltd., Forest Laboratories Ireland, Ltd., Ascend Laboratories, LLC, Alkem Laboratories Ltd., Hetero Labs Ltd. For these reasons, the Court holds that Plaintiffs have failed to state a claim with respect to all of the Agreements. Defendants' motion to dismiss the Direct Purchaser and Retailer Plaintiffs' Complaints for failure to state a claim is GRANTED with prejudice. Defendants' motion to dismiss the End-Payor Plaintiffs' Complaint for failure to state a claim is GRANTED with prejudice. Nonresident Defendants' motion to dismiss the End-Payor Plaintiffs' Complaint's non-New York, state law claims for lack of personal jurisdiction and Teva Israel's motion to dismiss for lack of personal jurisdiction are DENIED as moot. The motion of the New Civil Liberties Alliance and the International Center for Law and Economics for leave to file an amicus brief is GRANTED. The Clerk of Court is respectfully directed to close Dkt. Nos. 386, 388, 393, 397, 403. For the reasons explained in an accompanying Order, this Opinion and Order will be filed temporarily under seal until the Court can review any redactions the parties propose. The Clerk of Court is respectfully directed to file this Opinion and Order under seal, viewable only to the Court and the parties to this action. SO ORDERED. (Signed by Judge Lewis J. Liman on 2/21/2023) (va) (Entered: 02/21/2023) |
12/31/2022 | 437 | NOTICE of Withdrawal of Appearance re: 325 Notice of Appearance. Document filed by Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc...(Coster, Abigail) (Entered: 12/31/2022) |
12/9/2022 | 436 | NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a CONFERENCE proceeding held on 11/3/2022 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(McGuirk, Kelly) (Entered: 12/09/2022) |
12/9/2022 | 435 | TRANSCRIPT of Proceedings re: CONFERENCE held on 11/3/2022 before Judge Lewis J. Liman. Court Reporter/Transcriber: Carol Ganley, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 12/30/2022. Redacted Transcript Deadline set for 1/9/2023. Release of Transcript Restriction set for 3/9/2023.Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(McGuirk, Kelly) (Entered: 12/09/2022) |
11/3/2022 | | Minute Entry for proceedings held before Judge Lewis J. Liman: Oral Argument held on 11/3/2022 re: 386 MOTION to Dismiss for Lack of Personal Jurisdiction Under Rule 12(b)(2) filed by Watson Pharma, Inc., Hetero Drugs LTD., Forest Laboratories Holdings Ltd., Allergan, Inc., Allergan USA, Inc., Torrent Pharma Inc., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Glenmark Generics Inc., USA, Watson Laboratories, Inc. (DE), Amerigen Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Actavis Inc., Teva Pharmaceutical Industries Ltd., Forest Laboratories Ireland, Ltd., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Glenmark Pharmaceuticals S.A., Glenmark Generics Ltd., Teva Pharmaceuticals USA, Inc., AbbVie Inc., Hetero USA Inc., Watson Laboratories, Inc. (NV), Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Hetero Labs Ltd, and 388 MOTION to Dismiss the February 2022 Complaints Under Rule 12(b)(2) filed by Teva Pharmaceutical Industries Ltd., and 397 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the End-Payor Plaintiffs' Second Consolidated Amended Complaint filed by Watson Pharma, Inc., Allergan, Inc., Allergan USA, Inc., Torrent Pharma Inc., Glenmark Generics Inc., Indchemie Health Specialties Private Ltd., Glenmark Generics Inc., USA, Amerigen Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals S.A., Actavis, Inc., Glenmark Generics Ltd., Forest Laboratories, LLC, AbbVie Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NV), Hetero USA Inc., Glenmark Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Hetero Drugs LTD., ANI Pharmaceuticals, Inc., Watson Laboratories, Inc. (DE), Allergan Sales LLC, Forest Laboratories Ireland, Ltd., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Inc., Alkem Laboratories Ltd., Hetero Labs Ltd, Forest Laboratories Holdings, Ltd., Watson Pharmaceuticals Inc., and 393 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Third Amended Complaint filed by Watson Pharma, Inc., Allergan, Inc., Allergan USA, Inc., Torrent Pharma Inc., Glenmark Generics Inc., Indchemie Health Specialties Private Ltd., Glenmark Generics Inc., USA, Amerigen Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals S.A., Actavis, Inc., Glenmark Generics Ltd., Forest Laboratories, LLC, Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NV), Hetero USA Inc., Glenmark Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Hetero Drugs LTD., ANI Pharmaceuticals, Inc., Watson Laboratories, Inc. (DE), Allergan Sales, LLC, Amerigen Pharmaceuticals Ltd., Forest Laboratories Ireland, Ltd., Ascend Laboratories, LLC, Abbvie, Inc., Forest Laboratories Inc., Alkem Laboratories Ltd., Hetero Labs Ltd, Forest Laboratories Holdings, Ltd., Watson Pharmaceuticals Inc. Kimberly Hennings present on behalf of the Direct Purchaser Class Plaintiffs. Barry Refsin present on behalf of CVS and Rite Aid Plaintiffs. Robin van der Meulen and Sharon Robertson present on behalf of End-Payor Class Plaintiffs. Eric Grannon, Mark Gidley, Adam Acosta, and Celia McLaughlin present on behalf of Defendants AbbVie, Inc., Allergan Inc., Allergan Sales LLC, Allergan USA, Inc. Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Ireland, LTD., and Watson Pharmaceuticals Inc. Andrew Hatchett present on behalf of Glenmark Defendants. Court reporter present. The Court heard argument from all parties regarding the pending motions to dismiss. Arguments taken under advisement, decisions reserved by the Court. (mf) (Entered: 11/09/2022) |
10/28/2022 | 434 | NOTICE OF APPEARANCE by Bradley J. Demuth on behalf of J M Smith Corporation..(Demuth, Bradley) (Entered: 10/28/2022) |
10/25/2022 | 433 | MEMO ENDORSEMENT on re: 432 Letter,,, filed by Watson Pharma, Inc., Hetero Drugs LTD., Allergan, Inc., Allergan USA, Inc., Torrent Pharma Inc., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Glenmark Generics Inc., USA, Forest Laboratories, Inc., Watson Laboratories, Inc. (DE), Amerigen Pharmaceuticals Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Allergan Sales, LLC, Amerigen Pharmaceuticals Ltd., Forest Laboratories Ireland, Ltd., Ascend Laboratories, LLC, Abbvie, Inc., Actavis, Inc., Glenmark Generics Ltd., Teva Pharmaceuticals USA, Inc., Forest Laboratories, LLC, Watson Laboratories, Inc. (NV), Hetero USA Inc., Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Hetero Labs Ltd, Forest Laboratories Holdings, Ltd. ENDORSEMENT: The proposed agenda submitted by the parties for oral argument on November 3, 2022 at 9:30 a.m. is approved. 10 minutes of the 25 minutes allotted per side for argument on End-Payor Plaintiffs' Second Consolidated Amended Complaint will be dedicated to Nonresident Defendants' Rule 12(b)(2) Motion to Dismiss End-Payor Plaintiffs' Non-New York Claims for Lack of Personal Jurisdiction, Dkt. No. 386. (Signed by Judge Lewis J. Liman on 10/25/2022) (tg) (Entered: 10/25/2022) |
10/24/2022 | 432 | LETTER addressed to Judge Lewis J. Liman re: November 3, 2022 Oral Argument on Motions to Dismiss. Document filed by ANI Pharmaceuticals, Inc., Abbvie, Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings, Ltd., Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc...(Gidley, John) (Entered: 10/24/2022) |
10/13/2022 | 431 | ORDER: On September 30, 2022, the parties submitted a joint letter offering to propose an agenda for the argument on November 3, 2022 regarding the pending motions to dismiss. Dkt. No. 429. The argument, previously scheduled to begin at 11:00 a.m. on November 3, 2022, is rescheduled to take place from 9:30 a.m. to 1:00 p.m. on November 3, 2022, with a short comfort break. The Court believes that the majority of the time (more than 50%) should be devoted to arguments related to Defendants' motions to dismiss the Direct Purchaser and Retailer Plaintiffs Third Amended Complaints. The remaining time should be for argument related to Defendants' motions to dismiss End-Payor Plaintiffs' Second Amended Class Action Complaint. The Court directs the parties to meet and confer and, by October 25, 2022, jointly submit a proposed agenda consistent with this Order and similar in format to that agenda submitted to the Court on December 3, 2021, Dkt. No. 334. SO ORDERED. (Oral Argument set for 11/3/2022 at 09:30 AM before Judge Lewis J. Liman.) (Signed by Judge Lewis J. Liman on 10/13/2022) (mml) (Entered: 10/13/2022) |
10/13/2022 | | ORDER granting re: 430 Letter requesting that Amerigen's counsel be permitted to appear telephonically at the November 3, 2022 hearing filed by Amerigen Pharmaceuticals Ltd., Amerigen Pharmaceuticals Inc. Counsel for Defendants Amerigen Pharmaceuticals Ltd. and Amerigen Pharmaceuticals Inc. are permitted to appear at the November 3, 2022 hearing by telephone. Counsel may access the hearing by dialing into the Court's teleconference line at 888-251-2909 and using access code 2123101. (HEREBY ORDERED by Judge Lewis J. Liman) (Text Only Order) (mf) (Entered: 10/13/2022) |
10/12/2022 | 430 | LETTER addressed to Judge Lewis J. Liman from Tobias Snyder dated October 12, 2022 re: requesting that Amerigen's counsel be permitted to appear telephonically at the November 3, 2022, hearing. Document filed by Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd...(Snyder, Tobias) (Entered: 10/12/2022) |
9/30/2022 | 429 | JOINT LETTER addressed to Judge Lewis J. Liman from Robin A. van der Meulen dated September 30, 2022 re: November 3, 2022 Oral Argument on Motions to Dismiss. Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund..(Van Der Meulen, Robin) (Entered: 09/30/2022) |
9/21/2022 | | Set/Reset Hearings: Oral Argument set for 11/3/2022 at 11:00 AM in Courtroom 15C, 500 Pearl Street, New York, NY 10007 before Judge Lewis J. Liman. (mf) (Entered: 09/21/2022) |
9/21/2022 | | ORDER: The Court will hear oral argument from parties regarding the pending motions to dismiss on November 3, 2022 at 11:00AM. The hearing will be held in-person in Courtroom 15C at the 500 Pearl Street Courthouse. (HEREBY ORDERED by Judge Lewis J. Liman) (Text Only Order) (mf) (Entered: 09/21/2022) |
8/29/2022 | 428 | NOTICE of Withdrawal of Appearance of Monica L. Kiley. Document filed by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,..(Bloom, Eric) (Entered: 08/29/2022) |
8/22/2022 | 427 | THIRD AMENDED COMPLAINT amending 373 Amended Complaint,,,,,,, against ANI Pharmaceuticals, Inc., AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc. with JURY DEMAND.Document filed by J M Smith Corporation, KPH Healthcare Services, Inc.. Related document: 373 Amended Complaint,,,,,,,..(Hennings, Kimberly) (Entered: 08/22/2022) |
8/22/2022 | 426 | SECOND AMENDED COMPLAINT amending 376 Amended Complaint,,,,,,,,,,, against ANI Pharmaceuticals, Inc., AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc. with JURY DEMAND.Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Teamsters Local No. 1150 Prescription Drug Benefit Plan, Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, UFCW Local 1500 Welfare Fund, Teamsters Western Region & Local 177 Health Care Plan. Related document: 376 Amended Complaint,,,,,,,,,,,..(Van Der Meulen, Robin) (Entered: 08/22/2022) |
8/15/2022 | | Set/Reset Deadlines: Amended Pleadings due by 8/22/2022. Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL(ate) (Entered: 08/15/2022) |
8/15/2022 | 425 | ORDER denying (371) Letter Motion to Seal; denying (372) Letter Motion to Seal; denying (374) Letter Motion to Seal; denying (375) Letter Motion to Seal; granting (383) Letter Motion to Seal in case 1:20-cv-05735-LJL. This Order addresses several pending motions to seal in this case. The Court's decisions on these motions are without prejudice to the Courts unsealing either on motion or sua sponte. The motions at Dkt. Nos. 371, 372, 374, and 375 are DENIED. The motion at Dkt. No. 383 is GRANTED. Direct Purchaser Plaintiffs shall file a partially redacted Third Consolidated Amended Class Action Complaint consistent with the redactions at Dkt. Nos. 383-2, 384-2. End-Payor Plaintiffs shall file a partially redacted Second Consolidated Amended Class Action Complaint consistent with the redactions at Dkt. Nos. 383-3, 384-3. Plaintiffs in the Walgreen Action shall file on the docket of the Walgreen Action a partially redacted Third Amended Complaint consistent with the redactions at Dkt. Nos. 383-4, 384-4. Plaintiffs in the CVS Action shall file on the docket of the CVS Action a partially redacted Third Amended Complaint consistent with the redactions at Dkt. Nos. 383-1, 384-1. All filings shall be made in the form directed by this Order on the respective dockets by August 22, 2022. The Clerk of Court is respectfully directed to close the motions at Dkt. Nos. 371, 372, 374, 375, and 383. The Clerk of Court is also respectfully directed to close Dkt. Nos. 42 and 44 in the Walgreen Action (20-cv-9793) and Dkt. No. 40 in the CVS Action (20-cv-10087).. (Signed by Judge Lewis J. Liman on 8/15/2022) Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL (ate) (Entered: 08/15/2022) |
7/8/2022 | 424 | ***SELECTED PARTIES*** LETTER addressed to Judge Lewis J. Liman from Celia A. McLaughlin dated July 8, 2022 Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Rite Aid Corporation, Allergan Sales LLC, Law Enforcement Health Benefits, Inc., Hetero USA Inc., Teamsters Local No. 1150 Prescription Drug Benefit Plan, J M Smith Corporation, Glenmark Generics Inc., USA, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Actavis Inc., Allergan, Inc., Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Mayor and City Council of Baltimore, Walgreen Co., Amerigen Pharmaceuticals Ltd., ANI Pharmaceuticals, Inc., H-E-B L.P., Indchemie Health Specialties Private Ltd., Rite Aid Hdqtrs. Corp.,, UFCW Local 1500 Welfare Fund, Allergan USA, Inc., Ascend Laboratories, LLC, Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NY), Watson Laboratories, Inc. (DE), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Amerigen Pharmaceuticals Inc., KPH Healthcare Services, Inc., Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, LLC, Forest Laboratories, Inc., Teamsters Western Region & Local 177 Health Care Plan, Hetero Labs Ltd, Glenmark Pharmaceuticals Ltd., The Kroger Co., ALBERTSONS COMPANIES, INC., Hetero Drugs LTD., Forest Laboratories Holdings Ltd., CVS Pharmacy, Inc., Abbvie, Inc., Actavis, Inc., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC. (Attachments: # 1 Exhibit - Under-Seal Highlighted Version of Reply Memorandum of Law in Support of Defendants' Motion to Dismiss Direct Purchaser and Retailer Plaintiffs' Third Amended Complaints)Motion or Order to File Under Seal: 423 .(McLaughlin, Celia) (Entered: 07/08/2022) |
7/8/2022 | 423 | LETTER MOTION to Seal addressed to Judge Lewis J. Liman from Celia A. McLaughlin dated July 8, 2022. Document filed by AbbVie Inc., Actavis Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit - Public Redacted Version of Reply Memorandum of Law in Support of Defendants' Motion to Dismiss Direct Purchaser and Retailer Plaintiffs' Third Amended Complaints).(McLaughlin, Celia) (Entered: 07/08/2022) |
6/24/2022 | 422 | ***SELECTED PARTIES*** REPLY MEMORANDUM OF LAW in Support re: 393 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Third Amended Complaint. . Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Allergan Sales LLC, Actavis, Inc., Hetero USA Inc., Glenmark Generics Inc., USA, Watson Laboratories, Inc. (NV), Allergan, Inc., Amerigen Pharmaceuticals Ltd., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Allergan USA, Inc., Ascend Laboratories, LLC, Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NY), Watson Laboratories, Inc. (DE), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Glenmark Generics Ltd., Amerigen Pharmaceuticals Inc., Watson Laboratories, Inc. (CT), Glenmark Pharmaceuticals S.A., Forest Laboratories, LLC, Torrent Pharma Inc., Forest Laboratories Inc., Hetero Labs Ltd, Glenmark Pharmaceuticals Ltd., Hetero Drugs LTD., Forest Laboratories Holdings Ltd., ALBERTSONS COMPANIES, INC., Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., H-E-B L.P., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, The Kroger Co., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Walgreen Co.. Motion or Order to File Under Seal: 421 .(Gidley, John) (Entered: 06/24/2022) |
6/24/2022 | 421 | LETTER MOTION to Seal addressed to Judge Lewis J. Liman from J. Mark Gidley dated June 24, 2022. Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 06/24/2022) |
6/24/2022 | 420 | REPLY MEMORANDUM OF LAW in Support re: 397 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the End-Payor Plaintiffs' Second Consolidated Amended Complaint. . Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 06/24/2022) |
6/24/2022 | 419 | REPLY MEMORANDUM OF LAW in Support re: 388 MOTION to Dismiss the February 2022 Complaints Under Rule 12(b)(2). . Document filed by Teva Pharmaceutical Industries Ltd...(Holding, Christopher) (Entered: 06/24/2022) |
6/24/2022 | 418 | REPLY MEMORANDUM OF LAW in Support re: 386 MOTION to Dismiss for Lack of Personal Jurisdiction Under Rule 12(b)(2). . Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis Inc., Alkem Laboratories Ltd., Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Ireland, LTD, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Bonder, Teresa) (Entered: 06/24/2022) |
6/7/2022 | 417 | LETTER MOTION to Seal Exhibits A through G to the Evans Declaration addressed to Judge Lewis J. Liman from Teresa Bonder dated June 7, 2022. Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Bonder, Teresa) (Entered: 06/07/2022) |
6/6/2022 | 416 | ***SELECTED PARTIES*** LETTER addressed to Judge Lewis J. Liman from Celia McLaughlin dated June 6, 2022 re: Letter Motion for Approval to Seal. Document filed by AbbVie Inc., Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Rite Aid Corporation, Allergan Sales LLC, Law Enforcement Health Benefits, Inc., Hetero USA Inc., Teamsters Local No. 1150 Prescription Drug Benefit Plan, J M Smith Corporation, Glenmark Generics Inc., USA, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Actavis Inc., Allergan, Inc., Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Mayor and City Council of Baltimore, Walgreen Co., Amerigen Pharmaceuticals Ltd., ANI Pharmaceuticals, Inc., H-E-B L.P., Indchemie Health Specialties Private Ltd., Rite Aid Hdqtrs. Corp.,, UFCW Local 1500 Welfare Fund, Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Amerigen Pharmaceuticals Inc., KPH Healthcare Services, Inc., Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, LLC, Forest Laboratories Inc., Teamsters Western Region & Local 177 Health Care Plan, Hetero Labs Ltd, Forest Laboratories Ireland, LTD, Glenmark Pharmaceuticals Ltd., The Kroger Co., ALBERTSONS COMPANIES, INC., Hetero Drugs LTD., Forest Laboratories Holdings Ltd., CVS Pharmacy, Inc., Abbvie, Inc., Actavis, Inc., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC. (Attachments: # 1 Exhibit Highlighted Under-Seal Version of Memorandum of Law in Opposition to Defendants' Motion to Dismiss Direct Purchaser and Retailer Plaintiffs' Third Amended Complaints)Motion or Order to File Under Seal: 415 .(McLaughlin, Celia) (Entered: 06/06/2022) |
6/6/2022 | 415 | LETTER MOTION to Seal addressed to Judge Lewis J. Liman from Celia McLaughlin dated June 6, 2022. Document filed by AbbVie Inc., Actavis Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit Proposed Public Redacted Version of Memorandum of Law in Opposition to Defendants' Motion to Dismiss Direct Purchaser and Retailer Plaintiffs' Third Amended Complaints).(McLaughlin, Celia) (Entered: 06/06/2022) |
5/23/2022 | 414 | MEMORANDUM OF LAW in Opposition re: 386 MOTION to Dismiss for Lack of Personal Jurisdiction Under Rule 12(b)(2). (Filed Under Seal). Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund. (Attachments: # 1 Exhibit Declaration of Donna M. Evans - Filed Under Seal, # 2 Exhibit A - Filed Under Seal, # 3 Exhibit B - Filed Under Seal, # 4 Exhibit C - Filed Under Seal, # 5 Exhibit D - Filed Under Seal, # 6 Exhibit E - Filed Under Seal, # 7 Exhibit F - Filed Under Seal, # 8 Exhibit G - Filed Under Seal, # 9 Exhibit H, # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M).(Robertson, Sharon) (Entered: 05/23/2022) |
5/23/2022 | 413 | MEMORANDUM OF LAW in Opposition re: 388 MOTION to Dismiss the February 2022 Complaints Under Rule 12(b)(2). . Document filed by ALBERTSONS COMPANIES, INC., CVS Pharmacy, Inc., Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, H-E-B L.P., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, The Kroger Co., UFCW Local 1500 Welfare Fund, Walgreen Co...(Hennings, Kimberly) (Entered: 05/23/2022) |
5/23/2022 | 412 | ***SELECTED PARTIES*** MEMORANDUM OF LAW in Opposition re: 386 MOTION to Dismiss for Lack of Personal Jurisdiction Under Rule 12(b)(2). . Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Teamsters Local No. 1150 Prescription Drug Benefit Plan, Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, UFCW Local 1500 Welfare Fund, Teamsters Western Region & Local 177 Health Care Plan, ALBERTSONS COMPANIES, INC., ANI Pharmaceuticals, Inc., AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, CVS Pharmacy, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., H-E-B L.P., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., International Center for Law & Economics, J M Smith Corporation, KPH Healthcare Services, Inc., New Civil Liberties Alliance, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., The Kroger Co., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Walgreen Co., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit Declaration of Donna M. Evans, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M)Motion or Order to File Under Seal: 407 .(Robertson, Sharon) (Entered: 05/23/2022) |
5/23/2022 | 411 | MEMORANDUM OF LAW in Opposition re: 397 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the End-Payor Plaintiffs' Second Consolidated Amended Complaint. . Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund..(Van Der Meulen, Robin) (Entered: 05/23/2022) |
5/23/2022 | 410 | LETTER MOTION to Seal Opposition to Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Third Amended Complaints addressed to Judge Lewis J. Liman from Kimberly Hennings dated 05/23/2022. Document filed by CVS Pharmacy, Inc., J M Smith Corporation, KPH Healthcare Services, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, The Kroger Co., Walgreen Co...(Hennings, Kimberly) (Entered: 05/23/2022) |
5/23/2022 | 409 | ***SELECTED PARTIES*** MEMORANDUM OF LAW in Opposition re: 393 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Third Amended Complaint. . Document filed by Rite Aid Corporation, J M Smith Corporation, Walgreen Co., Rite Aid Hdqtrs. Corp.,, KPH Healthcare Services, Inc., The Kroger Co., CVS Pharmacy, Inc., ALBERTSONS COMPANIES, INC., ANI Pharmaceuticals, Inc., AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., H-E-B L.P., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. Motion or Order to File Under Seal: 408 .(Hennings, Kimberly) (Entered: 05/23/2022) |
5/23/2022 | 408 | FILING ERROR - DEFICIENT DOCKET ENTRY - (SEE DOCUMENT#410) LETTER MOTION to Seal Opposition to Defendants' Motion to Dismiss Direct Purchaser and Retailer Plaintiffs' Third Amended Complaints addressed to Judge Lewis J. Liman from Kimberly Hennings dated 05/23/2022. Document filed by CVS Pharmacy, Inc., J M Smith Corporation, KPH Healthcare Services, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, The Kroger Co., Walgreen Co...(Hennings, Kimberly) Modified on 5/24/2022 (lb). (Entered: 05/23/2022) |
5/23/2022 | 407 | LETTER MOTION to Seal End-Payor Plaintiffs Opposition to Nonresident Defendants Rule 12(b)(2) Motion to Dismiss End-Payor Plaintiffs Non-New York Claims for Lack of Personal Jurisdiction, Declaration of Donna M. Evans and Exhibits A through G addressed to Judge Lewis J. Liman from Sharon K. Robertson and Robin A. van der Meulen dated May 23, 2022. Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund..(Robertson, Sharon) (Entered: 05/23/2022) |
5/6/2022 | 406 | NOTICE OF CHANGE OF ADDRESS by Todd Seaver on behalf of Teamsters Western Region & Local 177 Health Care Plan. New Address: Berman Tabacco, 425 California Street, Suite 2300, San Francisco, CA, USA 94104, (415) 433-3200..(Seaver, Todd) (Entered: 05/06/2022) |
5/5/2022 | 405 | BRIEF re: 403 MOTION to File Amicus Brief . Proposed Amicus Brief. Document filed by International Center for Law & Economics, New Civil Liberties Alliance..(Little, Margaret) (Entered: 05/05/2022) |
5/5/2022 | 404 | AFFIRMATION of Margaret A. Little in Support re: 403 MOTION to File Amicus Brief .. Document filed by International Center for Law & Economics, New Civil Liberties Alliance..(Little, Margaret) (Entered: 05/05/2022) |
5/5/2022 | 403 | MOTION to File Amicus Brief . Document filed by International Center for Law & Economics, New Civil Liberties Alliance..(Little, Margaret) (Entered: 05/05/2022) |
5/3/2022 | | ***NOTICE TO ATTORNEY TO RE-FILE DOCUMENT - DEFICIENT DOCKET ENTRY ERROR. Notice to Attorney Margaret Little to RE-FILE Document 400 MOTION for Leave to File Amicus Curiae Brief .. ERROR(S): Supporting Documents are filed separately, each receiving their own document #. (Supporting Documents are found under the Event Type Affirmation in Support of Motion found under the Event List - Replies, Opposition and Supporting Documents. (kj) (Entered: 05/05/2022) |
5/3/2022 | 402 | ***SELECTED PARTIES*** LETTER addressed to Judge Lewis J. Liman from Celia A. McLaughlin dated May 3, 2022 re: Letter Motion for Approval to File Under Seal. Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Forest Laboratories Holdings, Ltd., Actavis, Inc., Watson Pharmaceuticals Inc., Forest Laboratories, Inc., Allergan USA, Inc., Allergan Sales, LLC, Allergan, Inc., Forest Laboratories, LLC, ALBERTSONS COMPANIES, INC., ANI Pharmaceuticals, Inc., Abbvie, Inc., Actavis Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, CVS Pharmacy, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., H-E-B L.P., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., The Kroger Co., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Walgreen Co., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc.. (Attachments: # 1 Exhibit Under-Seal Highlighted Version of Memorandum of in Support of Defendants' Motion to Dismiss Direct Purchaser and Retailer Plaintiffs' Third Amended Complaints, # 2 Exhibit Under-Seal Highlighted Appendix)Motion or Order to File Under Seal: 401 .(McLaughlin, Celia) (Entered: 05/03/2022) |
5/3/2022 | 401 | LETTER MOTION to Seal addressed to Judge Lewis J. Liman from Celia A. McLaughlin dated May 3, 2022. Document filed by AbbVie Inc., Actavis Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit Proposed Public Redacted Version of Memorandum of Law in Support of Defendants' Motion to Dismiss Direct Purchaser and Retailer Plaintiffs' Third Amended Complaint, # 2 Exhibit Proposed Public Redacted Version Appendix).(McLaughlin, Celia) (Entered: 05/03/2022) |
5/3/2022 | 400 | FILING ERROR - DEFICIENT DOCKET ENTRY - (SEE #403) MOTION for Leave to File Amicus Curiae Brief . Document filed by International Center for Law & Economics, New Civil Liberties Alliance. (Attachments: # 1 Exhibit Affirmation of Little ISO Amicus, # 2 Exhibit Amicus Brief).(Little, Margaret) Modified on 5/5/2022 (kj). Modified on 5/6/2022 (kj). (Entered: 05/03/2022) |
4/26/2022 | 399 | FILING ERROR - DEFICIENT DOCKET ENTRY - FILER ERROR - Amicus Curiae APPEARANCE entered by Margaret A Little on behalf of New Civil Liberties Alliance, International Center for Law & Economics. (Attachments: # 1 Affirmation of Little ISO Amicus, # 2 Amicus Brief).(Little, Margaret) Modified on 5/5/2022 (kj). Modified on 5/5/2022 (kj). (Entered: 04/26/2022) |
4/19/2022 | 398 | MEMORANDUM OF LAW in Support re: 397 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the End-Payor Plaintiffs' Second Consolidated Amended Complaint. . Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Appendix A, # 2 Appendix B).(Gidley, John) (Entered: 04/19/2022) |
4/19/2022 | 397 | MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the End-Payor Plaintiffs' Second Consolidated Amended Complaint. Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order).(Gidley, John) (Entered: 04/19/2022) |
4/19/2022 | 396 | DECLARATION of Peter J. Carney in Support re: 393 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Third Amended Complaint.. Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 23).(Carney, Peter) (Entered: 04/19/2022) |
4/19/2022 | 395 | ***SELECTED PARTIES*** MEMORANDUM OF LAW in Support re: 393 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Third Amended Complaint. . Document filed by Forest Laboratories Ireland, Ltd., Allergan Sales LLC, Actavis, Inc., Hetero USA Inc., Glenmark Generics Inc., USA, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Amerigen Pharmaceuticals Ltd., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Abbvie, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Glenmark Generics Ltd., Torrent Pharmaceuticals Ltd., Amerigen Pharmaceuticals Inc., Watson Laboratories, Inc. (CT), Glenmark Pharmaceuticals S.A., Forest Laboratories, LLC, Torrent Pharma Inc., Forest Laboratories Inc., Allergan USA, Inc., Allergan Sales, LLC, Allergan, Inc., Hetero Labs Ltd, Glenmark Pharmaceuticals Ltd., Hetero Drugs LTD., Forest Laboratories Holdings Ltd., ALBERTSONS COMPANIES, INC., AbbVie Inc., Actavis Inc., Allergan USA, Inc., Allergan, Inc., CVS Pharmacy, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories Ireland, LTD, Forest Laboratories, Inc., Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, H-E-B L.P., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, The Kroger Co., UFCW Local 1500 Welfare Fund, Walgreen Co.. (Attachments: # 1 Appendix)Motion or Order to File Under Seal: 394 .(Gidley, John) (Entered: 04/19/2022) |
4/19/2022 | 394 | LETTER MOTION to Seal addressed to Judge Lewis J. Liman from J. Mark Gidley dated April 19, 2022. Document filed by ANI Pharmaceuticals, Inc., Abbvie, Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 04/19/2022) |
4/19/2022 | 393 | MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Third Amended Complaint. Document filed by ANI Pharmaceuticals, Inc., Abbvie, Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order).(Gidley, John) (Entered: 04/19/2022) |
4/19/2022 | 392 | ***SELECTED PARTIES***NOTICE of Exhibit C of Shanahan Declaration. Document filed by Teva Pharmaceutical Industries Ltd., ALBERTSONS COMPANIES, INC., ANI Pharmaceuticals, Inc., AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, CVS Pharmacy, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., H-E-B L.P., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, Teva Pharmaceuticals USA, Inc., The Kroger Co., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Walgreen Co., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. Motion or Order to File Under Seal: 391 .(Holding, Christopher) (Entered: 04/19/2022) |
4/19/2022 | 391 | LETTER MOTION to Seal Exhibit C to the Shanahan Declaration addressed to Judge Lewis J. Liman from Christopher T. Holding dated April 19, 2022. Document filed by Teva Pharmaceutical Industries Ltd...(Holding, Christopher) (Entered: 04/19/2022) |
4/19/2022 | 390 | DECLARATION of Brian Shanahan in Support re: 388 MOTION to Dismiss the February 2022 Complaints Under Rule 12(b)(2).. Document filed by Teva Pharmaceutical Industries Ltd.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C).(Holding, Christopher) (Entered: 04/19/2022) |
4/19/2022 | 389 | MEMORANDUM OF LAW in Support re: 388 MOTION to Dismiss the February 2022 Complaints Under Rule 12(b)(2). . Document filed by Teva Pharmaceutical Industries Ltd.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2).(Holding, Christopher) (Entered: 04/19/2022) |
4/19/2022 | 388 | MOTION to Dismiss the February 2022 Complaints Under Rule 12(b)(2). Document filed by Teva Pharmaceutical Industries Ltd...(Holding, Christopher) (Entered: 04/19/2022) |
4/19/2022 | 387 | MEMORANDUM OF LAW in Support re: 386 MOTION to Dismiss for Lack of Personal Jurisdiction Under Rule 12(b)(2). . Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis Inc., Alkem Laboratories Ltd., Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Ireland, LTD, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Bonder, Teresa) (Entered: 04/19/2022) |
4/19/2022 | 386 | MOTION to Dismiss for Lack of Personal Jurisdiction Under Rule 12(b)(2). Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis Inc., Alkem Laboratories Ltd., Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Ireland, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Pharma, Inc...(Bonder, Teresa) (Entered: 04/19/2022) |
3/30/2022 | | ORDER: The Telephonic Case Management Conference scheduled for March 31, 2022 at 4:00PM is CANCELLED. (HEREBY ORDERED by Judge Lewis J. Liman) (Text Only Order) (mf) (Entered: 03/30/2022) |
3/10/2022 | 385 | ORDER GRANTING END-PAYOR PLAINTIFFS' INTERIM CO-LEAD COUNSEL'S MOTION TO AMEND OPINION AND ORDER granting (382) Motion to Amend/Correct (382 in 1:20-cv-05735-LJL) MOTION to Amend/Correct Opinion and Order in case 1:20-cv-05735-LJL. Having considered End-Payor Plaintiffs' Interim Co-Lead Counsel's ("Counsel") Motion for an Order amending the Court's Opinion and Order appointing leadership of the End-Payor Class ("Leadership Order") to substitute DiCello Levitt Gutzler for Labaton Sucharow LLP as the firm affiliated with Robin van der Meulen, IT IS HEREBY ORDERED, ADJUDGED AND DECREED that Counsel's Motion for an Order amending the Court's Leadership Order is granted, and DiCello Levitt Gutzler shall be substituted for Labaton Sucharow LLP as the firm affiliation of Robin van der Meulen in this Action. The Clerk of Court is respectfully directed to close Dkt. No. 382. IT IS SO ORDERED. (Signed by Judge Lewis J. Liman on 3/10/2022) Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL (va) (Entered: 03/11/2022) |
3/8/2022 | 384 | ***SELECTED PARTIES*** LETTER addressed to Judge Lewis J. Liman from Celia A. McLaughlin dated March 8, 2022 re: Letter Motion for Approval to File Under Seal. Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Allergan Sales LLC, Actavis Inc., Allergan, Inc., Allergan USA, Inc., Watson Pharmaceuticals Inc., Forest Laboratories, LLC, Forest Laboratories Inc., Forest Laboratories Holdings Ltd., ALBERTSONS COMPANIES, INC., ANI Pharmaceuticals, Inc., Abbvie, Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, CVS Pharmacy, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories Ireland, LTD, Forest Laboratories, Inc., Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., H-E-B L.P., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., The Kroger Co., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Walgreen Co., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc.. (Attachments: # 1 Under-Seal Highlighted Version of CVS and Rite Aid Plaintiffs' Third Amended Complaint and Demand for Jury Trial, # 2 Under-Seal Highlighted Version of Direct Purchaser Plaintiffs Third Consolidated and Amended Class Action Complaint, # 3 Under-Seal Highlighted Version of End-Payor Plaintiffs Second Consolidated Amended Class Action Complaint and Jury Demand, # 4 Under-Seal Highlighted Version of Walgreen Plaintiffs' Third Amended Complaint and Demand for Jury Trial)Motion or Order to File Under Seal: 383 .(McLaughlin, Celia) (Entered: 03/08/2022) |
3/8/2022 | 383 | LETTER MOTION to Seal addressed to Judge Lewis J. Liman from Celia A. McLaughlin dated March 8, 2022. Document filed by AbbVie Inc., Actavis Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc.. (Attachments: # 1 CVS and Rite Aid Plaintiffs' Third Amended Complaint and Demand for Jury Trial, # 2 Direct Purchaser Plaintiffs' Third Consolidated and Amended Class Action Complaint, # 3 End-Payor Plaintiffs' Second Consolidated Amended Class Action Complaint and Jury Demand, # 4 Walgreen Plaintiffs' Third Amended Complaint and Demand for Jury Trial).(McLaughlin, Celia) (Entered: 03/08/2022) |
3/7/2022 | 382 | MOTION to Amend/Correct Opinion and Order. Document filed by UFCW Local 1500 Welfare Fund. (Attachments: # 1 Text of Proposed Order)Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(Van Der Meulen, Robin) (Entered: 03/07/2022) |
3/7/2022 | 381 | JOINT STIPULATED SCHEDULING ORDER NO. 4: NOW, THEREFORE, THE PARTIES HEREBY STIPULATE AND AGREE TO THE FOLLOWING SCHEDULE: Defendants file Motion(s) to Dismiss the Amended Complaints due April 19, 2022; Plaintiffs file Opposition(s) to Motion(s) to Dismiss due May 23, 2022; Defendants file Repl(ies) in further support of Motion(s) to Dismiss due June 24, 2022. For the renewed motions, the parties have agreed to a minor revision of the page limits that applied to the motions previously considered by the Court, but the aggregate page count will be the same. IT IS SO ORDERED. ( Motions due by 4/19/2022., Responses due by 5/23/2022, Replies due by 6/24/2022.) (Signed by Judge Lewis J. Liman on 3/7/2022) (vfr) (Entered: 03/07/2022) |
3/4/2022 | 380 | JOINT LETTER addressed to Judge Lewis J. Liman from J. Mark Gidley dated March 4, 2022 re: Motion to Dismiss Briefing Schedule. Document filed by Abbvie, Inc., Actavis Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A - Joint [Proposed] Stipulated Scheduling Order No. 4).(Gidley, John) (Entered: 03/04/2022) |
3/2/2022 | 379 | NOTICE OF CHANGE OF ADDRESS by Ahmed M.T. Riaz on behalf of Alkem Laboratories Ltd., Ascend Laboratories, LLC, Indchemie Health Specialties Private Ltd.. New Address: ArentFox Schiff LLP, 1185 Avenue of the Americas, Suite No. 3000, New York, New York, United States 10036, 212 753-5000. Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08756-LJL.(Riaz, Ahmed) (Entered: 03/02/2022) |
2/24/2022 | | Set/Reset Hearings: Case Management Conference set for 3/31/2022 at 04:00 PM before Judge Lewis J. Liman. (mf) (Entered: 02/24/2022) |
2/24/2022 | 378 | ORDER. A telephonic case management conference is scheduled for March 31, 2022 at 4:00 p.m. Parties are directed to dial into the Court's teleconference line at 888-251-2909 and use access code 2123101. At the conference, the Court will address how the case is to proceed after Defendants have either answered or otherwise responded to the complaints. The Court will also review its Individual Practices regarding filing documents under seal or with redactions. To be approved, redactions must be narrowly tailored to serve whatever purpose justifies them and otherwise consistent with the presumption in favor of public access to judicial documents. See, e.g., Lugosch v. Pyramid Co. of Onondaga, 435 F.3d 110, 119-20 (2d Cir. 2006). (HEREBY ORDERED by Judge Lewis J. Liman) (Text Only Order) (kc) (Entered: 02/24/2022) |
2/24/2022 | 377 | ORDER granting 370 Motion to Withdraw as Attorney. Attorney Jessica B. Weiner terminated (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (kc) (Entered: 02/24/2022) |
2/22/2022 | 376 | ***SELECTED PARTIES***SECOND AMENDED COMPLAINT amending 251 Amended Complaint,,,,,,,,,,, against Forest Laboratories Ireland, Ltd., AbbVie Inc., Forest Laboratories Holdings, Ltd., Allergan Sales LLC, Actavis, Inc., Hetero USA Inc., Glenmark Generics Inc., USA, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Allergan, Inc., Actavis Inc., Amerigen Pharmaceuticals Ltd., Indchemie Health Specialties Private Ltd., Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Abbvie, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Amerigen Pharmaceuticals Inc., Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, LLC, Forest Laboratories Inc., Forest Laboratories, Inc., Allergan USA, Inc., Hetero Labs Ltd, Allergan Sales, LLC, Allergan, Inc., Glenmark Pharmaceuticals Ltd., Forest Laboratories Ireland, LTD, Hetero Drugs LTD., Forest Laboratories, LLC, Forest Laboratories Holdings Ltd. with JURY DEMAND.Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Forest Laboratories Holdings, Ltd., Allergan Sales LLC, Actavis, Inc., Hetero USA Inc., Law Enforcement Health Benefits, Inc., Glenmark Generics Inc., USA, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Allergan, Inc., Actavis Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Amerigen Pharmaceuticals Ltd., Indchemie Health Specialties Private Ltd., UFCW Local 1500 Welfare Fund, Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Abbvie, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Amerigen Pharmaceuticals Inc., Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, LLC, Forest Laboratories Inc., Forest Laboratories, Inc., Teamsters Western Region & Local 177 Health Care Plan, Allergan USA, Inc., Hetero Labs Ltd, Allergan Sales, LLC, Allergan, Inc., Glenmark Pharmaceuticals Ltd., Forest Laboratories Ireland, LTD, Hetero Drugs LTD., Forest Laboratories, LLC, Forest Laboratories Holdings Ltd., ALBERTSONS COMPANIES, INC., ANI Pharmaceuticals, Inc., CVS Pharmacy, Inc., H-E-B L.P., J M Smith Corporation, KPH Healthcare Services, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, The Kroger Co., Walgreen Co.. Related document: 251 Amended Complaint,,,,,,,,,,,.Motion or Order to File Under Seal: 375 .(Van Der Meulen, Robin) (Entered: 02/22/2022) |
2/22/2022 | 375 | LETTER MOTION to Seal EPP's Second Consolidated Amended Class Action Complaint addressed to Judge Lewis J. Liman from Robin A. van der Meulen and Sharon K. Robertson dated February 22, 2022. Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund..(Van Der Meulen, Robin) (Entered: 02/22/2022) |
2/22/2022 | 374 | LETTER MOTION to Seal addressed to Judge Lewis J. Liman from Barry L. Refsin dated 02/22/2022. Document filed by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,..(Refsin, Barry) (Entered: 02/22/2022) |
2/22/2022 | 373 | ***SELECTED PARTIES***THIRD AMENDED COMPLAINT amending 250 Amended Complaint,,,,,,,,,, against All Defendants with JURY DEMAND.Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Forest Laboratories Holdings, Ltd., Allergan Sales LLC, Actavis, Inc., Hetero USA Inc., Glenmark Generics Inc., USA, J M Smith Corporation, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Allergan, Inc., Actavis Inc., Amerigen Pharmaceuticals Ltd., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Abbvie, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Amerigen Pharmaceuticals Inc., KPH Healthcare Services, Inc., Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, LLC, Forest Laboratories Inc., Forest Laboratories, Inc., Allergan USA, Inc., Allergan, Inc., Allergan Sales, LLC, Hetero Labs Ltd, Forest Laboratories Ireland, LTD, Glenmark Pharmaceuticals Ltd., Hetero Drugs LTD., Forest Laboratories, LLC, Forest Laboratories Holdings Ltd., ALBERTSONS COMPANIES, INC., CVS Pharmacy, Inc., Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, H-E-B L.P., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, The Kroger Co., UFCW Local 1500 Welfare Fund, Walgreen Co.. Related document: 250 Amended Complaint,,,,,,,,,,.Motion or Order to File Under Seal: 372 .(Hennings, Kimberly) (Entered: 02/22/2022) |
2/22/2022 | 372 | LETTER MOTION to Seal Direct Purchaser Class Plaintiffs' Third Consolidated and Amended Class Action Complaint addressed to Judge Lewis J. Liman from Kimberly M. Hennings dated 2/22/2022. Document filed by J M Smith Corporation, KPH Healthcare Services, Inc...(Hennings, Kimberly) (Entered: 02/22/2022) |
2/22/2022 | 371 | LETTER MOTION to Seal addressed to Judge Lewis J. Liman from Scott E. Perwin dated 02/22/2022. Document filed by ALBERTSONS COMPANIES, INC., H-E-B L.P., The Kroger Co., Walgreen Co...(Perwin, Scott) (Entered: 02/22/2022) |
2/18/2022 | 370 | MOTION for Jessica Weiner to Withdraw as Attorney . Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund..(Robertson, Sharon) (Entered: 02/18/2022) |
2/16/2022 | 369 | NOTICE OF APPEARANCE by Deborah A. Elman on behalf of J M Smith Corporation..(Elman, Deborah) (Entered: 02/16/2022) |
2/16/2022 | 368 | MEMORANDUM OF LAW in Opposition re: 265 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2). . Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund. (Attachments: # 1 Declaration of Donna M. Evans, # 2 Exhibit A - Filed Under Seal, # 3 Exhibit B - Filed Under Seal, # 4 Exhibit C - Filed Under Seal, # 5 Exhibit D - Filed Under Seal, # 6 Exhibit E - Filed Under Seal, # 7 Exhibit F - Filed Under Seal, # 8 Exhibit G - Filed Under Seal, # 9 Exhibit H, # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M).(Robertson, Sharon) (Entered: 02/16/2022) |
2/10/2022 | 367 | ORDER granting 359 Letter Motion to Seal; granting 362 Letter Motion to Seal. This Order addresses two sealing motions on the docket that were filed in response to the Court's Order at Dkt. No. 355. The motion at Dkt. No. 359 is granted. The motion at Dkt. No. 362 is granted. By February 17, 2022, End-Payor Plaintiffs are ordered to file on the public docket their Opposition to Certain Defendants' Rule 12(b)(2) Motion to Dismiss for Lack of Personal Jurisdiction (as filed under seal at Dkt. No. 281), the Declaration of Donna M. Evans (as filed under seal at Dkt. No. 281-1), and Exhibits A-M, with Exhibits A-G remaining under seal. The Clerk of Court is respectfully directed to close Dkt. Nos. 359 and 362. SO ORDERED. (Signed by Judge Lewis J. Liman on 2/10/2022) (vfr) (Entered: 02/10/2022) |
2/10/2022 | 366 | ORDER granting 356 Motion to Withdraw as Attorney. Attorney Elyse D. Echtman terminated (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (kc) (Entered: 02/10/2022) |
2/9/2022 | 365 | REPLY MEMORANDUM OF LAW in Support re: 267 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints. [Public Version]. Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Ascend Laboratories, LLC, Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 02/09/2022) |
2/9/2022 | 364 | DECLARATION of Peter J. Carney [Public Version] in Support re: 267 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints.. Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19).(Carney, Peter) (Entered: 02/09/2022) |
2/9/2022 | 363 | MEMORANDUM OF LAW in Support re: 267 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints. [Public Version]. Document filed by ANI Pharmaceuticals, Inc., Abbvie, Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Ascend Laboratories, LLC, Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 02/09/2022) |
2/9/2022 | 362 | LETTER MOTION to Seal /Unseal addressed to Judge Lewis J. Liman from Sharon K. Robertson & Robin A. van der Meulen dated 2/09/2022. Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund..(Robertson, Sharon) (Entered: 02/09/2022) |
2/9/2022 | 361 | ***SELECTED PARTIES*** MEMORANDUM OF LAW in Opposition re: 359 LETTER MOTION to Seal Redact addressed to Judge Lewis J. Liman from Kimberly Hennings dated 02/09/2022. . Document filed by J M Smith Corporation, ALBERTSONS COMPANIES, INC., ANI Pharmaceuticals, Inc., AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, CVS Pharmacy, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., H-E-B L.P., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., The Kroger Co., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Walgreen Co., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. Motion or Order to File Under Seal: 359 .(Hennings, Kimberly) (Entered: 02/09/2022) |
2/9/2022 | 360 | MEMORANDUM OF LAW in Opposition re: 359 LETTER MOTION to Seal Redact addressed to Judge Lewis J. Liman from Kimberly Hennings dated 02/09/2022. . Document filed by J M Smith Corporation..(Hennings, Kimberly) (Entered: 02/09/2022) |
2/9/2022 | 359 | LETTER MOTION to Seal Redact addressed to Judge Lewis J. Liman from Kimberly Hennings dated 02/09/2022. Document filed by J M Smith Corporation..(Hennings, Kimberly) (Entered: 02/09/2022) |
2/7/2022 | 358 | NOTICE OF APPEARANCE by Eileen Marie Cole on behalf of ANI Pharmaceuticals, Inc...(Cole, Eileen) (Entered: 02/07/2022) |
2/7/2022 | 357 | DECLARATION of James J. Tierney in Support re: 356 MOTION for Elyse D. Echtman to Withdraw as Attorney .. Document filed by ANI Pharmaceuticals, Inc...(Tierney, James) (Entered: 02/07/2022) |
2/7/2022 | 356 | MOTION for Elyse D. Echtman to Withdraw as Attorney . Document filed by ANI Pharmaceuticals, Inc.. (Attachments: # 1 Certificate of Service).(Tierney, James) (Entered: 02/07/2022) |
2/2/2022 | 355 | ORDER: granting 263 Letter Motion to Seal; denying 268 Letter Motion to Seal; granting 273 Letter Motion to Seal; denying 279 Letter Motion to Seal; denying 280 Letter Motion to Seal; denying 290 Letter Motion to Seal; granting 294 Letter Motion to Seal. This order addresses several pending motions to seal in this case. The motion at Dkt. No. 263 is granted, and the exhibit at Dkt. No. 262-3 may be maintained under seal. The motion at Dkt. No. 268 is denied. The motion at Dkt. No. 273 is granted, and Defendants are ordered to file their Memorandum of Law in Support of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints in partially redacted form as set forth in Dkt. No. 273-1. Defendants are also ordered to file the Declaration of Peter J. Carney; Exhibits 1 through 19 to the Carney Declaration may remain under seal. The motion at Dkt. No. 279 is denied. Direct Purchaser Plaintiffs and Retailer Plaintiffs are ordered to meet and confer with Defendants and propose for filing on the public docket a partially redacted Memorandum of Law in Opposition to Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints. The motion at Dkt. No. 280 is denied. End-Payor Plaintiffs are ordered to meet and confer with Defendants and propose for filing on the public docket a partially redacted Opposition to Certain Defendants' Rule 12(b)(2) Motion to Dismiss for Lack of Personal Jurisdiction, including the Declaration of Donna M. Evans and Exhibits A through G. All proposed redactions should be limited to that material which is confidential and which satisfies the standards under Lugosch v. Pyramid Co. of Onondaga, 435 F.3d 110 (2d Cir. 2006). Thus, where only a portion of an exhibit or a filing would satisfy the standards under Lugosch, only that portion should be redacted. The motion at Dkt. No. 290 is denied. The motion at Dkt. No. 294 is granted, and Defendants are ordered to file their Reply Memorandum of Law in Support of Their Motion toDismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints in partially redacted form as set forth in Dkt. No. 294-1. All filings are to be made in the form directed by this Order by February 9, 2022. Parties proposing redactions should follow the Court's Individual Practices, available at https://www.nysd.uscourts.gov/hon-lewis-j-liman. The Clerk of Court is respectfully directed to close the motions at Dkt. Nos. 263, 268, 273, 279, 280, 290, and 294. SO ORDERED. (Signed by Judge Lewis J. Liman on 2/02/2022) (ama) (Entered: 02/02/2022) |
2/2/2022 | 354 | OPINION AND ORDER: Defendants' motion to dismiss the Direct Purchaser and Retailer Plaintiffs' Complaints for failure to state a claim is GRANTED, and the Direct Purchaser and Retailer Plaintiffs' Complaints are DISMISSSED without prejudice to Direct Purchaser Plaintiffs and Retailer Plaintiffs filing amended complaints by February 22, 2022. Defendants' motion to dismiss the End-Payor Plaintiffs' Complaint for failure to state a claim is GRANTED, and the End-Payor Plaintiffs' Complaint is DISMISSED without prejudice to End-Payor Plaintiffs filing an amended complaint by February 22, 2022. Nonresident Defendants' motion to dismiss the End- Payor Plaintiffs' Complaint's ninety-nine non-New York, state-law claims for lack of personal jurisdiction and Teva Israel's motion to dismiss for lack of personal jurisdiction are DENIED without prejudice as moot. The Clerk of Court is respectfully directed to close Dkt. Nos. 260, 265, 267, 271. SO ORDERED.., ( Amended Pleadings due by 2/22/2022.) (Signed by Judge Lewis J. Liman on 2/02/2022) (ama) (Entered: 02/02/2022) |
2/2/2022 | 353 | ORDER: granting in part and denying in part 351 Letter Motion to Seal. The letter motion at Dkt. No. 351 to seal certain portions of the Court's Opinion and Order, filed under seal at Dkt. N. 349, is granted in part and denied in part. A partially redacted Opinion and Order will be filed. The Clerk of Court is respectfully directed to close the motion to seal at Dkt. No. 351. SO ORDERED. (Signed by Judge Lewis J. Liman on 2/02/2022) (ama) (Entered: 02/02/2022) |
1/31/2022 | 352 | ***SELECTED PARTIES*** LETTER addressed to Judge Lewis J. Liman from Celia A. McLaughlin dated January 31, 2022 re: Approval to Seal. Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Rite Aid Corporation, Allergan Sales LLC, Law Enforcement Health Benefits, Inc., Hetero USA Inc., Teamsters Local No. 1150 Prescription Drug Benefit Plan, J M Smith Corporation, Glenmark Generics Inc., USA, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Actavis Inc., Allergan, Inc., Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Mayor and City Council of Baltimore, Walgreen Co., Amerigen Pharmaceuticals Ltd., ANI Pharmaceuticals, Inc., H-E-B L.P., Indchemie Health Specialties Private Ltd., Rite Aid Hdqtrs. Corp.,, UFCW Local 1500 Welfare Fund, Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Amerigen Pharmaceuticals Inc., KPH Healthcare Services, Inc., Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, LLC, Forest Laboratories Inc., Teamsters Western Region & Local 177 Health Care Plan, Hetero Labs Ltd, Glenmark Pharmaceuticals Ltd., The Kroger Co., ALBERTSONS COMPANIES, INC., Hetero Drugs LTD., Forest Laboratories Holdings Ltd., CVS Pharmacy, Inc., Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories Ireland, LTD, Forest Laboratories, Inc., Forest Laboratories, LLC. (Attachments: # 1 Opinion and Order (Under-Seal Version))Motion or Order to File Under Seal: 351 .(McLaughlin, Celia) (Entered: 01/31/2022) |
1/31/2022 | 351 | LETTER MOTION to Seal addressed to Judge Lewis J. Liman from Celia A. McLaughlin dated January 31, 2022. Document filed by AbbVie Inc., Actavis Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc.. (Attachments: # 1 Opinion and Order (Public Redacted Version)).(McLaughlin, Celia) (Entered: 01/31/2022) |
1/24/2022 | 350 | ORDER: For the reasons stated in the Opinion and Order filed by the Court today: Defendants' motion to dismiss the Direct Purchaser and Retailer Plaintiffs' Complaints for failure to state a claim is GRANTED, and the Direct Purchaser and Retailer Plaintiffs' Complaints are DISMISSED without prejudice to Direct Purchaser Plaintiffs and Retailer Plaintiffs filing amended complaints by February 22, 2022. Defendants' motion to dismiss the End-Payor Plaintiffs' Complaint for failure to state a claim is GRANTED, and the End-Payo r Plaintiffs' Complaint is DISMISSED without prejudice to End-Payor Plaintiffs filing an amended complaint by February 22, 2022. Nonresident Defendants' motion to dismiss the End-Payor Plaintiffs' Complaint's ninety-nine non-New York, state-law claims for lack of personal jurisdiction and Teva Israel's motion to dismiss for lack of personal jurisdiction are DENIED without prejudice as moot. In order to preserve the ability of the parties to move the Court for redactions from the Opinion and Order, the Opinion and Order is temporarily filed under seal. The parties shall meet and confer with respect to potential redactions and, by January 31, 2022, the parties shall file any proposed redactions pursuant to the Court's Individual Practices. In addition, the parties are invited to inform the Court of any errors in citation, typography, or similar errors they discover in their review. The Court will rule on any outstanding motions to seal at the same time it rules on any proposed redactions to the Opinion and Order. SO ORDERED. ( Amended Pleadings due by 2/22/2022.) (Signed by Judge Lewis J. Liman on 1/24/2022) (va) (Entered: 01/24/2022) |
1/24/2022 | 349 | ***SELECTED PARTIES*** OPINION AND ORDER re: 260 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2) filed by Teva Pharmaceutical Industries Ltd., 267 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints filed by Watson Pharma, Inc., Hetero Drugs LTD., Allergan, Inc., Allergan USA, Inc., Torrent Pharma Inc., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Glenmark Generics Inc., USA, Forest Laboratories, Inc., Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Allergan Sales, LLC, Forest Laboratories Ireland, Ltd., Ascend Laboratories, LLC, Glenmark Pharmaceuticals S.A., Abbvie, Inc., Actavis, Inc., Glenmark Generics Ltd., Teva Pharmaceuticals USA, Inc., Forest Laboratories, LLC, Watson Laboratories, Inc. (NV), Hetero USA Inc., Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Hetero Labs Ltd, Forest Laboratories Holdings, Ltd., Watson Pharmaceuticals Inc., 271 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the End-Payor or Plaintiffs' Amended Consolidated Class Action Complaint filed by Watson Pharma, Inc., Hetero Drugs LTD., Allergan, Inc., Allergan USA, Inc., Torrent Pharma Inc., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Glenmark Generics Inc., USA, Forest Laboratories, Inc., Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NY), Allergan Sales, LLC, Teva Pharmaceutical Industries Ltd., Forest Laboratories Ireland, Ltd., Ascend Laboratories, LLC, Glenmark Pharmaceuticals S.A., Abbvie, Inc., Actavis, Inc., Glenmark Generics Ltd., Forest Laboratories, LLC, Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NV), Hetero USA Inc., Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Hetero Labs Ltd, Forest Laboratories Holdings, Ltd., Watson Pharmaceuticals Inc., 265 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2) filed by Watson Pharma, Inc., Hetero Drugs LTD., Forest Laboratories Holdings Ltd., Allergan, Inc., Allergan USA, Inc., Forest Laboratories Ireland, LTD, Torrent Pharma Inc., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Glenmark Generics Inc., USA, Watson Laboratories, Inc. (DE), Amerigen Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Actavis Inc., Teva Pharmaceutical Industries Ltd., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Glenmark Pharmaceuticals S.A., Abbvie, Inc., Glenmark Generics Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NV), Hetero USA Inc., Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Hetero Labs Ltd. Defendants' motion to dismiss the Direct Purchaser and Retailer Plaintiffs' Complaints for failure to state a claim is GRANTED, and the Direct Purchaser and Retailer Plaintiffs' Complaints are DISMISSSED without prejudice to Direct Purchaser Plaintiffs and Retailer Plaintiffs filing amended complaints by February 22, 2022. Defendants' motion to dismiss the End-Payor Plaintiffs' Complaint for failure to state a claim is GRANTED, and the End-Payor Plaintiffs' Complaint is DISMISSED without prejudice to End-Payor Plaintiffs filing an amended complaint by February 22, 2022. Nonresident Defendants' motion to dismiss the End-Payor Plaintiffs' Complaint's ninety-nine non-New York, state-law claims for lack of personal jurisdiction and Teva Israel's motion to dismiss for lack of personal jurisdiction are DENIED without prejudice as moot. The Clerk of Court is respectfully directed to close Dkt. Nos. 260, 265, 267, 271. For the reasons explained in an accompanying Order, this Opinion and Order will be filed temporarily under seal until the Court can review any redactions the parties propose. The Clerk of Court is respectfully directed to file this Opinion and Order under seal, viewable only to the Court and the parties to this action. SO ORDERED. (Signed by Judge Lewis J. Liman on 1/24/2022) (va) (Entered: 01/24/2022) |
1/18/2022 | 348 | JOINT LETTER addressed to Judge Lewis J. Liman from Kimberly Hennings dated 1/18/2022 re: Notice of Supplemental Authority. Document filed by J M Smith Corporation..(Hennings, Kimberly) (Entered: 01/18/2022) |
1/12/2022 | 347 | ORDER granting 346 Motion to Withdraw as Attorney. Attorney Noah Brumfield terminated (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (LCkc) (Entered: 01/12/2022) |
1/11/2022 | 346 | MOTION for Noah Brumfield to Withdraw as Attorney . Document filed by AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Watson Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order re: Withdrawal of Noah Brumfield In Re Bystolic Antitrust).(Brumfield, Noah) (Entered: 01/11/2022) |
1/7/2022 | 345 | LETTER addressed to Judge Lewis J. Liman from Christopher T. Holding dated January 7, 2022 re: Notice of Supplemental Authority. Document filed by Teva Pharmaceutical Industries Ltd.. (Attachments: # 1 Exhibit A).(Holding, Christopher) (Entered: 01/07/2022) |
12/20/2021 | 344 | NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a CONFERENCE proceeding held on 12/14/21 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(Moya, Goretti) (Entered: 12/20/2021) |
12/20/2021 | 343 | TRANSCRIPT of Proceedings re: CONFERENCE held on 12/14/2021 before Judge Lewis J. Liman. Court Reporter/Transcriber: Sadie Herbert, (212) 805-0310. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 1/10/2022. Redacted Transcript Deadline set for 1/20/2022. Release of Transcript Restriction set for 3/21/2022.Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(Moya, Goretti) (Entered: 12/20/2021) |
12/14/2021 | | Minute Entry for proceedings held before Judge Lewis J. Liman: Oral Argument held on 12/14/2021 in re: (Dkt. Nos. 267, 272, and 265) pending motions to dismiss. Kimberly Hennings and Donna Evans present on behalf of Plaintiffs. Eric Grannon and Teresa Bonder present on behalf of Defendants. Court reporter present. The Court heard argument from parties regarding Dkt. No. 267 Defendants Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs Second Amended Complaint, Dkt. No. 272 Defendants Motion to Dismiss the End-Payor Plaintiffs Amended Consolidated Class Action Complaint, and Dkt. No. 265 Non-Resident Defendants Rule 12(b)(2) Motion to Dismiss for Lack of Personal Jurisdiction. Argument taken under advisement, decision reserved by the Court. Parties directed to order a copy of the transcript of the hearing on an expedited basis. (mf) (Entered: 12/17/2021) |
12/13/2021 | | Set/Reset Hearings: Oral Argument set for 12/14/2021 at 01:30 PM in Courtroom 15C, 500 Pearl Street, New York, NY 10007 before Judge Lewis J. Liman. (mf) (Entered: 12/13/2021) |
12/13/2021 | | ORDER: The Oral Argument on the motions to dismiss scheduled for December 14, 2021 is MOVED to 1:30PM in Courtroom 15C at the 500 Pearl Street Courthouse. (HEREBY ORDERED by Judge Lewis J. Liman) (Text Only Order) (mf) (Entered: 12/13/2021) |
12/13/2021 | 342 | ORDER granting 329 Motion to Withdraw as Attorney. Attorney Nicholas Urban terminated (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (LCkc) (Entered: 12/13/2021) |
12/13/2021 | 341 | ORDER granting 332 Motion for Adam M. Acosta to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (LCkc) Transmission to Attorney Services/Help Desk. (Entered: 12/13/2021) |
12/13/2021 | 340 | ORDER granting 331 Motion for Holly Letourneau to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (LCkc) Transmission to Attorney Services/Help Desk. (Entered: 12/13/2021) |
12/13/2021 | 339 | ORDER granting 330 Motion for Celia McLaughlin to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (LCkc) Transmission to Attorney Services/Help Desk. (Entered: 12/13/2021) |
12/13/2021 | 338 | ORDER granting 336 Motion for Allen R. Davis to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (LCkc) Transmission to Attorney Services/Help Desk. (Entered: 12/13/2021) |
12/9/2021 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 336 MOTION for Allen R. Davis to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-25442352. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) (Entered: 12/09/2021) |
12/8/2021 | 337 | JOINT LETTER addressed to Judge Lewis J. Liman dated December 8, 2021 re: Electronics Order for December 14, 2021 Oral Argument. Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A - Proposed Electronic Order).(Gidley, John) (Entered: 12/08/2021) |
12/8/2021 | 336 | MOTION for Allen R. Davis to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-25442352. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by ANI Pharmaceuticals, Inc.. (Attachments: # 1 Affidavit of Allen Davis in Support, # 2 Certificate of Good Standing - NY, # 3 Certificate of Good Standing - DC, # 4 Text of Proposed Order).(Davis, Allen) (Entered: 12/08/2021) |
12/3/2021 | 335 | MEMO ENDORSEMENT: on re: 334 Letter filed by Watson Pharma, Inc., Hetero Drugs LTD., Allergan, Inc., Allergan USA, Inc., Torrent Pharma Inc., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Glenmark Generics Inc., USA, Forest Laboratories, Inc., Watson Laboratories, Inc. (DE), Amerigen Pharmaceuticals Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Allergan Sales, LLC, Amerigen Pharmaceuticals Ltd., Forest Laboratories Ireland, Ltd., Ascend Laboratories, LLC, Abbvie, Inc., Actavis, Inc., Glenmark Generics Ltd., Teva Pharmaceuticals USA, Inc., Forest Laboratories, LLC, Watson Laboratories, Inc. (NV), Hetero USA Inc., Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Hetero Labs Ltd, Forest Laboratories Holdings, Ltd. ENDORSEMENT: The Court approves the proposed agenda. The Court will inform the parties in advance if it has any particular questions it wishes the parties to address. SO ORDERED. (Signed by Judge Lewis J. Liman on 12/03/2021) (ama) (Entered: 12/03/2021) |
12/3/2021 | 334 | JOINT LETTER addressed to Judge Lewis J. Liman re: December 14, 2021 Oral Argument on Motions to Dismiss. Document filed by ANI Pharmaceuticals, Inc., Abbvie, Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings, Ltd., Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc...(Gidley, John) (Entered: 12/03/2021) |
12/1/2021 | 333 | NOTICE OF APPEARANCE by Christine Kelly Newman on behalf of AbbVie Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc...(Newman, Christine) (Entered: 12/01/2021) |
12/1/2021 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 332 MOTION for Adam M. Acosta to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-25402331. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) (Entered: 12/01/2021) |
12/1/2021 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 331 MOTION for Holly Letourneau to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-25402282. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) (Entered: 12/01/2021) |
12/1/2021 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 330 MOTION for Celia McLaughlin to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-25401800. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) (Entered: 12/01/2021) |
11/30/2021 | 332 | MOTION for Adam M. Acosta to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-25402331. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by AbbVie Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc.. (Attachments: # 1 Notarized Affidavit, # 2 Proposed Order, # 3 DC Certificate of Good Standing, # 4 Indiana Certificate of Good Standing).(Acosta, Adam) (Entered: 11/30/2021) |
11/30/2021 | 331 | MOTION for Holly Letourneau to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-25402282. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by AbbVie Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc.. (Attachments: # 1 Notarized Affidavit, # 2 Proposed Order, # 3 DC Certificate of Good Standing, # 4 VA Certificate of Good Standing).(Letourneau, Holly) (Entered: 11/30/2021) |
11/30/2021 | 330 | MOTION for Celia McLaughlin to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-25401800. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by AbbVie Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc.. (Attachments: # 1 Notarized Affidavit, # 2 Proposed Order, # 3 DC Certificate of Good Standing, # 4 NY Certificate of Good Standing).(McLaughlin, Celia) (Entered: 11/30/2021) |
11/30/2021 | 329 | MOTION for Nicholas Urban to Withdraw as Attorney . Document filed by J M Smith Corporation. (Attachments: # 1 Text of Proposed Order).(Coslett, Caitlin) (Entered: 11/30/2021) |
11/24/2021 | 328 | MEMO ENDORSEMENT on re: 327 Letter, filed by Amerigen Pharmaceuticals Ltd., Amerigen Pharmaceuticals Inc. ENDORSEMENT: The request is GRANTED. SO ORDERED. (Signed by Judge Lewis J. Liman on 11/24/2021) (va) (Entered: 11/24/2021) |
11/23/2021 | 327 | LETTER addressed to Judge Lewis J. Liman from Tobias Snyder dated November 23, 2021 re: requesting that Amerigen's counsel be permitted to appear telephonically at the December 14, 2021 hearing. Document filed by Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd...(Snyder, Tobias) (Entered: 11/23/2021) |
11/4/2021 | 326 | ORDER, It is hereby ORDERED that the parties appear for oral argument on the four motions to dismiss currently pending before the Court in this case. See Dkt. Nos. 260, 265, 267, 271. The argument shall take place on December 14, 2021 at 2:00 p.m. in Courtroom 15C of the 500 Pearl Street Courthouse and will last one hour. The parties are directed to meet and confer and, by December 7, 2021, file on the docket a letter informing the Court of a proposed agenda and order of argument. Members of the public may listen to the argument by dialing into 888-251-2909, using access code 2123101, and following the necessary prompts. SO ORDERED. ( Oral Argument set for 12/14/2021 at 02:00 PM in Courtroom 15C, 500 Pearl Street, New York, NY 10007 before Judge Lewis J. Liman.) (Signed by Judge Lewis J. Liman on 11/4/21) (yv) (Entered: 11/04/2021) |
10/26/2021 | 325 | NOTICE OF APPEARANCE by Abigail Flynn Coster on behalf of Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc...(Coster, Abigail) (Entered: 10/26/2021) |
10/26/2021 | 324 | NOTICE OF APPEARANCE by Jonathan Daniel Janow on behalf of Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc...(Janow, Jonathan) (Entered: 10/26/2021) |
9/28/2021 | 323 | NOTICE OF APPEARANCE by Travis Roher on behalf of Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc...(Roher, Travis) (Entered: 09/28/2021) |
9/27/2021 | 322 | NOTICE OF APPEARANCE by Gilad Bendheim on behalf of Torrent Pharmaceuticals Ltd.. Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(Bendheim, Gilad) (Entered: 09/27/2021) |
9/27/2021 | 321 | NOTICE OF APPEARANCE by Jay Philip Lefkowitz on behalf of Torrent Pharmaceuticals Ltd.. Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(Lefkowitz, Jay) (Entered: 09/27/2021) |
9/27/2021 | 320 | NOTICE OF APPEARANCE by Devora Whitman Allon on behalf of Torrent Pharmaceuticals Ltd.. Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(Allon, Devora) (Entered: 09/27/2021) |
9/24/2021 | 319 | STIPULATION AND ORDER REGARDING SERVICE FOR DEFENDANT TORRENT PHARMACEUTICALS, LTD.: NOW THEREFORE, THE PARTIES HEREBY STIPULATE AND AGREE, subject to Court approval, by and among the undersigned counsel, on behalf of their respective clients, as follows: 1. Torrent Pharmaceuticals Ltd. has actual notice of this litigation. 2. Torrent Pharmaceuticals Ltd. hereby accepts, and agrees not to challenge the adequacy of, service of the Complaints of the DPPs (ECF No. 255), EPPs (ECF No. 256), and Retailer Plaintiffs (ECF Nos. 254-2, 258-2). 3. Torrent Pharmaceuticals Ltd. hereby joins in Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints (ECF No. 269); Motion to Dismiss the End-Payor Plaintiffs' Amended Consolidated Class Action Complaint (ECF No. 272); and Rule 12(b)(2) Motion to Dismiss for Lack of Personal Jurisdiction (ECF No. 266), and agrees that it will be bound by the Court's resolution of those fully-briefed motions. IT IS SO ORDERED. (Signed by Judge Lewis J. Liman on 9/24/2021) Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL (va) (Entered: 09/27/2021) |
9/24/2021 | 318 | PROPOSED STIPULATION AND ORDER. Document filed by Torrent Pharmaceuticals Ltd...(Allon, Devora) (Entered: 09/24/2021) |
9/21/2021 | 317 | AMENDED COMPLAINT amending 113 Amended Complaint,,,,,,,,,, against ANI Pharmaceuticals, Inc., AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc. with JURY DEMAND.Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Teamsters Local No. 1150 Prescription Drug Benefit Plan, Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, UFCW Local 1500 Welfare Fund, Teamsters Western Region & Local 177 Health Care Plan. Related document: 113 Amended Complaint,,,,,,,,,,..(Robertson, Sharon) (Entered: 09/21/2021) |
9/21/2021 | 316 | ORDER: End-Payor Plaintiffs ("EPPs") seek clarification of the Courts Order regarding sealing motions. See Dkt. No. 314. The Court directs EPPs to file a redacted version of the initial consolidated complaint on the public docket in accordance with its Order at Dkt. No. 307. SO ORDERED. (Signed by Judge Lewis J. Liman on 9/21/2021) Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL (ama) (Entered: 09/21/2021) |
9/21/2021 | 315 | ORDER: For the reasons given in the Court's Opinion and Order dated September 20, 2021, see Dkt. No. 312, the Court hereby orders that Retailer Plaintiffs may serve Torrent via email to its Vice President (Legal) & Company Secretary Mahesh Agrawal at maheshagrawal@torrentpharma.com. And as set forth herein. SO ORDERED. (Signed by Judge Lewis J. Liman on 9/21/2021) Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL (ama) (Entered: 09/21/2021) |
9/20/2021 | 314 | LETTER addressed to Judge Lewis J. Liman from Sharon K. Robertson and Robin A. van der Meulen dated September 20, 2021 re: Order ECF No. 307. Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund..(Robertson, Sharon) (Entered: 09/20/2021) |
9/20/2021 | 313 | DECLARATION of Peter J. Carney in Support re: 223 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Complaints.. Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1 - Filed Under Seal, # 2 Exhibit 2 - Filed Under Seal, # 3 Exhibit 3 - Filed Under Seal, # 4 Exhibit 4 - Filed Under Seal, # 5 Exhibit 5 - Filed Under Seal, # 6 Exhibit 6 - Filed Under Seal, # 7 Exhibit 7 - Filed Under Seal, # 8 Exhibit 8 - Filed Under Seal, # 9 Exhibit 9 - Filed Under Seal, # 10 Exhibit 10 - Filed Under Seal, # 11 Exhibit 11 - Filed Under Seal, # 12 Exhibit 12 - Filed Under Seal, # 13 Exhibit 13 - Filed Under Seal, # 14 Exhibit 14 - Filed Under Seal, # 15 Exhibit 15 - Filed Under Seal, # 16 Exhibit 16 - Filed Under Seal, # 17 Exhibit 17 - Filed Under Seal, # 18 Exhibit 18 - Filed Under Seal, # 19 Exhibit 19 - Filed Under Seal).(Carney, Peter) (Entered: 09/20/2021) |
9/20/2021 | 312 | OPINION & ORDER re: 296 MOTION to Serve DIRECT PURCHASER CLASS PLAINTIFFS MOTION FOR ALTERNATIVE SERVICE ON TORRENT PHARMACEUTICALS, LTD. filed by J M Smith Corporation, KPH Healthcare Services, Inc. The motion for alternative service on Torrent is GRANTED. The Court hereby orders that Plaintiffs may serve Torrent via email to its Vice President (Legal) & Company Secretary, Mahesh Agrawal at maheshagrawal@torrentpharma.com. The Clerk of Court is respectfully directed to close Dkt. No. 296. SO ORDERED. (Signed by Judge Lewis J. Liman on 9/20/2021) (va) (Entered: 09/20/2021) |
9/20/2021 | 311 | MEMORANDUM OF LAW in Support re: 223 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Complaints. (Public Redacted Memorandum). Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 09/20/2021) |
9/20/2021 | 310 | JOINDER to join re: 296 MOTION to Serve DIRECT PURCHASER CLASS PLAINTIFFS MOTION FOR ALTERNATIVE SERVICE ON TORRENT PHARMACEUTICALS, LTD.. by Retailer Plaintiffs. Document filed by ALBERTSONS COMPANIES, INC., CVS Pharmacy, Inc., H-E-B L.P., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, The Kroger Co., Walgreen Co.. (Attachments: # 1 Declaration of Barry L. Refsin in Support of Retailer Plaintiffs' Joinder in Motion for Alternate Service, # 2 Exhibit 1 to Declaration, # 3 Exhibit 2 to Declaration).(Refsin, Barry) (Entered: 09/20/2021) |
9/20/2021 | 309 | LETTER addressed to Judge Lewis J. Liman from Kimberly M. Hennings dated 9/20/2021 re: Redacted Second Consolidated and Amended Complaint. Document filed by J M Smith Corporation..(Hennings, Kimberly) (Entered: 09/20/2021) |
9/20/2021 | 308 | LETTER addressed to Judge Lewis J. Liman from Barry L. Refsin dated September 20, 2021 re: Redacted Second Amended Complaint filed by CVS & Rite Aid. Document filed by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,..(Refsin, Barry) (Entered: 09/20/2021) |
9/17/2021 | 307 | ORDER denying 102 Letter Motion to Seal; granting 106 Letter Motion to Seal; denying 110 Letter Motion to Seal; denying 112 Letter Motion to Seal; granting 139 Letter Motion to Seal; granting 221 Letter Motion to Seal; denying 224 Letter Motion to Seal; granting 237 Letter Motion to Seal; granting 249 Letter Motion to Seal. This order addresses several pending motions to seal in this case. The Courts decisions on these motions are without prejudice to the Court's unsealing either on motion or sua sponte. The motion at Dkt. No. 102 is denied. The motion at Dkt. No. 106 is granted, and the exhibits at Dkt. Nos. 104-2 through 104-16 shall remain under seal. The Clerk is respectfully directed to unseal Dkt. Nos. 103, 104, 104-1, 104-17, 104-18. The motions at Dkt. Nos. 110 and 112 are denied. The motion at Dkt. No. 139 is granted. Plaintiffs shall file the partially redacted complaints consistent with the redactions at Dkt. Nos. 139-1 and 139-2. The motion at Dkt. No. 221 is granted, and the exhibit at Dkt. No. 222-3 may be maintained under seal. The motion at Dkt. No. 224 is denied. The motion at Dkt. No. 237 is granted, and the memorandum and declaration shall be filed in partially redacted form as set forth in Dkt. Nos. 237-1 and 237-2, respectively. The exhibits filed at Dkt. Nos. 227-1 through 227-19 shall remain under seal. The motion at Dkt. No. 249 is granted to the extent that it seeks to file publicly a second consolidated and amended class action complaint with redactions consistent with those approved at Dkt. No. 161. All filings to be made in the form directed by this order on the public docket by September 20, 2021. The Clerk is respectfully directed to close the motions at Dkt. Nos. 102, 106, 110, 112, 139, 221, 224, 237, and 249. SO ORDERED.. (Signed by Judge Lewis J. Liman on 9/17/2021) (kv) (Entered: 09/17/2021) |
9/14/2021 | 306 | ORDER granting 293 Motion for Nicholas Urban to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (kc) Transmission to Attorney Services/Help Desk. (Entered: 09/14/2021) |
9/14/2021 | 305 | ORDER granting 239 Motion to Withdraw as Attorney. Attorney Sarah K. Frederick terminated (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (kc) (Entered: 09/14/2021) |
9/14/2021 | 304 | ORDER granting 211 Motion for John ("Jay") Jurata, Jr. to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (kc) Transmission to Attorney Services/Help Desk. (Entered: 09/14/2021) |
9/14/2021 | 303 | ORDER granting 210 Motion for James Tierney to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (kc) Transmission to Attorney Services/Help Desk. (Entered: 09/14/2021) |
9/14/2021 | 302 | ORDER granting 209 Motion for Eric Grannon to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (kc) Transmission to Attorney Services/Help Desk. (Entered: 09/14/2021) |
9/14/2021 | 301 | ORDER granting 207 Motion for Anna T. Neill to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (kc) Transmission to Attorney Services/Help Desk. (Entered: 09/14/2021) |
9/13/2021 | 300 | DECLARATION of Robin van der Meulen in Support re: 299 Joinder. Document filed by UFCW Local 1500 Welfare Fund. (Attachments: # 1 Exhibit 1 - Delivery Confirmation from UPS).(Van Der Meulen, Robin) (Entered: 09/13/2021) |
9/13/2021 | 299 | JOINDER to join re: 296 MOTION to Serve DIRECT PURCHASER CLASS PLAINTIFFS MOTION FOR ALTERNATIVE SERVICE ON TORRENT PHARMACEUTICALS, LTD.. . Document filed by UFCW Local 1500 Welfare Fund..(Van Der Meulen, Robin) (Entered: 09/13/2021) |
9/3/2021 | 298 | MEMORANDUM OF LAW in Support re: 296 MOTION to Serve DIRECT PURCHASER CLASS PLAINTIFFS MOTION FOR ALTERNATIVE SERVICE ON TORRENT PHARMACEUTICALS, LTD.. . Document filed by J M Smith Corporation, KPH Healthcare Services, Inc...(Litvin, Dan) (Entered: 09/03/2021) |
9/3/2021 | 297 | DECLARATION of Dan Litvin in Support re: 296 MOTION to Serve DIRECT PURCHASER CLASS PLAINTIFFS MOTION FOR ALTERNATIVE SERVICE ON TORRENT PHARMACEUTICALS, LTD... Document filed by J M Smith Corporation, KPH Healthcare Services, Inc.. (Attachments: # 1 Ex. 1, # 2 Ex. 2, # 3 Ex. 3, # 4 Ex. 4).(Litvin, Dan) (Entered: 09/03/2021) |
9/3/2021 | 296 | MOTION to Serve DIRECT PURCHASER CLASS PLAINTIFFS MOTION FOR ALTERNATIVE SERVICE ON TORRENT PHARMACEUTICALS, LTD.. Document filed by J M Smith Corporation, KPH Healthcare Services, Inc...(Litvin, Dan) (Entered: 09/03/2021) |
7/14/2021 | 295 | ***SELECTED PARTIES*** LETTER addressed to Judge Lewis J. Liman from Peter J. Carney dated July 14, 2021 Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Rite Aid Corporation, Allergan Sales LLC, Actavis, Inc., Law Enforcement Health Benefits, Inc., Hetero USA Inc., Teamsters Local No. 1150 Prescription Drug Benefit Plan, J M Smith Corporation, Glenmark Generics Inc., USA, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Allergan, Inc., Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Mayor and City Council of Baltimore, Walgreen Co., Amerigen Pharmaceuticals Ltd., ANI Pharmaceuticals, Inc., H-E-B L.P., Indchemie Health Specialties Private Ltd., Rite Aid Hdqtrs. Corp.,, UFCW Local 1500 Welfare Fund, Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Amerigen Pharmaceuticals Inc., KPH Healthcare Services, Inc., Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, LLC, Forest Laboratories Inc., Teamsters Western Region & Local 177 Health Care Plan, Allergan, Inc., Hetero Labs Ltd, Glenmark Pharmaceuticals Ltd., The Kroger Co., ALBERTSONS COMPANIES, INC., Hetero Drugs LTD., Forest Laboratories Holdings Ltd., CVS Pharmacy, Inc., Forest Laboratories, LLC. (Attachments: # 1 Reply Memorandum of Law in Support of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints)Motion or Order to File Under Seal: 294 .(Carney, Peter) (Entered: 07/14/2021) |
7/14/2021 | 294 | LETTER MOTION to Seal addressed to Judge Lewis J. Liman from Peter J. Carney dated July 14, 2021. Document filed by AbbVie Inc., Actavis, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc.. (Attachments: # 1 Reply Memorandum of Law in Support of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints).(Carney, Peter) (Entered: 07/14/2021) |
7/7/2021 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 293 MOTION for Nicholas Urban to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-24762618. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) (Entered: 07/07/2021) |
7/7/2021 | 293 | MOTION for Nicholas Urban to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-24762618. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Affidavit Urban Declaration in Support of Pro Hac Vice Motion, # 2 Exhibit Urban Certificates of Good Standing, # 3 Text of Proposed Order Proposed Order).(Urban, Nicholas) (Entered: 07/07/2021) |
6/30/2021 | 292 | ***SELECTED PARTIES*** REPLY MEMORANDUM OF LAW in Support re: 267 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints. . Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Forest Laboratories Holdings, Ltd., Allergan Sales LLC, Hetero USA Inc., Glenmark Generics Inc., USA, Watson Laboratories, Inc. (NV), Actavis Inc., Allergan, Inc., Amerigen Pharmaceuticals Ltd., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Glenmark Generics Ltd., Amerigen Pharmaceuticals Inc., Watson Laboratories, Inc. (CT), Glenmark Pharmaceuticals S.A., Forest Laboratories, LLC, Torrent Pharma Inc., Forest Laboratories Inc., Hetero Labs Ltd, Glenmark Pharmaceuticals Ltd., Hetero Drugs LTD., ALBERTSONS COMPANIES, INC., CVS Pharmacy, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Ireland, LTD, Forest Laboratories, Inc., Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., H-E-B L.P., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, The Kroger Co., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Walgreen Co.. Motion or Order to File Under Seal: 290 .(Gidley, John) (Entered: 06/30/2021) |
6/30/2021 | 291 | DECLARATION of Peter J. Carney in Support re: 267 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints.. Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 20 - Excerpt of Agreement and Plan of Merger 2-17-2014, # 2 Exhibit 21 - Email chain between Eric Agovino and others dated 3-1-2014 to 3-4-2014, # 3 Exhibit 22 - FTC FAQ's re: filing agreements created 2/9/2005).(Carney, Peter) (Entered: 06/30/2021) |
6/30/2021 | 290 | LETTER MOTION to Seal addressed to Judge Lewis J. Liman from J. Mark Gidley dated June 30, 2021. Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 06/30/2021) |
6/30/2021 | 289 | REPLY MEMORANDUM OF LAW in Support re: 271 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the End-Payor or Plaintiffs' Amended Consolidated Class Action Complaint. . Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 06/30/2021) |
6/30/2021 | 288 | REPLY MEMORANDUM OF LAW in Support re: 260 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2). . Document filed by Teva Pharmaceutical Industries Ltd...(Holding, Christopher) (Entered: 06/30/2021) |
6/30/2021 | 287 | REPLY MEMORANDUM OF LAW in Support re: 265 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2). . Document filed by ANI Pharmaceuticals, Inc., Abbvie, Inc., Actavis Inc., Alkem Laboratories Ltd., Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Ireland, LTD, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Pharma, Inc...(Bonder, Teresa) (Entered: 06/30/2021) |
5/27/2021 | 286 | MEMORANDUM OF LAW in Opposition re: 271 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the End-Payor or Plaintiffs' Amended Consolidated Class Action Complaint. . Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund..(Van Der Meulen, Robin) (Entered: 05/27/2021) |
5/27/2021 | 285 | ***SELECTED PARTIES*** MEMORANDUM OF LAW in Opposition re: 267 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints. . Document filed by Rite Aid Corporation, J M Smith Corporation, Walgreen Co., H-E-B L.P., Rite Aid Hdqtrs. Corp.,, KPH Healthcare Services, Inc., The Kroger Co., ALBERTSONS COMPANIES, INC., ANI Pharmaceuticals, Inc., AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, CVS Pharmacy, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. Motion or Order to File Under Seal: 279 .(Hennings, Kimberly) (Entered: 05/27/2021) |
5/27/2021 | 284 | DECLARATION of Kimberly M. Hennings in Opposition re: 260 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2).. Document filed by ALBERTSONS COMPANIES, INC., Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, H-E-B L.P., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, The Kroger Co., UFCW Local 1500 Welfare Fund, Walgreen Co.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 1A, # 3 Exhibit 1B, # 4 Exhibit 1C, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4, # 8 Exhibit 5, # 9 Exhibit 6, # 10 Exhibit 7, # 11 Exhibit 8).(Hennings, Kimberly) (Entered: 05/27/2021) |
5/27/2021 | 283 | MEMORANDUM OF LAW in Opposition re: 260 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2). . Document filed by ALBERTSONS COMPANIES, INC., CVS Pharmacy, Inc., Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, H-E-B L.P., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, The Kroger Co., UFCW Local 1500 Welfare Fund, Walgreen Co...(Hennings, Kimberly) (Entered: 05/27/2021) |
5/27/2021 | 282 | MEMORANDUM OF LAW in Opposition re: 265 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2). (Filed Under Seal). Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund. (Attachments: # 1 Declaration of Donna M. Evans - Filed Under Seal, # 2 Exhibit A - Filed Under Seal, # 3 Exhibit B - Filed Under Seal, # 4 Exhibit C - Filed Under Seal, # 5 Exhibit D - Filed Under Seal, # 6 Exhibit E - Filed Under Seal, # 7 Exhibit F - Filed Under Seal, # 8 Exhibit G - Filed Under Seal, # 9 Exhibit H, # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M).(Robertson, Sharon) (Entered: 05/27/2021) |
5/27/2021 | 281 | ***SELECTED PARTIES*** MEMORANDUM OF LAW in Opposition re: 265 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2). . Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Teamsters Local No. 1150 Prescription Drug Benefit Plan, Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, UFCW Local 1500 Welfare Fund, Teamsters Western Region & Local 177 Health Care Plan, ALBERTSONS COMPANIES, INC., ANI Pharmaceuticals, Inc., AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, CVS Pharmacy, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., H-E-B L.P., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., J M Smith Corporation, KPH Healthcare Services, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., The Kroger Co., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Walgreen Co., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Declaration of Donna M. Evans, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M)Motion or Order to File Under Seal: 280 .(Robertson, Sharon) (Entered: 05/27/2021) |
5/27/2021 | 280 | LETTER MOTION to Seal End-Payor Plaintiffs' Opposition to Certain Defendants' Rule 12(b)(2) Motion to Dismiss for Lack of Personal Jurisdiction, Declaration of Donna M. Evans, and Exhibits A through G addressed to Judge Lewis J. Liman from Sharon K. Robertson and Robin A. van der Meulen dated May 27, 2021. Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund..(Robertson, Sharon) (Entered: 05/27/2021) |
5/27/2021 | 279 | LETTER MOTION to Seal Memorandum of Law in Opposition to Defendants Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs Second Amended Complaints addressed to Judge Lewis J. Liman from Kimberly M. Hennings dated May 27, 2021. Document filed by ALBERTSONS COMPANIES, INC., CVS Pharmacy, Inc., H-E-B L.P., J M Smith Corporation, KPH Healthcare Services, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, The Kroger Co., Walgreen Co...(Hennings, Kimberly) (Entered: 05/27/2021) |
5/17/2021 | 278 | NOTICE OF APPEARANCE by Tobias George Snyder on behalf of Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd...(Snyder, Tobias) (Entered: 05/17/2021) |
5/13/2021 | 277 | JOINDER to join re: 271 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the End-Payor or Plaintiffs' Amended Consolidated Class Action Complaint., 272 Memorandum of Law in Support of Motion,,,, . Document filed by Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd...(Snyder, Tobias) (Entered: 05/13/2021) |
5/13/2021 | 276 | JOINDER to join re: 265 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2)., 266 Memorandum of Law in Support of Motion,,, . Document filed by Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd...(Snyder, Tobias) (Entered: 05/13/2021) |
5/13/2021 | 275 | JOINDER to join re: 267 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints. . Document filed by Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd...(Snyder, Tobias) (Entered: 05/13/2021) |
5/7/2021 | 274 | ***SELECTED PARTIES*** LETTER addressed to Judge Lewis J. Liman from Peter J. Carney dated May 7, 2021 Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Rite Aid Corporation, Allergan Sales LLC, Actavis, Inc., Law Enforcement Health Benefits, Inc., Hetero USA Inc., Teamsters Local No. 1150 Prescription Drug Benefit Plan, J M Smith Corporation, Glenmark Generics Inc., USA, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Allergan, Inc., Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Mayor and City Council of Baltimore, Walgreen Co., Amerigen Pharmaceuticals Ltd., ANI Pharmaceuticals, Inc., H-E-B L.P., Indchemie Health Specialties Private Ltd., Rite Aid Hdqtrs. Corp.,, UFCW Local 1500 Welfare Fund, Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Amerigen Pharmaceuticals Inc., KPH Healthcare Services, Inc., Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories Inc., Teamsters Western Region & Local 177 Health Care Plan, Allergan, Inc., Hetero Labs Ltd, Glenmark Pharmaceuticals Ltd., The Kroger Co., ALBERTSONS COMPANIES, INC., Hetero Drugs LTD., Forest Laboratories, LLC, Forest Laboratories Holdings Ltd., CVS Pharmacy, Inc.. (Attachments: # 1 Memorandum of Law in Support of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints, # 2 Declaration of Peter J. Carney in Support of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Complaints Pursuant to Federal Rule of Civil Procedure 12(b)(6), # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18, # 21 Exhibit 19)Motion or Order to File Under Seal: 273 .(Carney, Peter) (Entered: 05/07/2021) |
5/7/2021 | 273 | LETTER MOTION to Seal [Public Version] addressed to Judge Lewis J. Liman from Peter J. Carney dated May 7, 2021. Document filed by AbbVie Inc., Actavis, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc.. (Attachments: # 1 Memorandum of Law in Support of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints, # 2 Declaration of Peter J. Carney in Support of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Complaints Pursuant to Federal Rule of Civil Procedure 12(b)(6), # 3 Exhibit 1 - Filed Under Seal, # 4 Exhibit 2 - Filed Under Seal, # 5 Exhibit 3 - Filed Under Seal, # 6 Exhibit 4 - Filed Under Seal, # 7 Exhibit 5 - Filed Under Seal, # 8 Exhibit 6 - Filed Under Seal, # 9 Exhibit 7 - Filed Under Seal, # 10 Exhibit 8 - Filed Under Seal, # 11 Exhibit 9 - Filed Under Seal, # 12 Exhibit 10 - Filed Under Seal, # 13 Exhibit 11 - Filed Under Seal, # 14 Exhibit 12 - Filed Under Seal, # 15 Exhibit 13 - Filed Under Seal, # 16 Exhibit 14 - Filed Under Seal, # 17 Exhibit 15 - Filed Under Seal, # 18 Exhibit 16 - Filed Under Seal, # 19 Exhibit 17 - Filed Under Seal, # 20 Exhibit 18 - Filed Under Seal, # 21 Exhibit 19 - Filed Under Seal).(Carney, Peter) (Entered: 05/07/2021) |
4/23/2021 | 272 | MEMORANDUM OF LAW in Support re: 271 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the End-Payor or Plaintiffs' Amended Consolidated Class Action Complaint. . Document filed by ANI Pharmaceuticals, Inc., Abbvie, Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Ascend Laboratories, LLC, Forest Laboratories Holdings, Ltd., Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 04/23/2021) |
4/23/2021 | 271 | MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the End-Payor or Plaintiffs' Amended Consolidated Class Action Complaint. Document filed by ANI Pharmaceuticals, Inc., Abbvie, Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Ascend Laboratories, LLC, Forest Laboratories Holdings, Ltd., Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order).(Gidley, John) (Entered: 04/23/2021) |
4/23/2021 | 270 | ***SELECTED PARTIES***DECLARATION of Peter J. Carney in Support re: 267 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints.. Document filed by Forest Laboratories Ireland, Ltd., Forest Laboratories Holdings, Ltd., Actavis, Inc., Hetero USA Inc., Glenmark Generics Inc., USA, Watson Laboratories, Inc. (NV), ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Abbvie, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, Inc., Allergan USA, Inc., Hetero Labs Ltd, Allergan Sales, LLC, Allergan, Inc., Glenmark Pharmaceuticals Ltd., Hetero Drugs LTD., Forest Laboratories, LLC, ALBERTSONS COMPANIES, INC., AbbVie Inc., Actavis Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., CVS Pharmacy, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., H-E-B L.P., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, The Kroger Co., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Walgreen Co.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19)Motion or Order to File Under Seal: 147 .(Carney, Peter) (Entered: 04/23/2021) |
4/23/2021 | 269 | ***SELECTED PARTIES*** MEMORANDUM OF LAW in Support re: 267 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints. . Document filed by Forest Laboratories Ireland, Ltd., Forest Laboratories Holdings, Ltd., Actavis, Inc., Hetero USA Inc., Glenmark Generics Inc., USA, Watson Laboratories, Inc. (NV), Allergan, Inc., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Abbvie, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, Inc., Allergan USA, Inc., Hetero Labs Ltd, Allergan Sales, LLC, Glenmark Pharmaceuticals Ltd., Hetero Drugs LTD., Forest Laboratories, LLC, ALBERTSONS COMPANIES, INC., AbbVie Inc., Actavis Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., CVS Pharmacy, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., H-E-B L.P., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, The Kroger Co., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Walgreen Co.. (Attachments: # 1 Appendix)Motion or Order to File Under Seal: 147 .(Gidley, John) (Entered: 04/23/2021) |
4/23/2021 | 268 | LETTER MOTION to Seal addressed to Judge Lewis J. Liman from J. Mark Gidley dated April 23, 2021. Document filed by ANI Pharmaceuticals, Inc., Abbvie, Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 04/23/2021) |
4/23/2021 | 267 | MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Second Amended Complaints. Document filed by ANI Pharmaceuticals, Inc., Abbvie, Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Ascend Laboratories, LLC, Forest Laboratories Holdings, Ltd., Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order).(Gidley, John) (Entered: 04/23/2021) |
4/23/2021 | 266 | MEMORANDUM OF LAW in Support re: 265 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2). . Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis Inc., Alkem Laboratories Ltd., Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Ireland, LTD, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Pharma, Inc...(Bonder, Teresa) (Entered: 04/23/2021) |
4/23/2021 | 265 | MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2). Document filed by ANI Pharmaceuticals, Inc., Abbvie, Inc., Actavis Inc., Alkem Laboratories Ltd., Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Ireland, LTD, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Pharma, Inc...(Bonder, Teresa) (Entered: 04/23/2021) |
4/23/2021 | 264 | ***SELECTED PARTIES***DECLARATION of Brian E. Shanahan in Support re: 260 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2).. Document filed by Teva Pharmaceutical Industries Ltd., ALBERTSONS COMPANIES, INC., ANI Pharmaceuticals, Inc., AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, CVS Pharmacy, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., H-E-B L.P., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, Teva Pharmaceuticals USA, Inc., The Kroger Co., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Walgreen Co., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)Motion or Order to File Under Seal: 263 .(Holding, Christopher) (Entered: 04/23/2021) |
4/23/2021 | 263 | LETTER MOTION to Seal Exhibit C to the Shanahan Declaration addressed to Judge Lewis J. Liman from Christopher T. Holding dated April 23, 2021. Document filed by Teva Pharmaceutical Industries Ltd...(Holding, Christopher) (Entered: 04/23/2021) |
4/23/2021 | 262 | DECLARATION of Brian E. Shanahan in Support re: 260 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2).. Document filed by Teva Pharmaceutical Industries Ltd.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C).(Holding, Christopher) (Entered: 04/23/2021) |
4/23/2021 | 261 | MEMORANDUM OF LAW in Support re: 260 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2). . Document filed by Teva Pharmaceutical Industries Ltd.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2).(Holding, Christopher) (Entered: 04/23/2021) |
4/23/2021 | 260 | MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2). Document filed by Teva Pharmaceutical Industries Ltd...(Holding, Christopher) (Entered: 04/23/2021) |
4/14/2021 | 259 | JOINT LETTER addressed to Judge Lewis J. Liman from Peter J. Carney dated April 14, 2021 re: Motion to Dismiss Briefing Schedule. Document filed by Abbvie, Inc., Actavis, Inc., Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc...(Carney, Peter) (Entered: 04/14/2021) |
3/23/2021 | 258 | ***SELECTED PARTIES***NOTICE of Filing re: 249 LETTER MOTION to Seal Second Amended Complaint addressed to Judge Lewis J. Liman from Barry L. Refsin dated 03/15/2021.. Document filed by Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, CVS Pharmacy, Inc., ALBERTSONS COMPANIES, INC., ANI Pharmaceuticals, Inc., AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., H-E-B L.P., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., The Kroger Co., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Walgreen Co., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit CVS/Rite Aid Plaintiffs' Redacted Second Amended Complaint, # 2 Exhibit CVS/Rite Aid Plaintiffs' Highlighted Second Amended Complaint)Motion or Order to File Under Seal: 249 .(Refsin, Barry) (Entered: 03/23/2021) |
3/23/2021 | 257 | NOTICE of Filing re: 249 LETTER MOTION to Seal Second Amended Complaint addressed to Judge Lewis J. Liman from Barry L. Refsin dated 03/15/2021.. Document filed by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,. (Attachments: # 1 Exhibit CVS/Rite Aid Plaintiffs' Redacted Second Amended Complaint, # 2 Exhibit CVS/Rite Aid Plaintiffs' Highlighted Second Amended Complaint).(Refsin, Barry) (Entered: 03/23/2021) |
3/22/2021 | 256 | FIRST AMENDED COMPLAINT amending 251 Amended Complaint,,,,,,,,,,, against ANI Pharmaceuticals, Inc., AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc. with JURY DEMAND.Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Teamsters Local No. 1150 Prescription Drug Benefit Plan, Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, UFCW Local 1500 Welfare Fund, Teamsters Western Region & Local 177 Health Care Plan. Related document: 251 Amended Complaint,,,,,,,,,,,..(Robertson, Sharon) (Entered: 03/22/2021) |
3/22/2021 | 255 | AMENDED COMPLAINT amending 250 Amended Complaint,,,,,,,,,, against AbbVie Inc., Actavis Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc. with JURY DEMAND.Document filed by J M Smith Corporation, KPH Healthcare Services, Inc.. Related document: 250 Amended Complaint,,,,,,,,,,..(Gerstein, Bruce) (Entered: 03/22/2021) |
3/18/2021 | 254 | ***SELECTED PARTIES***NOTICE of Filing re: 243 LETTER MOTION to Seal Second Amended Complaint addressed to Judge Lewis J. Liman from Scott E. Perwin dated March 15, 2021.. Document filed by Walgreen Co., H-E-B L.P., The Kroger Co., ALBERTSONS COMPANIES, INC.. (Attachments: # 1 Exhibit Walgreen Plaintiffs' Redacted Second Amended Complaint, # 2 Exhibit Sealed Walgreen Plaintiffs' Highlighted Second Amended Complaint)Motion or Order to File Under Seal: 243 .(Perwin, Scott) (Entered: 03/18/2021) |
3/18/2021 | 253 | NOTICE of Filing re: 243 LETTER MOTION to Seal Second Amended Complaint addressed to Judge Lewis J. Liman from Scott E. Perwin dated March 15, 2021.. Document filed by ALBERTSONS COMPANIES, INC., H-E-B L.P., The Kroger Co., Walgreen Co.. (Attachments: # 1 Exhibit Walgreen Plaintiffs' Redacted Second Amended Complaint, # 2 Exhibit Walgreen Plaintiffs' Highlighted Second Complaint).(Perwin, Scott) (Entered: 03/18/2021) |
3/16/2021 | 252 | PROPOSED STIPULATION AND ORDER. Document filed by J M Smith Corporation. (Attachments: # 1 Exhibit A: Specifications for the Production of Documents).(Coslett, Caitlin) (Entered: 03/16/2021) |
3/15/2021 | 251 | ***SELECTED PARTIES***FIRST AMENDED COMPLAINT amending 113 Amended Complaint,,,,,,,,,, against Forest Laboratories Ireland, Ltd., AbbVie Inc., Forest Laboratories Holdings, Ltd., Allergan Sales LLC, Actavis, Inc., Hetero USA Inc., Glenmark Generics Inc., USA, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Allergan, Inc., Actavis Inc., Amerigen Pharmaceuticals Ltd., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Abbvie, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Amerigen Pharmaceuticals Inc., Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, LLC, Forest Laboratories Inc., Forest Laboratories, Inc., Allergan USA, Inc., Hetero Labs Ltd, Allergan Sales, LLC, Allergan, Inc., Glenmark Pharmaceuticals Ltd., Forest Laboratories Ireland, LTD, Hetero Drugs LTD., Forest Laboratories, LLC, Forest Laboratories Holdings Ltd. with JURY DEMAND.Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Forest Laboratories Holdings, Ltd., Allergan Sales LLC, Actavis, Inc., Hetero USA Inc., Law Enforcement Health Benefits, Inc., Glenmark Generics Inc., USA, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Allergan, Inc., Actavis Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Amerigen Pharmaceuticals Ltd., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., UFCW Local 1500 Welfare Fund, Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Abbvie, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Amerigen Pharmaceuticals Inc., Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, LLC, Forest Laboratories Inc., Forest Laboratories, Inc., Teamsters Western Region & Local 177 Health Care Plan, Allergan USA, Inc., Hetero Labs Ltd, Allergan Sales, LLC, Allergan, Inc., Glenmark Pharmaceuticals Ltd., Forest Laboratories Ireland, LTD, Hetero Drugs LTD., Forest Laboratories, LLC, Forest Laboratories Holdings Ltd.. Related document: 113 Amended Complaint,,,,,,,,,,.Motion or Order to File Under Seal: 248 .(Robertson, Sharon) (Entered: 03/15/2021) |
3/15/2021 | 250 | ***SELECTED PARTIES***SECOND AMENDED COMPLAINT amending 1 Complaint, 111 Amended Complaint,,,,,,,,, against Forest Laboratories Ireland, Ltd., AbbVie Inc., Allergan Sales LLC, Hetero USA Inc., Glenmark Generics Inc., USA, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Allergan, Inc., Actavis Inc., Amerigen Pharmaceuticals Ltd., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Glenmark Generics Ltd., Torrent Pharmaceuticals Ltd., Amerigen Pharmaceuticals Inc., Watson Laboratories, Inc. (CT), Glenmark Pharmaceuticals S.A., Forest Laboratories, LLC, Torrent Pharma Inc., Forest Laboratories Inc., Hetero Labs Ltd, Glenmark Pharmaceuticals Ltd., Hetero Drugs LTD., Forest Laboratories Holdings Ltd. with JURY DEMAND.Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Allergan Sales LLC, Hetero USA Inc., Glenmark Generics Inc., USA, J M Smith Corporation, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Allergan, Inc., Actavis Inc., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Glenmark Generics Ltd., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), KPH Healthcare Services, Inc., Glenmark Pharmaceuticals S.A., Forest Laboratories, LLC, Torrent Pharma Inc., Forest Laboratories Inc., Hetero Labs Ltd, Glenmark Pharmaceuticals Ltd., Hetero Drugs LTD., Forest Laboratories Holdings Ltd., ALBERTSONS COMPANIES, INC., Abbvie, Inc., Actavis, Inc., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., CVS Pharmacy, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories Ireland, LTD, Forest Laboratories, Inc., Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, H-E-B L.P., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, The Kroger Co., UFCW Local 1500 Welfare Fund, Walgreen Co.. Related document: 1 Complaint, 111 Amended Complaint,,,,,,,,,.Motion or Order to File Under Seal: 247 .(Gerstein, Bruce) (Entered: 03/15/2021) |
3/15/2021 | 249 | LETTER MOTION to Seal Second Amended Complaint addressed to Judge Lewis J. Liman from Barry L. Refsin dated 03/15/2021. Document filed by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,..(Refsin, Barry) (Entered: 03/15/2021) |
3/15/2021 | 248 | ORDER granting (245) Letter Motion to Seal in case 1:20-cv-05735-LJL. Plaintiffs to publicly file redacted complaint within one week of filing complaint under seal. (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL (Liman, Lewis) (Entered: 03/15/2021) |
3/15/2021 | 247 | ORDER granting (244) Letter Motion to Seal in case 1:20-cv-05735-LJL. Plaintiffs to publicly filed redacted complaint within one week of the filing of the complaint under seal. (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL (Liman, Lewis) (Entered: 03/15/2021) |
3/15/2021 | 246 | ORDER granting (243) Letter Motion to Seal in case 1:20-cv-05735-LJL. Plaintiffs to file redacted complaint publicly within one week of filing of the complaint under seal. (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL (Liman, Lewis) (Entered: 03/15/2021) |
3/15/2021 | 245 | LETTER MOTION to Seal End-Payor Plaintiffs' Consolidated Amended Class Action Complaint addressed to Judge Lewis J. Liman from Sharon K. Robertson and Robin A. van der Meulen dated March 15, 2021. Document filed by Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund..(Robertson, Sharon) (Entered: 03/15/2021) |
3/15/2021 | 244 | LETTER MOTION to Seal Second Consolidated and Amended Class Action Complaint addressed to Judge Lewis J. Liman from Kimberly M. Hennings dated 03/15/2021. Document filed by J M Smith Corporation, KPH Healthcare Services, Inc...(Hennings, Kimberly) (Entered: 03/15/2021) |
3/15/2021 | 243 | LETTER MOTION to Seal Second Amended Complaint addressed to Judge Lewis J. Liman from Scott E. Perwin dated March 15, 2021. Document filed by ALBERTSONS COMPANIES, INC., H-E-B L.P., The Kroger Co., Walgreen Co...(Perwin, Scott) (Entered: 03/15/2021) |
3/9/2021 | 242 | MEMORANDUM & ORDER terminating (234) Motion for Discovery in case 1:20-cv-05735-LJL. Accordingly, each individual email withheld as privileged within an email thread must be logged. The parties are ORDERED to meet and confer and propose a revised stipulation and proposed order regarding the production of ESI and hard copy documents within one week of the date of this order. The Clerk of Court is respectfully directed to terminate the motion at Dkt. No. 234. SO ORDERED. (Signed by Judge Lewis J. Liman on 3/9/2021) Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL (va) (Entered: 03/09/2021) |
3/5/2021 | 241 | MEMO ENDORSEMENT on re: 240 Letter filed by J M Smith Corporation. ENDORSEMENT: MEMORANDUM ENDORSED. The briefing schedule proposed herein is adopted. The motions to dismiss at Dkt. Nos. 215, 218, 223, 226 are DISMISSED without prejudice as moot. The Clerk of Court is respectfully directed to terminate those motions. SO ORDERED. Motions terminated: 218 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2). filed by Teva Pharmaceutical Industries Ltd., 226 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the End-Payor Plaintiffs' Consolidated Class Action. filed by Watson Pharma, Inc., Hetero Drugs LTD., Forest Laboratories Holdings Ltd., Allergan, Inc., Allergan USA, Inc., Torrent Pharma Inc., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Glenmark Generics Inc., USA, Forest Laboratories, Inc., Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Allergan Sales, LLC, Forest Laboratories Ireland, Ltd., Ascend Laboratories, LLC, Glenmark Pharmaceuticals S.A., Actavis, Inc., Glenmark Generics Ltd., Forest Laboratories, LLC, Teva Pharmaceuticals USA, Inc., AbbVie Inc., Watson Laboratories, Inc. (NV), Hetero USA Inc., Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Hetero Labs Ltd, Watson Pharmaceuticals Inc., 215 MOTION to Dismiss for Lack of Jurisdiction . filed by Watson Pharma, Inc., Hetero Drugs LTD., Forest Laboratories Holdings Ltd., Allergan, Inc., Allergan USA, Inc., Torrent Pharma Inc., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Glenmark Generics Inc., USA, Watson Laboratories, Inc. (DE), Amerigen Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Actavis Inc., Teva Pharmaceutical Industries Ltd., Amerigen Pharmaceuticals Ltd., Forest Laboratories Ireland, Ltd., Ascend Laboratories, LLC, Glenmark Pharmaceuticals S.A., Glenmark Generics Ltd., AbbVie Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NV), Hetero USA Inc., Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Hetero Labs Ltd, 223 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Complaints. filed by Watson Pharma, Inc., Hetero Drugs LTD., Allergan, Inc., Allergan USA, Inc., Torrent Pharma Inc., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Glenmark Generics Inc., USA, Watson Laboratories, Inc. (DE), Amerigen Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (NY), Allergan Sales, LLC, Teva Pharmaceutical Industries Ltd., Amerigen Pharmaceuticals Ltd., Forest Laboratories Ireland, Ltd., Ascend Laboratories, LLC, Glenmark Pharmaceuticals S.A., Actavis, Inc., Glenmark Generics Ltd., Forest Laboratories, LLC, AbbVie Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NV), Hetero USA Inc., Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Hetero Labs Ltd, Forest Laboratories Holdings, Ltd., Watson Pharmaceuticals Inc. (Signed by Judge Lewis J. Liman on 3/5/2021) (va) (Entered: 03/05/2021) |
3/5/2021 | 240 | JOINT LETTER addressed to Judge Lewis J. Liman from Kimberly M. Hennings dated 03/05/2021 re: Motion to Dismiss Briefing Schedule. Document filed by J M Smith Corporation..(Hennings, Kimberly) (Entered: 03/05/2021) |
2/25/2021 | 239 | MOTION for Sarah K. Frederick to Withdraw as Attorney . Document filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Pharma, Inc.. (Attachments: # 1 Text of Proposed Order).(Frederick, Sarah) (Entered: 02/25/2021) |
2/22/2021 | 238 | ***SELECTED PARTIES*** LETTER addressed to Judge Lewis J. Liman from Peter J. Carney dated February 22, 2021 Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Forest Laboratories Holdings, Ltd., Actavis Inc., Allergan, Inc., Watson Pharmaceuticals Inc., Forest Laboratories, LLC, Forest Laboratories Inc., Allergan USA, Inc., Allergan Sales, LLC, ALBERTSONS COMPANIES, INC., ANI Pharmaceuticals, Inc., Abbvie, Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, CVS Pharmacy, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Ireland, LTD, Forest Laboratories, Inc., Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., H-E-B L.P., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., The Kroger Co., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Walgreen Co., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc.. (Attachments: # 1 Memorandum of Law in Support of Defendants' Motion to Dismiss the Direct Purchaser Plaintiffs', WalGreen and CVS Complaints, # 2 Declaration of Peter J. Carney in Support of Defendants' Motion to Dismiss the Direct Purchaser Plaintiffs', WalGreen and CVS Complaints, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18, # 21 Exhibit 19)Motion or Order to File Under Seal: 147 .(Carney, Peter) (Entered: 02/22/2021) |
2/22/2021 | 237 | LETTER MOTION to Seal [Public Version] addressed to Judge Lewis J. Liman from Peter J. Carney dated February 22, 2021. Document filed by AbbVie Inc., Actavis, Inc., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC, Watson Pharmaceuticals Inc.. (Attachments: # 1 Memorandum of Law in Support of Defendants' Motion to Dismiss the Direct Purchaser Plaintiffs', WalGreen and CVS Complaints, # 2 Declaration of Peter J. Carney in Support of Defendants' Motion to Dismiss the Direct Purchaser Plaintiffs', WalGreen and CVS Complaints, # 3 Exhibit 1 - Filed Under Seal, # 4 Exhibit 2 - Filed Under Seal, # 5 Exhibit 3 - Filed Under Seal, # 6 Exhibit 4 - Filed Under Seal, # 7 Exhibit 5 - Filed Under Seal, # 8 Exhibit 6 - Filed Under Seal, # 9 Exhibit 7 - Filed Under Seal, # 10 Exhibit 8 - Filed Under Seal, # 11 Exhibit 9 - Filed Under Seal, # 12 Exhibit 10 - Filed Under Seal, # 13 Exhibit 11 - Filed Under Seal, # 14 Exhibit 12 - Filed Under Seal, # 15 Exhibit 13 - Filed Under Seal, # 16 Exhibit 14 - Filed Under Seal, # 17 Exhibit 15 - Filed Under Seal, # 18 Exhibit 16 - Filed Under Seal, # 19 Exhibit 17 - Filed Under Seal, # 20 Exhibit 18 - Filed Under Seal, # 21 Exhibit 19 - Filed Under Seal).(Carney, Peter) (Entered: 02/22/2021) |
2/22/2021 | 236 | FILING ERROR - DEFICIENT DOCKET ENTRY - MEMORANDUM OF LAW in Support re: 235 LETTER MOTION to Seal addressed to Judge Lewis J. Liman from Peter J. Carney dated February 22, 2021. . Document filed by AbbVie Inc., Actavis, Inc., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc...(Carney, Peter) Modified on 2/24/2021 (ldi). (Entered: 02/22/2021) |
2/22/2021 | 235 | FILING ERROR - DEFICIENT DOCKET ENTRY (SEE DOCUMENT #237) - LETTER MOTION to Seal addressed to Judge Lewis J. Liman from Peter J. Carney dated February 22, 2021. Document filed by AbbVie Inc., Actavis, Inc., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc...(Carney, Peter) Modified on 2/24/2021 (ldi). (Entered: 02/22/2021) |
2/16/2021 | 234 | LETTER MOTION for Discovery re: Defendants' Submission on ESI Protocol addressed to Judge Lewis J. Liman from White & Case LLP dated February 16, 2021. Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 02/16/2021) |
2/16/2021 | 233 | LETTER addressed to Judge Lewis J. Liman from Caitlin G. Coslett on behalf of Plaintiffs dated February 16, 2021 re: Plaintiffs ESI Protocol proposals, set forth in ECF No. 232. Document filed by J M Smith Corporation. (Attachments: # 1 Exhibit 1).(Coslett, Caitlin) (Entered: 02/16/2021) |
2/16/2021 | 232 | PROPOSED STIPULATION AND ORDER. Document filed by J M Smith Corporation..(Coslett, Caitlin) (Entered: 02/16/2021) |
2/9/2021 | 231 | RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Other Affiliate BlackRock Inc. for ANI Pharmaceuticals, Inc.. Document filed by ANI Pharmaceuticals, Inc...(Echtman, Elyse) (Entered: 02/09/2021) |
2/9/2021 | 230 | AFFIDAVIT OF SERVICE. Watson Laboratories, Inc. (NY) served on 2/9/2021, answer due 3/2/2021. Service was accepted by Emily Schroeder, SOP Specialist. Service was made by Electronic Mail. Document filed by Walgreen Co.; H-E-B L.P.; The Kroger Co.; ALBERTSONS COMPANIES, INC...(Perwin, Scott) (Entered: 02/09/2021) |
2/9/2021 | | ***NOTICE TO ATTORNEY TO RE-FILE DOCUMENT - DEFICIENT DOCKET ENTRY ERROR. Notice to Attorney Elyse D. Echtman to RE-FILE Document 213 Rule 7.1 Corporate Disclosure Statement. ERROR(S): Corporate Parents/Other affiliates were not added. Please re-file this document and when prompted: Are there any corporate parents or other affiliates?, select the YES radio button and enter the Corporate Parent(s) or Affiliate(s). (ldi) (Entered: 02/09/2021) |
2/9/2021 | 229 | AFFIDAVIT OF SERVICE. Amerigen Pharmaceuticals Inc. served on 1/26/2021, answer due 2/16/2021. Service was accepted by Lynanne Gares, Litigation Services Manager. Document filed by Walgreen Co.; H-E-B L.P.; The Kroger Co.; ALBERTSONS COMPANIES, INC...(Perwin, Scott) (Entered: 02/09/2021) |
2/9/2021 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 210 MOTION for James Tierney to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23858224. Motion and supporting papers to be reviewed by Clerk's Office staff., 211 MOTION for John ("Jay") Jurata, Jr. to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23858536. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) (Entered: 02/09/2021) |
2/8/2021 | 228 | MEMORANDUM OF LAW in Support re: 226 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the End-Payor Plaintiffs' Consolidated Class Action. . Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 02/08/2021) |
2/8/2021 | 227 | ***SELECTED PARTIES***DECLARATION of Peter J. Carney in Support re: 223 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Complaints.. Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Forest Laboratories Holdings, Ltd., Actavis, Inc., Hetero USA Inc., Glenmark Generics Inc., Watson Laboratories, Inc. (NV), ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Allergan USA, Inc., Hetero Labs Ltd, Allergan Sales, LLC, Allergan, Inc., Glenmark Pharmaceuticals Ltd., Hetero Drugs LTD., Forest Laboratories, LLC, ALBERTSONS COMPANIES, INC., Abbvie, Inc., Actavis Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., CVS Pharmacy, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, Inc., Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., USA, H-E-B L.P., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, The Kroger Co., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Walgreen Co.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19)Motion or Order to File Under Seal: 147 .(Carney, Peter) (Entered: 02/08/2021) |
2/8/2021 | 226 | MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the End-Payor Plaintiffs' Consolidated Class Action. Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order).(Gidley, John) (Entered: 02/08/2021) |
2/8/2021 | 225 | ***SELECTED PARTIES*** MEMORANDUM OF LAW in Support re: 223 MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Complaints. . Document filed by AbbVie Inc., Hetero USA Inc., Glenmark Generics Inc., USA, Watson Laboratories, Inc. (NV), Actavis Inc., ANI Pharmaceuticals, Inc., Indchemie Health Specialties Private Ltd., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Allergan USA, Inc., Hetero Labs Ltd, Allergan Sales, LLC, Allergan, Inc., Glenmark Pharmaceuticals Ltd., Hetero Drugs LTD., ALBERTSONS COMPANIES, INC., Abbvie, Inc., Actavis, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., CVS Pharmacy, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., H-E-B L.P., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, The Kroger Co., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Walgreen Co.. Motion or Order to File Under Seal: 147 .(Gidley, John) (Entered: 02/08/2021) |
2/8/2021 | 224 | CONSENT LETTER MOTION to Seal addressed to Judge Lewis J. Liman from J.Mark Gidley dated February 8, 2021. Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Ascend Laboratories, LLC, Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 02/08/2021) |
2/8/2021 | 223 | MOTION to Dismiss / Notice of Defendants' Motion to Dismiss the Direct Purchaser and Retailer Plaintiffs' Complaints. Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings, Ltd., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order).(Gidley, John) (Entered: 02/08/2021) |
2/8/2021 | 222 | ***SELECTED PARTIES***DECLARATION of Brian E. Shanahan in Support re: 218 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2).. Document filed by Teva Pharmaceutical Industries Ltd., ALBERTSONS COMPANIES, INC., ANI Pharmaceuticals, Inc., AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, CVS Pharmacy, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., H-E-B L.P., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, Teva Pharmaceuticals USA, Inc., The Kroger Co., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Walgreen Co., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)Motion or Order to File Under Seal: 221 .(Holding, Christopher) (Entered: 02/08/2021) |
2/8/2021 | 221 | LETTER MOTION to Seal Exhibit C to the Shanahan Declaration addressed to Judge Lewis J. Liman from Christopher T. Holding dated February 8, 2021. Document filed by Teva Pharmaceutical Industries Ltd...(Holding, Christopher) (Entered: 02/08/2021) |
2/8/2021 | 220 | DECLARATION of Brian E. Shanahan in Support re: 218 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2).. Document filed by Teva Pharmaceutical Industries Ltd.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C).(Holding, Christopher) (Entered: 02/08/2021) |
2/8/2021 | 219 | MEMORANDUM OF LAW in Support re: 218 MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2). . Document filed by Teva Pharmaceutical Industries Ltd...(Holding, Christopher) (Entered: 02/08/2021) |
2/8/2021 | 218 | MOTION to Dismiss for Lack of Jurisdiction Under Rule 12(b)(2). Document filed by Teva Pharmaceutical Industries Ltd...(Holding, Christopher) (Entered: 02/08/2021) |
2/8/2021 | 217 | NOTICE OF APPEARANCE by Brian Timothy Burgess on behalf of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc...(Burgess, Brian) (Entered: 02/08/2021) |
2/8/2021 | 216 | MEMORANDUM OF LAW in Support re: 215 MOTION to Dismiss for Lack of Jurisdiction . . Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis Inc., Alkem Laboratories Ltd., Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Ireland, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Pharma, Inc...(Bonder, Teresa) (Entered: 02/08/2021) |
2/8/2021 | 215 | MOTION to Dismiss for Lack of Jurisdiction . Document filed by ANI Pharmaceuticals, Inc., AbbVie Inc., Actavis Inc., Alkem Laboratories Ltd., Allergan USA, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Ireland, Ltd., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Pharma, Inc.. (Attachments: # 1 Text of Proposed Order).(Bonder, Teresa) (Entered: 02/08/2021) |
2/8/2021 | 214 | RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Glenmark Pharmaceuticals Ltd. for Glenmark Generics Inc., USA, Glenmark Pharmaceuticals S.A.. Document filed by Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A...(Bonder, Teresa) (Entered: 02/08/2021) |
2/8/2021 | 213 | FILING ERROR - CORPORATE PARENT/OTHER AFFILIATE NOT ADDED - RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by ANI Pharmaceuticals, Inc...(Echtman, Elyse) Modified on 2/9/2021 (ldi). (Entered: 02/08/2021) |
2/8/2021 | 212 | NOTICE OF APPEARANCE by Elyse D. Echtman on behalf of ANI Pharmaceuticals, Inc...(Echtman, Elyse) (Entered: 02/08/2021) |
2/8/2021 | 211 | MOTION for John ("Jay") Jurata, Jr. to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23858536. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by ANI Pharmaceuticals, Inc.. (Attachments: # 1 Affidavit of John Jurata, Jr. in Support, # 2 Certificate of Good Standing - DC, # 3 Certificate of Good Standing - VA, # 4 Text of Proposed Order).(Jurata, John) (Entered: 02/08/2021) |
2/8/2021 | 210 | MOTION for James Tierney to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23858224. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by ANI Pharmaceuticals, Inc.. (Attachments: # 1 Affidavit of James Tierney in Support, # 2 Certificate of Good Standing - DC, # 3 Certificate of Good Standing - MD, # 4 Text of Proposed Order).(Tierney, James) (Entered: 02/08/2021) |
2/7/2021 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 209 MOTION for Eric Grannon to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23842623. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) (Entered: 02/07/2021) |
2/5/2021 | 209 | MOTION for Eric Grannon to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23842623. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by AbbVie Inc., Actavis Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, Ltd., Forest Laboratories, LLC, Watson Pharmaceuticals Inc.. (Attachments: # 1 Affidavit, # 2 DC - Certificate of Good Standing, # 3 MD - Certificate of Good Standing, # 4 Text of Proposed Order).(Grannon, Eric) (Entered: 02/05/2021) |
2/5/2021 | 208 | NOTICE OF APPEARANCE by Brian D Brooks on behalf of Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund..(Brooks, Brian) (Entered: 02/05/2021) |
2/3/2021 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 207 MOTION for Anna T. Neill to Appear Pro Hac Vice "Corrected". Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) (Entered: 02/03/2021) |
2/3/2021 | 207 | MOTION for Anna T. Neill to Appear Pro Hac Vice "Corrected". Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by ALBERTSONS COMPANIES, INC., H-E-B L.P., The Kroger Co., Walgreen Co...(Perwin, Scott) (Entered: 02/03/2021) |
2/2/2021 | 206 | NOTICE of Memorandum of Law in Support of Interim Co-Lead Counsel's Motion for Clarification and Permission to Delegate Work to Selected Counsel re: 205 Notice (Other). Document filed by J M Smith Corporation..(Gerstein, Bruce) (Entered: 02/02/2021) |
2/2/2021 | 205 | NOTICE of Interim Co-Lead Counsel's Motion for Clarification and Permission to Delegate Work to Selected Counsel. Document filed by J M Smith Corporation. (Attachments: # 1 Text of Proposed Order).(Gerstein, Bruce) (Entered: 02/02/2021) |
2/1/2021 | | CASE ACCEPTED AS RELATED. Create association to 1:20-cv-09793-LJL. Notice of Assignment to follow. (ks) (Entered: 02/01/2021) |
2/1/2021 | | CASE ACCEPTED AS RELATED. Create association to 1:20-cv-10087-LJL. Notice of Assignment to follow. (ks) (Entered: 02/01/2021) |
2/1/2021 | 204 | ORDER: IT IS HEREBY ORDERED that the Clerk's Office shall associate the CVS & Rite Aid case (Case No. 1:20-cv-10087-LJL) and the Walgreen case (Case No. 1:20-cv-09793-LJL) as related cases to In re Bystolic Antitrust Litigation, Case No. 1:20-cv-05735-LJL, in the CM/ECF system. (Signed by Judge Lewis J. Liman on 2/1/2021) (ks) (Entered: 02/01/2021) |
2/1/2021 | 203 | ORDER granting 196 Motion for Scott E. Perwin to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 02/01/2021) |
2/1/2021 | 202 | ORDER granting 197 Motion for Lauren C. Ravkind to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 02/01/2021) |
2/1/2021 | 201 | AFFIDAVIT OF SERVICE. Watson Laboratories, Inc. (NY) served on 1/15/2021, answer due 2/5/2021. Service was accepted by Carol Doe and Aiasha Doe. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 02/01/2021) |
2/1/2021 | 200 | AFFIDAVIT OF SERVICE. Amerigen Pharmaceuticals Ltd. served on 1/14/2021, answer due 2/4/2021. Service was accepted by via drop-box, at Corporation Service Company. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 02/01/2021) |
2/1/2021 | 199 | AFFIDAVIT OF SERVICE. Amerigen Pharmaceuticals Inc. served on 1/14/2021, answer due 2/4/2021. Service was accepted by via drop-box, at Corporation Service Company. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 02/01/2021) |
1/29/2021 | 198 | LETTER addressed to Judge Lewis J. Liman from Caitlin V. McHugh dated January 29, 2021 re: Association of CVS & Walgreen cases as related to In re Bystolic Antitrust Litigation in the CM/ECF system. Document filed by ALBERTSONS COMPANIES, INC., CVS Pharmacy, Inc., H-E-B L.P., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, The Kroger Co., Walgreen Co.. (Attachments: # 1 Text of Proposed Order).(McHugh, Caitlin) (Entered: 01/29/2021) |
1/28/2021 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 197 MOTION for Lauren C. Ravkind to Appear Pro Hac Vice (REFILING IN MAIN DOCKET). Motion and supporting papers to be reviewed by Clerk's Office staff., 196 MOTION for Scott E. Perwin to Appear Pro Hac Vice (REFILING IN MAIN DOCKET). Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) (Entered: 01/28/2021) |
1/28/2021 | 197 | MOTION for Lauren C. Ravkind to Appear Pro Hac Vice (REFILING IN MAIN DOCKET). Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by ALBERTSONS COMPANIES, INC., H-E-B L.P., The Kroger Co., Walgreen Co...(Perwin, Scott) (Entered: 01/28/2021) |
1/28/2021 | 196 | MOTION for Scott E. Perwin to Appear Pro Hac Vice (REFILING IN MAIN DOCKET). Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by ALBERTSONS COMPANIES, INC., H-E-B L.P., The Kroger Co., Walgreen Co...(Perwin, Scott) (Entered: 01/28/2021) |
1/28/2021 | | >>>NOTICE REGARDING DEFICIENT MOTION TO APPEAR PRO HAC VICE. Notice to RE-FILE Document No. 195 MOTION for Anna T. Neill to Appear Pro Hac Vice (REFILING IN MAIN DOCKET). Motion and supporting papers to be reviewed by Clerk's Office staff. The filing is deficient for the following reason(s): expired Certificate of Good Standing from Supreme Court of Florida; The case number is incorrect. Re-file the corrected motion as a Motion to Appear Pro Hac Vice - attach the correct signed PDF - select the correct named filer/filers - attach valid Certificates of Good Standing issued within the past 30 days - attach Proposed Order. (aea) (Entered: 01/28/2021) |
1/28/2021 | 195 | FILING ERROR - DEFICIENT DOCKET ENTRY - MOTION for Anna T. Neill to Appear Pro Hac Vice (REFILING IN MAIN DOCKET). Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by ALBERTSONS COMPANIES, INC., H-E-B L.P., The Kroger Co., Walgreen Co...(Perwin, Scott) Modified on 1/28/2021 (aea). (Entered: 01/28/2021) |
1/27/2021 | 194 | ORDER granting 181 Motion for Monica L. Kiley to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 01/27/2021) |
1/27/2021 | 193 | ORDER granting 180 Motion for Eric L. Bloom to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 01/27/2021) |
1/27/2021 | 192 | ORDER granting 176 Motion for Chelsea M. Nichols to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 01/27/2021) |
1/27/2021 | 191 | ORDER granting 175 Motion for Travis Roher to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 01/27/2021) |
1/27/2021 | 190 | ORDER granting 174 Motion for Barry L. Refsin to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 01/27/2021) |
1/27/2021 | 189 | ORDER granting 173 Motion for Caitlin V McHugh to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 01/27/2021) |
1/27/2021 | 188 | ORDER granting 88 Motion for Donna M. Evans to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 01/27/2021) |
1/27/2021 | 187 | ORDER granting 87 Motion for Jessica Weiner to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 01/27/2021) |
1/27/2021 | 186 | ORDER granting 74 Motion for Noah A. Brumfield to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 01/27/2021) |
1/27/2021 | 185 | ORDER granting 73 Motion for Susan C. Segura to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 01/27/2021) |
1/27/2021 | 184 | WAIVER OF SERVICE RETURNED EXECUTED. Glenmark Pharmaceuticals S.A. waiver sent on 1/27/2021, answer due 3/29/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 01/27/2021) |
1/27/2021 | 183 | ORDER granting 72 Motion for Erin R. Leger to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) () (Entered: 01/27/2021) |
1/27/2021 | 182 | ORDER granting 56 Motion for Amanda Hass to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 01/27/2021) |
1/25/2021 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 180 MOTION for Eric L. Bloom to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23649179. Motion and supporting papers to be reviewed by Clerk's Office staff., 181 MOTION for Monica L. Kiley to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23649529. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) (Entered: 01/25/2021) |
1/22/2021 | 181 | MOTION for Monica L. Kiley to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23649529. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,. (Attachments: # 1 Declaration of Monica L. Kiley in Support of Motion for Admission Pro Hac Vice, # 2 Certificate of Good Standing - Supreme Court of Pennsylvania, # 3 Text of Proposed Order).(Kiley, Monica) (Entered: 01/22/2021) |
1/22/2021 | 180 | MOTION for Eric L. Bloom to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23649179. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,. (Attachments: # 1 Declaration of Eric L. Bloom in Support of Motion for Admission Pro Hac Vice, # 2 Certificate of Good Standing - Supreme Court of Pennsylvania, # 3 Text of Proposed Order).(Bloom, Eric) (Entered: 01/22/2021) |
1/22/2021 | 179 | WAIVER OF SERVICE RETURNED EXECUTED. ANI Pharmaceuticals, Inc. waiver sent on 1/6/2021, answer due 3/8/2021. Document filed by Rite Aid Corporation; Rite Aid Hdqtrs. Corp.,; CVS Pharmacy, Inc...(Egervary, Alexander) (Entered: 01/22/2021) |
1/15/2021 | 178 | ORDER denying (79) Motion to Change Venue in case 1:20-cv-05735-LJL. Defendants' motion to transfer venue is DENIED. The Clerk of Court is respectfully directed to terminate the motion at Dkt. No. 79. SO ORDERED. (Signed by Judge Lewis J. Liman on 1/15/2021) Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL (va) (Entered: 01/15/2021) |
1/12/2021 | 177 | AFFIDAVIT OF SERVICE. ANI Pharmaceuticals, Inc. served on 1/11/2021, answer due 2/2/2021. Service was accepted by Patrick Duffy. Document filed by J M Smith Corporation; KPH Healthcare Services, Inc...(Hennings, Kimberly) (Entered: 01/12/2021) |
1/12/2021 | | ***DELETED DOCUMENT. Deleted document number [177, 178 and 179] Summonses Issued. The document was incorrectly filed in this case. (gp) Modified on 1/12/2021 (gp). (Entered: 01/12/2021) |
1/8/2021 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 176 MOTION for Chelsea M. Nichols to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23418567. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) (Entered: 01/08/2021) |
1/8/2021 | 176 | MOTION for Chelsea M. Nichols to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23418567. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,. (Attachments: # 1 Declaration of Chelsea M. Nichols in Support of Motion for Admission Pro Hac Vice, # 2 Certificate of Good Standing - Supreme Court of Pennsylvania, # 3 Text of Proposed Order).(Nichols, Chelsea) (Entered: 01/08/2021) |
1/8/2021 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 175 MOTION for Travis Roher to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23417316. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) (Entered: 01/08/2021) |
1/8/2021 | 175 | MOTION for Travis Roher to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23417316. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc...(Schoenstein, Richard) (Entered: 01/08/2021) |
1/8/2021 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 174 MOTION for Barry L. Refsin to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23416284. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) (Entered: 01/08/2021) |
1/8/2021 | 174 | MOTION for Barry L. Refsin to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23416284. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,. (Attachments: # 1 Declaration of Barry L. Refsin in Support of Motion for Admission Pro Hac Vice, # 2 Certificate of Good Standing - Supreme Court of Pennsylvania, # 3 Certificate of Good Standing - Supreme Court of New Jersey, # 4 Text of Proposed Order).(Refsin, Barry) (Entered: 01/08/2021) |
1/7/2021 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 173 MOTION for Caitlin V McHugh to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23405845. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) (Entered: 01/07/2021) |
1/7/2021 | 173 | MOTION for Caitlin V McHugh to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-23405845. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,. (Attachments: # 1 Declaration of Caitlin V. McHugh in Support of Motion for Admission Pro Hac Vice, # 2 Certificate of Good Standing - Supreme Court of Pennsylvania, # 3 Certificate of Good Standing - Supreme Court of New Jersey, # 4 Text of Proposed Order).(McHugh, Caitlin) (Entered: 01/07/2021) |
1/6/2021 | 172 | AFFIDAVIT OF SERVICE. Service was accepted by Lynanne Gares. Document filed by Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, CVS Pharmacy, Inc...(Perwin, Scott) (Entered: 01/06/2021) |
1/6/2021 | 171 | AFFIDAVIT OF SERVICE. Amerigen Pharmaceuticals Inc. served on 12/18/2020, answer due 1/8/2021. Service was accepted by Lynanne Gares. Document filed by Walgreen Co.; H-E-B L.P.; The Kroger Co.; ALBERTSONS COMPANIES, INC...(Perwin, Scott) (Entered: 01/06/2021) |
1/4/2021 | 170 | ***SELECTED PARTIES***NOTICE of Filing re: 161 Order on Motion to Seal. Document filed by Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,, CVS Pharmacy, Inc., ALBERTSONS COMPANIES, INC., ANI Pharmaceuticals, Inc., AbbVie Inc., Abbvie, Inc., Actavis Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals S.A., H-E-B L.P., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., The Kroger Co., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., UFCW Local 1500 Welfare Fund, Walgreen Co., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit REDACTED Amended Complaint, # 2 Exhibit HIGHLIGHTED Sealed Amended Complaint)Motion or Order to File Under Seal: 161 .(Egervary, Alexander) (Entered: 01/04/2021) |
1/4/2021 | 169 | NOTICE of Filing re: 159 CONSENT LETTER MOTION to Seal Amended Complaint addressed to Judge Lewis J. Liman from Alexander J. Egervary dated December 23, 2020.. Document filed by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,. (Attachments: # 1 Exhibit REDACTED Amended Complaint, # 2 Exhibit Sealed Exhibit 2 sheet).(Egervary, Alexander) (Entered: 01/04/2021) |
1/4/2021 | 168 | ***SELECTED PARTIES***NOTICE of of Filing Sealed Amended Complaint re: 160 Order on Motion to Seal. Document filed by All Defendants. (Attachments: # 1 Exhibit REDACTED Amended Complaint, # 2 Exhibit HIGHLIGHTED Sealed Amended Complaint)Motion or Order to File Under Seal: 158 .(Perwin, Scott) (Entered: 01/04/2021) |
1/4/2021 | 167 | NOTICE of of Filing re: 158 CONSENT LETTER MOTION to Seal by Walgreen Plaintiffs addressed to Judge Lewis J. Liman from Scott E. Perwin dated 12/23/2020.. Document filed by ALBERTSONS COMPANIES, INC., H-E-B L.P., The Kroger Co., Walgreen Co.. (Attachments: # 1 Exhibit REDACTED Amended Complaint, # 2 Exhibit Sealed Exhibit 2 Sheet).(Perwin, Scott) (Entered: 01/04/2021) |
1/4/2021 | 166 | WAIVER OF SERVICE RETURNED EXECUTED. ANI Pharmaceuticals, Inc. waiver sent on 12/4/2020, answer due 2/2/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 01/04/2021) |
1/4/2021 | 165 | WAIVER OF SERVICE RETURNED EXECUTED. Alkem Laboratories Ltd. waiver sent on 12/4/2020, answer due 2/2/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 01/04/2021) |
1/4/2021 | 164 | WAIVER OF SERVICE RETURNED EXECUTED. Ascend Laboratories, LLC waiver sent on 12/4/2020, answer due 2/2/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 01/04/2021) |
1/4/2021 | 163 | WAIVER OF SERVICE RETURNED EXECUTED. Indchemie Health Specialties Private Ltd. waiver sent on 12/4/2020, answer due 2/2/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 01/04/2021) |
12/28/2020 | 162 | NOTICE of Withdraw of Appearance of Christopher T Stow-Serge. Document filed by J M Smith Corporation. Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL.(Kelly, Andrew) (Entered: 12/28/2020) |
12/26/2020 | 161 | ORDER granting (159) Letter Motion to Seal in case 1:20-cv-05735-LJL (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL (Liman, Lewis) (Entered: 12/26/2020) |
12/26/2020 | 160 | ORDER granting (158) Letter Motion to Seal in case 1:20-cv-05735-LJL (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL (Liman, Lewis) (Entered: 12/26/2020) |
12/23/2020 | 159 | CONSENT LETTER MOTION to Seal Amended Complaint addressed to Judge Lewis J. Liman from Alexander J. Egervary dated December 23, 2020. Document filed by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp.,..(Egervary, Alexander) (Entered: 12/23/2020) |
12/23/2020 | 158 | CONSENT LETTER MOTION to Seal by Walgreen Plaintiffs addressed to Judge Lewis J. Liman from Scott E. Perwin dated 12/23/2020. Document filed by ALBERTSONS COMPANIES, INC., H-E-B L.P., The Kroger Co., Walgreen Co...(Perwin, Scott) (Entered: 12/23/2020) |
12/19/2020 | 157 | SUMMONS RETURNED EXECUTED Summons and Amended Complaint,,,,,,,,, served. Service was accepted by Sabrina Schaffter. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 12/19/2020) |
12/18/2020 | 156 | WAIVER OF SERVICE RETURNED EXECUTED. Watson Pharma, Inc. waiver sent on 12/4/2020, answer due 2/2/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/18/2020) |
12/18/2020 | 155 | WAIVER OF SERVICE RETURNED EXECUTED. Watson Laboratories, Inc. (NV) waiver sent on 12/4/2020, answer due 2/2/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/18/2020) |
12/18/2020 | 154 | WAIVER OF SERVICE RETURNED EXECUTED. Watson Laboratories, Inc. (DE) waiver sent on 12/4/2020, answer due 2/2/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/18/2020) |
12/18/2020 | 153 | WAIVER OF SERVICE RETURNED EXECUTED. Watson Laboratories, Inc. (CT) waiver sent on 12/4/2020, answer due 2/2/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/18/2020) |
12/18/2020 | 152 | WAIVER OF SERVICE RETURNED EXECUTED. Teva Pharmaceuticals USA, Inc. waiver sent on 12/4/2020, answer due 2/2/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/18/2020) |
12/18/2020 | 151 | WAIVER OF SERVICE RETURNED EXECUTED. Teva Pharmaceutical Industries Ltd. waiver sent on 12/4/2020, answer due 2/2/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/18/2020) |
12/16/2020 | 150 | WAIVER OF SERVICE RETURNED EXECUTED. Actavis Inc. waiver sent on 12/10/2020, answer due 2/8/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/16/2020) |
12/16/2020 | 149 | WAIVER OF SERVICE RETURNED EXECUTED. Watson Pharmaceuticals Inc. waiver sent on 12/10/2020, answer due 2/8/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/16/2020) |
12/16/2020 | 148 | PROTECTIVE ORDER...regarding procedures to be followed that shall govern the handling of confidential material...This Order reflects a proposed order filed by the parties, with the addition of language to the second sentence of paragraph 18. The added language is underlined. (Signed by Judge Lewis J. Liman on 12/16/2020) (mro) (Entered: 12/16/2020) |
12/15/2020 | 147 | PROPOSED PROTECTIVE ORDER. Document filed by J M Smith Corporation, KPH Healthcare Services, Inc., Law Enforcement Health Benefits, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Western Region & Local 177 Health Care Plan, UFCW Local 1500 Welfare Fund. (Attachments: # 1 Exhibit A, # 2 Exhibit B).(Hennings, Kimberly) (Entered: 12/15/2020) |
12/14/2020 | 146 | WAIVER OF SERVICE RETURNED EXECUTED. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 12/14/2020) |
12/11/2020 | 145 | DECLARATION of Peter J. Carney in Support re: 79 MOTION to Change Venue / Defendants' Notice of Motion to Transfer Venue to the District of of New Jersey Pursuant to 28 U.S.C.§ 1404(a).. Document filed by Abbvie, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC. (Attachments: # 1 Exhibit A).(Gidley, John) (Entered: 12/11/2020) |
12/11/2020 | 144 | REPLY MEMORANDUM OF LAW in Support re: 79 MOTION to Change Venue / Defendants' Notice of Motion to Transfer Venue to the District of of New Jersey Pursuant to 28 U.S.C.§ 1404(a). . Document filed by Abbvie, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC..(Gidley, John) (Entered: 12/11/2020) |
12/11/2020 | 143 | WAIVER OF SERVICE RETURNED EXECUTED. Glenmark Pharmaceuticals Ltd. waiver sent on 12/4/2020, answer due 2/2/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/11/2020) |
12/11/2020 | 142 | WAIVER OF SERVICE RETURNED EXECUTED. Glenmark Generics Ltd. waiver sent on 12/4/2020, answer due 2/2/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/11/2020) |
12/11/2020 | 141 | WAIVER OF SERVICE RETURNED EXECUTED. Glenmark Generics Inc., USA waiver sent on 12/4/2020, answer due 2/2/2021. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/11/2020) |
12/10/2020 | 140 | ***SELECTED PARTIES*** LETTER addressed to Judge Lewis J. Liman from Peter J. Carney dated December 10, 2020 re: Pursuant to Paragraph 13 of the Joint Case Management Plan and Scheduling Order No. 1 (CMO), ECF No. 82, and this Court's Individual Practices in Civil Cases Sections 1.B and 2.G.. Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Allergan Sales LLC, Hetero USA Inc., J M Smith Corporation, Glenmark Generics Inc., USA, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Actavis Inc., Allergan, Inc., Mayor and City Council of Baltimore, Indchemie Health Specialties Private Ltd., UFCW Local 1500 Welfare Fund, Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Glenmark Generics Ltd., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), KPH Healthcare Services, Inc., Glenmark Pharmaceuticals S.A., Forest Laboratories, LLC, Torrent Pharma Inc., Forest Laboratories, Inc., Forest Laboratories Inc., Hetero Labs Ltd, Hetero Drugs LTD., Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Ireland, LTD. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)Motion or Order to File Under Seal: 139 .(Carney, Peter) (Entered: 12/10/2020) |
12/10/2020 | 139 | LETTER MOTION to Seal [Public Version] addressed to Judge Lewis J. Liman from Peter J. Carney dated December 10, 2020. Document filed by AbbVie Inc., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Ireland, LTD, Forest Laboratories, Inc., Forest Laboratories, LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2).(Carney, Peter) (Entered: 12/10/2020) |
12/8/2020 | 138 | ELECTRONIC SUMMONS ISSUED as to Watson Laboratories, Inc. (NY)..(dnh) (Entered: 12/08/2020) |
12/8/2020 | 137 | ELECTRONIC SUMMONS ISSUED as to Watson Laboratories, Inc. (NY)..(dnh) (Entered: 12/08/2020) |
12/8/2020 | 136 | ELECTRONIC SUMMONS ISSUED as to Amerigen Pharmaceuticals Inc...(dnh) (Entered: 12/08/2020) |
12/8/2020 | 135 | ELECTRONIC SUMMONS ISSUED as to Amerigen Pharmaceuticals Ltd...(dnh) (Entered: 12/08/2020) |
12/8/2020 | 134 | ELECTRONIC SUMMONS ISSUED as to Glenmark Pharmaceuticals Ltd...(dnh) (Entered: 12/08/2020) |
12/8/2020 | 133 | ELECTRONIC SUMMONS ISSUED as to Glenmark Pharmaceuticals S.A...(dnh) (Entered: 12/08/2020) |
12/8/2020 | 132 | ELECTRONIC SUMMONS ISSUED as to Torrent Pharmaceuticals Ltd...(dnh) (Entered: 12/08/2020) |
12/8/2020 | 131 | ELECTRONIC SUMMONS ISSUED as to ANI Pharmaceuticals, Inc...(dnh) (Entered: 12/08/2020) |
12/7/2020 | 130 | REQUEST FOR ISSUANCE OF SUMMONS as to Watson Laboratories, Inc. (NY), re: 113 Amended Complaint,,,,,,,,,,. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/07/2020) |
12/7/2020 | 129 | REQUEST FOR ISSUANCE OF SUMMONS as to Watson Laboratories, Inc. (NY), re: 113 Amended Complaint,,,,,,,,,,. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/07/2020) |
12/7/2020 | 128 | REQUEST FOR ISSUANCE OF SUMMONS as to Amerigen Pharmaceuticals, Inc., re: 113 Amended Complaint,,,,,,,,,,. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/07/2020) |
12/7/2020 | 127 | REQUEST FOR ISSUANCE OF SUMMONS as to Amerigen Pharmaceuticals, Ltd., re: 113 Amended Complaint,,,,,,,,,,. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/07/2020) |
12/7/2020 | 126 | REQUEST FOR ISSUANCE OF SUMMONS as to Glenmark Pharmaceuticals Ltd., re: 113 Amended Complaint,,,,,,,,,,. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/07/2020) |
12/7/2020 | 125 | REQUEST FOR ISSUANCE OF SUMMONS as to Glenmark Pharmaceuticals S.A., re: 113 Amended Complaint,,,,,,,,,,. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/07/2020) |
12/7/2020 | 124 | REQUEST FOR ISSUANCE OF SUMMONS as to Torrent Pharmaceuticals Ltd., re: 113 Amended Complaint,,,,,,,,,,. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/07/2020) |
12/7/2020 | 123 | REQUEST FOR ISSUANCE OF SUMMONS as to ANI Pharmaceuticals, Inc., re: 113 Amended Complaint,,,,,,,,,,. Document filed by Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 12/07/2020) |
12/7/2020 | 122 | ELECTRONIC SUMMONS ISSUED as to ANI Pharmaceuticals, Inc...(pc) (Entered: 12/07/2020) |
12/7/2020 | 121 | ELECTRONIC SUMMONS ISSUED as to Glenmark Pharmaceuticals Ltd...(pc) (Entered: 12/07/2020) |
12/7/2020 | 120 | NOTICE OF APPEARANCE by Noah Brumfield on behalf of Actavis, Inc., Watson Pharmaceuticals Inc...(Brumfield, Noah) (Entered: 12/07/2020) |
12/7/2020 | 119 | NOTICE OF APPEARANCE by Peter J. Carney on behalf of Actavis, Inc., Watson Pharmaceuticals Inc...(Carney, Peter) (Entered: 12/07/2020) |
12/7/2020 | 118 | NOTICE OF APPEARANCE by John Mark Gidley on behalf of Actavis, Inc., Watson Pharmaceuticals Inc...(Gidley, John) (Entered: 12/07/2020) |
12/7/2020 | 117 | NOTICE OF CHANGE OF ADDRESS by Janet Beth Linn on behalf of Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc.. New Address: Tarter Krinsky & Drogin, LLP, 1350 Broadway, 11th Floor, New York, New York, United States 10018, 212-216-8000..(Linn, Janet) (Entered: 12/07/2020) |
12/5/2020 | 116 | REQUEST FOR ISSUANCE OF SUMMONS as to Glenmark Pharmaceuticals Ltd., re: 111 Amended Complaint,,,,,,,,,. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 12/05/2020) |
12/5/2020 | 115 | REQUEST FOR ISSUANCE OF SUMMONS as to ANI Pharmaceuticals, Inc., re: 111 Amended Complaint,,,,,,,,,. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 12/05/2020) |
12/4/2020 | 114 | NOTICE OF APPEARANCE by Janet Beth Linn on behalf of Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc...(Linn, Janet) (Entered: 12/04/2020) |
12/3/2020 | 113 | ***SELECTED PARTIES*** AMENDED COMPLAINT amending 1 Complaint, against Forest Laboratories Ireland, Ltd., AbbVie Inc., Forest Laboratories Holdings, Ltd., Allergan Sales LLC, Actavis, Inc., Hetero USA Inc., Glenmark Generics Inc., USA, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Allergan, Inc., Amerigen Pharmaceuticals Ltd., Indchemie Health Specialties Private Ltd., Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Abbvie, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Amerigen Pharmaceuticals Inc., Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, LLC, Forest Laboratories Inc., Forest Laboratories, Inc., Allergan USA, Inc., Allergan, Inc., Allergan Sales, LLC, Hetero Labs Ltd, Forest Laboratories Ireland, LTD, Hetero Drugs LTD., Forest Laboratories, LLC, Forest Laboratories Holdings Ltd., ANI Pharmaceuticals, Inc., Actavis Inc., Glenmark Pharmaceuticals Ltd. with JURY DEMAND.Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Forest Laboratories Holdings, Ltd., Allergan Sales LLC, Actavis, Inc., Hetero USA Inc., Law Enforcement Health Benefits, Inc., Glenmark Generics Inc., USA, Teamsters Local No. 1150 Prescription Drug Benefit Plan, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Allergan, Inc., Mayor and City Council of Baltimore, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Amerigen Pharmaceuticals Ltd., Indchemie Health Specialties Private Ltd., UFCW Local 1500 Welfare Fund, Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Abbvie, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Amerigen Pharmaceuticals Inc., Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, LLC, Forest Laboratories Inc., Forest Laboratories, Inc., Teamsters Western Region & Local 177 Health Care Plan, Allergan USA, Inc., Allergan, Inc., Allergan Sales, LLC, Hetero Labs Ltd, Forest Laboratories Ireland, LTD, Hetero Drugs LTD., Forest Laboratories, LLC, Forest Laboratories Holdings Ltd., ANI Pharmaceuticals, Inc., Actavis Inc., Glenmark Pharmaceuticals Ltd.. Related document: 1 Complaint,.Motion or Order to File Under Seal: 112 .(Robertson, Sharon) (Entered: 12/03/2020) |
12/3/2020 | 112 | LETTER MOTION to Seal End-Payor Plaintiffs' Consolidated Class Action Complaint addressed to Judge Lewis J. Liman from Sharon K. Robertson and Robin A. van der Meulen dated December 3, 2020. Document filed by Mayor and City Council of Baltimore, UFCW Local 1500 Welfare Fund, Teamsters Western Region & Local 177 Health Care Plan, Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund..(Robertson, Sharon) (Entered: 12/03/2020) |
12/3/2020 | 111 | ***SELECTED PARTIES*** AMENDED COMPLAINT amending 1 Complaint, against Forest Laboratories Ireland, Ltd., AbbVie Inc., Forest Laboratories Holdings, Ltd., Allergan Sales LLC, Actavis, Inc., Hetero USA Inc., Glenmark Generics Inc., USA, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Allergan, Inc., Amerigen Pharmaceuticals Ltd., Indchemie Health Specialties Private Ltd., Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Abbvie, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Amerigen Pharmaceuticals Inc., Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, LLC, Forest Laboratories Inc., Forest Laboratories, Inc., Allergan USA, Inc., Allergan, Inc., Allergan Sales, LLC, Hetero Labs Ltd, Forest Laboratories Ireland, LTD, Hetero Drugs LTD., Forest Laboratories, LLC, Forest Laboratories Holdings Ltd. with JURY DEMAND.Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Forest Laboratories Holdings, Ltd., Allergan Sales LLC, Actavis, Inc., Hetero USA Inc., Glenmark Generics Inc., USA, J M Smith Corporation, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Allergan, Inc., Amerigen Pharmaceuticals Ltd., Indchemie Health Specialties Private Ltd., Allergan USA, Inc., Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Abbvie, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Glenmark Generics Ltd., Watson Laboratories, Inc. (CT), Amerigen Pharmaceuticals Inc., KPH Healthcare Services, Inc., Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, LLC, Forest Laboratories Inc., Forest Laboratories, Inc., Allergan USA, Inc., Allergan, Inc., Allergan Sales, LLC, Hetero Labs Ltd, Forest Laboratories Ireland, LTD, Hetero Drugs LTD., Forest Laboratories, LLC, Forest Laboratories Holdings Ltd., Mayor and City Council of Baltimore, UFCW Local 1500 Welfare Fund. Related document: 1 Complaint,.Motion or Order to File Under Seal: 110 .(Hennings, Kimberly) (Entered: 12/03/2020) |
12/3/2020 | 110 | LETTER MOTION to Seal Direct Purchaser Class Plaintiffs' Consolidated and Amended Class Action Complaint addressed to Judge Lewis J. Liman from Kimberly M. Hennings dated 12/03/2020. Document filed by J M Smith Corporation, KPH Healthcare Services, Inc...(Hennings, Kimberly) (Entered: 12/03/2020) |
12/3/2020 | 109 | NOTICE of CORRECTED NOTICE OF APPEARANCE AND REQUEST FOR SERVICE OF PAPERS. Document filed by Hetero USA Inc...(Schoenstein, Richard) (Entered: 12/03/2020) |
12/3/2020 | 108 | NOTICE OF APPEARANCE by Richard Carl Schoenstein on behalf of Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc...(Schoenstein, Richard) (Entered: 12/03/2020) |
12/2/2020 | 107 | ***SELECTED PARTIES*** LETTER addressed to Judge Lewis J. Liman from Peter J. Carney dated December 2, 2020 re: Pursuant to Paragraph 13 of the Joint Case Management Plan and Scheduling Order No. 1 (CMO), ECF No. 82 , and this Court's Individual Practices in Civil Cases Sections 1.B and 2.G. Document filed by Forest Laboratories Ireland, Ltd., AbbVie Inc., Forest Laboratories Holdings, Ltd., Allergan Sales LLC, Actavis, Inc., Hetero USA Inc., J M Smith Corporation, Glenmark Generics Inc., USA, Glenmark Generics Inc., Watson Laboratories, Inc. (NV), Mayor and City Council of Baltimore, Indchemie Health Specialties Private Ltd., UFCW Local 1500 Welfare Fund, Ascend Laboratories, LLC, Watson Laboratories, Inc. (DE), Watson Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (NY), Teva Pharmaceutical Industries Ltd., Watson Pharma, Inc., Alkem Laboratories Ltd., Glenmark Generics Ltd., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), KPH Healthcare Services, Inc., Glenmark Pharmaceuticals S.A., Torrent Pharma Inc., Forest Laboratories, Inc., Forest Laboratories Inc., Allergan USA, Inc., Hetero Labs Ltd, Allergan, Inc., Hetero Drugs LTD., Forest Laboratories, LLC, Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories, LLC. (Attachments: # 1 Exhibit B, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit E, # 5 Exhibit F, # 6 Exhibit G, # 7 Exhibit H, # 8 Exhibit I, # 9 Exhibit J, # 10 Exhibit K, # 11 Exhibit L, # 12 Exhibit M, # 13 Exhibit N, # 14 Exhibit O, # 15 Exhibit P)Motion or Order to File Under Seal: 106 .(Carney, Peter) (Entered: 12/02/2020) |
12/2/2020 | 106 | LETTER MOTION to Seal [Public Version] addressed to Judge Lewis J. Liman from Peter J. Carney dated December 2, 2020. Document filed by AbbVie Inc., Allergan Sales, LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC. (Attachments: # 1 Exhibit B, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit E, # 5 Exhibit F, # 6 Exhibit G, # 7 Exhibit H, # 8 Exhibit I, # 9 Exhibit J, # 10 Exhibit K, # 11 Exhibit L, # 12 Exhibit M, # 13 Exhibit N, # 14 Exhibit O, # 15 Exhibit P).(Carney, Peter) (Entered: 12/02/2020) |
12/1/2020 | 105 | NOTICE OF APPEARANCE by Archana Tamoshunas on behalf of Mayor and City Council of Baltimore..(Tamoshunas, Archana) (Entered: 12/01/2020) |
11/30/2020 | 104 | ***SELECTED PARTIES***DECLARATION of Kimberly M. Hennings in Opposition re: 79 MOTION to Change Venue / Defendants' Notice of Motion to Transfer Venue to the District of of New Jersey Pursuant to 28 U.S.C.§ 1404(a).. Document filed by J M Smith Corporation, Mayor and City Council of Baltimore, UFCW Local 1500 Welfare Fund, KPH Healthcare Services, Inc., AbbVie Inc., Abbvie, Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R)Motion or Order to File Under Seal: 102 .(Hennings, Kimberly) (Entered: 11/30/2020) |
11/30/2020 | 103 | ***SELECTED PARTIES*** MEMORANDUM OF LAW in Opposition re: 79 MOTION to Change Venue / Defendants' Notice of Motion to Transfer Venue to the District of of New Jersey Pursuant to 28 U.S.C.§ 1404(a). . Document filed by J M Smith Corporation, Mayor and City Council of Baltimore, UFCW Local 1500 Welfare Fund, KPH Healthcare Services, Inc., AbbVie Inc., Abbvie, Inc., Actavis, Inc., Alkem Laboratories Ltd., Allergan Sales LLC, Allergan Sales, LLC, Allergan USA, Inc., Allergan USA, Inc., Allergan, Inc., Allergan, Inc., Amerigen Pharmaceuticals Inc., Amerigen Pharmaceuticals Ltd., Ascend Laboratories, LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Holdings, Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Ireland, Ltd., Forest Laboratories, Inc., Forest Laboratories, LLC, Forest Laboratories, LLC, Glenmark Generics Inc., Glenmark Generics Inc., USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals S.A., Hetero Drugs LTD., Hetero Labs Ltd, Hetero USA Inc., Indchemie Health Specialties Private Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Watson Laboratories, Inc. (CT), Watson Laboratories, Inc. (DE), Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (NY), Watson Pharma, Inc., Watson Pharmaceuticals Inc.. Motion or Order to File Under Seal: 102 .(Hennings, Kimberly) (Entered: 11/30/2020) |
11/30/2020 | 102 | LETTER MOTION to Seal addressed to Judge Lewis J. Liman from Kimberly M. Hennings dated 11/30/2020. Document filed by J M Smith Corporation, KPH Healthcare Services, Inc., Mayor and City Council of Baltimore, UFCW Local 1500 Welfare Fund..(Hennings, Kimberly) (Entered: 11/30/2020) |
11/30/2020 | 101 | ORDER denying without prejudice 97 Letter Motion to Seal. ORDERED that this motion is DENIED WITHOUT PREJUDICE. The documents that the plaintiffs have moved to seal were filed ex-parte. See Dkt. Nos. 98 and 99. Pursuant to Rule 2(G) of the Court's Individual Practices and paragraph 13 of the operative case management plan, at Dkt. No. 24, a motion to seal must be accompanied by contemporaneous filing of the documents that are the subject of the motion, and such documents must be filed under seal, not ex-parte. Plaintiffs are directed to re-file the documents at Dkt. Nos. 98 and 99 under seal, along with a renewed motion to seal. The Court will then follow the procedure prescribed in paragraph 13 of the case management plan at Dkt. No. 24. SO ORDERED. (Signed by Judge Lewis J. Liman on 11/30/2020) (jca) (Entered: 11/30/2020) |
11/24/2020 | 100 | DECLARATION of Kimberly M. Hennings in Opposition re: 79 MOTION to Change Venue / Defendants' Notice of Motion to Transfer Venue to the District of of New Jersey Pursuant to 28 U.S.C.§ 1404(a).. Document filed by J M Smith Corporation, KPH Healthcare Services, Inc., Mayor and City Council of Baltimore, UFCW Local 1500 Welfare Fund. (Attachments: # 1 Exhibit Q, # 2 Exhibit R).(Hennings, Kimberly) (Entered: 11/24/2020) |
11/24/2020 | 99 | ***EX-PARTE***DECLARATION of Kimberly M. Hennings in Opposition re: 79 MOTION to Change Venue / Defendants' Notice of Motion to Transfer Venue to the District of of New Jersey Pursuant to 28 U.S.C.§ 1404(a).. Document filed by J M Smith Corporation, KPH Healthcare Services, Inc., Mayor and City Council of Baltimore, UFCW Local 1500 Welfare Fund. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P)Motion or Order to File Under Seal: 97 .(Hennings, Kimberly) (Entered: 11/24/2020) |
11/24/2020 | 98 | ***EX-PARTE***JOINT MEMORANDUM OF LAW in Opposition re: 79 MOTION to Change Venue / Defendants' Notice of Motion to Transfer Venue to the District of of New Jersey Pursuant to 28 U.S.C.§ 1404(a). . Document filed by J M Smith Corporation, KPH Healthcare Services, Inc., Mayor and City Council of Baltimore, UFCW Local 1500 Welfare Fund. Motion or Order to File Under Seal: 97 .(Hennings, Kimberly) (Entered: 11/24/2020) |
11/24/2020 | 97 | LETTER MOTION to Seal addressed to Judge Lewis J. Liman from Kimberly M. Hennings dated 11/24/2020. Document filed by J M Smith Corporation, KPH Healthcare Services, Inc., Mayor and City Council of Baltimore, UFCW Local 1500 Welfare Fund..(Hennings, Kimberly) (Entered: 11/24/2020) |
11/23/2020 | 96 | NOTICE OF APPEARANCE by Matthew Joseph Perez on behalf of UFCW Local 1500 Welfare Fund..(Perez, Matthew) (Entered: 11/23/2020) |
11/23/2020 | 95 | NOTICE OF APPEARANCE by Veronica Bosco on behalf of UFCW Local 1500 Welfare Fund..(Bosco, Veronica) (Entered: 11/23/2020) |
11/23/2020 | 94 | NOTICE OF APPEARANCE by Gregory Scott Asciolla on behalf of UFCW Local 1500 Welfare Fund..(Asciolla, Gregory) (Entered: 11/23/2020) |
11/23/2020 | 93 | NOTICE OF APPEARANCE by Robin Ann Van Der Meulen on behalf of UFCW Local 1500 Welfare Fund..(Van Der Meulen, Robin) (Entered: 11/23/2020) |
11/23/2020 | 92 | NOTICE OF APPEARANCE by Robert Abraham Braun on behalf of Mayor and City Council of Baltimore..(Braun, Robert) (Entered: 11/23/2020) |
11/23/2020 | 91 | NOTICE OF APPEARANCE by Sharon Kunjumon Robertson on behalf of Mayor and City Council of Baltimore..(Robertson, Sharon) (Entered: 11/23/2020) |
11/16/2020 | 90 | NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a CONFERENCE proceeding held on 11/6/2020 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(McGuirk, Kelly) (Entered: 11/16/2020) |
11/16/2020 | 89 | TRANSCRIPT of Proceedings re: CONFERENCE held on 11/6/2020 before Judge Lewis J. Liman. Court Reporter/Transcriber: Vincent Bologna, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 12/7/2020. Redacted Transcript Deadline set for 12/17/2020. Release of Transcript Restriction set for 2/16/2021.Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL.(McGuirk, Kelly) (Entered: 11/16/2020) |
11/16/2020 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 88 MOTION for Donna M. Evans to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-22604711. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) (Entered: 11/16/2020) |
11/16/2020 | 88 | MOTION for Donna M. Evans to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-22604711. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Mayor and City Council of Baltimore. (Attachments: # 1 Declaration of Donna M. Evans in Support of Plaintiff's Motion for Donna M. Evans' Admission Pro Hac Vice, # 2 Certificate of Good Standing, # 3 Text of Proposed Order).(Evans, Donna) (Entered: 11/16/2020) |
11/13/2020 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 87 MOTION for Jessica Weiner to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-22573874. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) (Entered: 11/13/2020) |
11/13/2020 | 87 | MOTION for Jessica Weiner to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-22573874. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Mayor and City Council of Baltimore. (Attachments: # 1 Declaration of Jessica Weiner in Support of Plaintiff's Motion for Jessica Weiner's Admission Pro Hac Vice, # 2 Exhibit Certificates of Good Standing, # 3 Text of Proposed Order).(Weiner, Jessica) (Entered: 11/13/2020) |
11/12/2020 | 86 | ORDER granting in part and denying in part (76) Motion to Appoint Counsel in case 1:20-cv-05735-LJL; granting in part and denying in part (15) Motion to Appoint Counsel in case 1:20-cv-08754-LJL; denying (6) Motion to Appoint Counsel ; granting in part and denying in part (17) Motion to Appoint Counsel in case 1:20-cv-08756-LJL. As an initial matter, all parties agree that the Direct Purchaser Actions should be consolidated with one another. The Clerk of Court is respectfully directed to consolidate the above captioned cases under No. 20-cv-5735. As set forth in the operative case management plan, at No. 20-cv-5735, Dkt. No. 82, the Direct Purchaser Actions will be coordinated with the End Payor Actions. The Court hereby GRANTS the application, at No. 20-cv-5735, Dkt. No. 45, to appoint Bruce E. Gerstein and his firm, Garwin Gerstein & Fisher LLP ("Garwin"), and David F. Sorensen and his firm, Berger Montague PC (Berger), as interim co-lead class counsel for the putative direct purchaser class pursuant to Fed. R. Civ. P. 23(g)(3). Garwin and Bergers request to appoint an executive committee is DENIED. The application to appoint Dianne M. Nast ("Nast") and Michael L. Roberts ("Roberts") as interim lead class counsel is DENIED. The request to appoint an executive committee is denied as further set forth in this Order. (Signed by Judge Lewis J. Liman on 11/12/20) Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL (yv) (Entered: 11/13/2020) |
11/6/2020 | | Minute Entry for proceedings held before Judge Lewis J. Liman: Telephone Conference held on 11/6/2020. Counsel present by telephone for Plaintiffs. Counsel present by telephone for Defendants. Court reporter present by telephone. The Court held a hearing and heard from various counsel on the pending applications to appoint interim lead counsel in the Direct Purchaser Actions. Motions taken under advisement, decision reserved by the Court. Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL(mf) (Entered: 11/17/2020) |
11/6/2020 | 85 | NOTICE OF APPEARANCE by Kristyn Fields on behalf of J M Smith Corporation..(Fields, Kristyn) (Entered: 11/06/2020) |
11/6/2020 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 56 MOTION for Amanda Hass to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) (Entered: 11/06/2020) |
11/5/2020 | 84 | ORDER: The Court will hold a hearing on the pending applications to appoint interim lead counsel in the Direct Purchaser Actions at 4:30 p.m. on Friday, November 6, 2020 by TELEPHONE CONFERENCE. At that date and time the parties are directed to dial the Court's teleconference line at 888-251-2909 (access code: 2123101). At the conference, the parties should be prepared to address: (As further set forth herein.)( Telephone Conference set for 11/6/2020 at 04:30 PM before Judge Lewis J. Liman.) (Signed by Judge Lewis J. Liman on 11/5/2020) (va) (Entered: 11/05/2020) |
11/5/2020 | 83 | ORDER The Court will hold a hearing on the pending motions to appoint interim class counsel in the Direct Purchaser Actions by TELEPHONE CONFERENCE tomorrow, November 6, 2020 at 4:30 p.m. An order with further details is forthcoming shortly. (HEREBY ORDERED by Judge Lewis J. Liman) (Text Only Order) (wt) (Entered: 11/05/2020) |
11/4/2020 | 82 | JOINT CASE MANAGEMENT PLAN AND SCHEDULING ORDER NO. 1: All parties do not consent to conducting all further proceedings before a United States Magistrate Judge, including motions and trial, pursuant to 28 U.S.C. § 636(c). Defendants shall file their motions to transfer by Friday, October 30, 2020. Plaintiffs shall file any opposition(s) to Defendants' motion(s) to transfer no later than Friday, November 24, 2020. Defendants shall file any reply in support of their motion to transfer no later than Monday, December 11, 2020. Oral argument, if any, on the motion to transfer shall be on a date set by the Court. J M Smith Drug Company shall file a Response to KPH's Motion regarding appointment of interim lead counsel for the proposed Direct Purchaser Class by October 30, 2020. Direct Purchaser Plaintiffs and End-Payor Plaintiffs shall file their respective Consolidated Class Action Complaints 21 days following the appointment of interim lead counsel for the direct purchaser class. Plaintiffs may amend their respective Consolidated Class Action Complaints no later than 35 days following the filing of Defendants' motion to dismiss, pursuant to the Court's Individual Practice 3.B. Defendants shall move in response to the Direct Purchaser Plaintiffs' Consolidated Class Action Complaint and the End-Payor Plaintiffs' Consolidated Class Action Complaint no later than 65 days following the filing of Plaintiffs' Consolidated Class Action Complaints. Defendants' Answers shall be due in accordance with Fed. R. Civ. P. 12(a)(4)(A). Direct Purchaser Plaintiffs and End-Payor Plaintiffs shall file their opposition(s) no later than 35 days after Defendants file any motion(s) in response to the Direct Purchaser Plaintiffs' Consolidated Complaint and the End-Payor Plaintiffs' Consolidated Complaint. Defendants shall file their replies in support of their motion(s), if any, no later than 28 days after Plaintiffs file any opposition(s). The parties shall file a proposed Protective Order, or proposed competing Protective Orders if the parties do not reach an agreement, no later than December 15, 2020. The files of the coordinated actions shall be maintained in one file under Case No. 1:20-cv-05735-LJL with the following caption: In re Bystolic Antitrust Litigation. When a filing is intended to apply to all actions, the words "All Actions" should appear immediately after the words "This Document Relates To:" in the caption set out above. When a filing is intended to apply only to one, or to some, but not all, of such actions, the party filing the document should indicate the action(s) to which the document is intended to apply. The parties may indicate, for example, "All Direct Purchaser Actions" or "All End-Payor Actions." Following the Court's ruling on any motions to dismiss, the parties agree to meet and confer on deadlines for the remainder of discovery and post-discovery proceedings, including fact and expert discovery, class certification and summary judgment motions and to submit agreed upon or competing scheduling proposals to the Court within 14 days of any ruling on the motions to dismiss and further set forth in this Order. (Motions due by 10/30/2020. Responses due by 11/24/2020 Replies due by 12/11/2020.) (Signed by Judge Lewis J. Liman on 11/4/2020) (rro) (Entered: 11/04/2020) |
10/30/2020 | 81 | DECLARATION of Peter J. Carney in Support re: 79 MOTION to Change Venue / Defendants' Notice of Motion to Transfer Venue to the District of of New Jersey Pursuant to 28 U.S.C.§ 1404(a).. Document filed by Abbvie, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7).(Gidley, John) (Entered: 10/30/2020) |
10/30/2020 | 80 | MEMORANDUM OF LAW in Support re: 79 MOTION to Change Venue / Defendants' Notice of Motion to Transfer Venue to the District of of New Jersey Pursuant to 28 U.S.C.§ 1404(a). . Document filed by Abbvie, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC..(Gidley, John) (Entered: 10/30/2020) |
10/30/2020 | 79 | MOTION to Change Venue / Defendants' Notice of Motion to Transfer Venue to the District of of New Jersey Pursuant to 28 U.S.C.§ 1404(a). Document filed by Abbvie, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC..(Gidley, John) (Entered: 10/30/2020) |
10/30/2020 | 78 | DECLARATION of Bruce E. Gerstein in Support re: 76 SUPPLEMENTAL MOTION to Appoint Counsel .. Document filed by J M Smith Corporation. (Attachments: # 1 Exhibit - Brand Complaint Comparison, # 2 Exhibit - Generic Complaint Comparison, # 3 Exhibit - Seroquel Complaint Comparison).(Gerstein, Bruce) (Entered: 10/30/2020) |
10/30/2020 | 77 | MEMORANDUM OF LAW in Support re: 76 SUPPLEMENTAL MOTION to Appoint Counsel . . Document filed by J M Smith Corporation..(Gerstein, Bruce) (Entered: 10/30/2020) |
10/30/2020 | 76 | SUPPLEMENTAL MOTION to Appoint Counsel . Document filed by J M Smith Corporation. (Attachments: # 1 Text of Proposed Order).(Gerstein, Bruce) (Entered: 10/30/2020) |
10/30/2020 | 75 | PROPOSED CASE MANAGEMENT PLAN. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 10/30/2020) |
10/28/2020 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 74 MOTION for Noah A. Brumfield to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-22355724. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) (Entered: 10/28/2020) |
10/28/2020 | 74 | MOTION for Noah A. Brumfield to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-22355724. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Abbvie, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC. (Attachments: # 1 Affidavit In Support of Motion for Admission of Noah Brumfield, # 2 Exhibit A - Certificates of Good Standing, # 3 Text of Proposed Order).(Brumfield, Noah) (Entered: 10/28/2020) |
10/26/2020 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 72 MOTION for Erin R. Leger to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-22314842. Motion and supporting papers to be reviewed by Clerk's Office staff., 73 MOTION for Susan C. Segura to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number BNYSDC-22315158. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) (Entered: 10/26/2020) |
10/26/2020 | 73 | MOTION for Susan C. Segura to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number BNYSDC-22315158. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Declaration, # 2 Text of Proposed Order).(Segura, Susan) (Entered: 10/26/2020) |
10/26/2020 | 72 | MOTION for Erin R. Leger to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-22314842. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Declaration, # 2 Text of Proposed Order).(Leger, Erin) (Entered: 10/26/2020) |
10/25/2020 | 71 | NOTICE OF APPEARANCE by Kimberly Marion Hennings on behalf of J M Smith Corporation..(Hennings, Kimberly) (Entered: 10/25/2020) |
10/25/2020 | 70 | ORDER granting 57 Motion for Russell A. Chorush to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 10/25/2020) |
10/25/2020 | 69 | ORDER granting 55 Motion for Dan Chiorean to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 10/25/2020) |
10/25/2020 | 68 | ORDER granting 54 Motion for Stuart E. Des Roches to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 10/25/2020) |
10/25/2020 | 67 | ORDER granting 53 Motion for Chris Letter to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 10/25/2020) |
10/25/2020 | 66 | ORDER granting 51 Motion for Andrew W. Kelly to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 10/25/2020) |
10/25/2020 | 65 | ORDER granting 52 Motion for Christopher T. Stow-Serge to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 10/25/2020) |
10/25/2020 | 64 | ORDER granting 48 Motion for Caitlin G. Coslett to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 10/25/2020) |
10/25/2020 | 63 | ORDER granting 47 Motion for David F. Sorensen to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 10/25/2020) |
10/25/2020 | 62 | ORDER granting 42 Motion for Peter J. Carney to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 10/25/2020) |
10/25/2020 | 61 | ORDER granting 30 Motion for Joseph T. Lukens to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 10/25/2020) |
10/25/2020 | 60 | ORDER granting 29 Motion for Peter Kohn to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lewis J. Liman)(Text Only Order) (wt) (Entered: 10/25/2020) |
10/22/2020 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. (56 in 1:20-cv-05735-LJL) MOTION for Amanda Hass to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. Payment was submitted on 10/22/2020. Filed In Associated Cases: 1:20-cv-05735-LJL, 1:20-cv-07110-LJL, 1:20-cv-08754-LJL, 1:20-cv-08756-LJL(ad) (Entered: 12/09/2020) |
10/22/2020 | 59 | PROPOSED CASE MANAGEMENT PLAN. Document filed by J M Smith Corporation..(Gerstein, Bruce) (Entered: 10/22/2020) |
10/22/2020 | | Pro Hac Vice Fee Payment: for 56 MOTION for Amanda Hass to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff.. Filing fee $ 200.00, receipt number ANYSDC-22266152..(Hass, Amanda) (Entered: 10/22/2020) |
10/21/2020 | 58 | LETTER addressed to Judge Lewis J. Liman from Bruce E. Gerstein dated October 21, 2020 re: Consolidation. Document filed by J M Smith Corporation..(Gerstein, Bruce) (Entered: 10/21/2020) |
10/21/2020 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 57 MOTION for Russell A. Chorush to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-22244549. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (vba) (Entered: 10/21/2020) |
10/21/2020 | 57 | MOTION for Russell A. Chorush to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-22244549. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Declaration of Russell A. Chorush, # 2 Certificate of Good Standing, # 3 Text of Proposed Order).(Chorush, Russell) (Entered: 10/21/2020) |
10/20/2020 | 56 | MOTION for Amanda Hass to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Declaration of Amanda Hass, # 2 Exhibit Certificate of Good Standing for Amanda Hass, # 3 Text of Proposed Order).(Hass, Amanda) Modified on 10/20/2020 (vba). Modified on 11/6/2020 (wb). (Entered: 10/20/2020) |
10/20/2020 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 53 MOTION for Chris Letter to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff., 51 MOTION for Andrew W. Kelly to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff., 54 MOTION for Stuart E. Des Roches to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-22205440. Motion and supporting papers to be reviewed by Clerk's Office staff., 52 MOTION for Christopher T. Stow-Serge to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff., 55 MOTION for Dan Chiorean to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-22205524. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) (Entered: 10/20/2020) |
10/19/2020 | 55 | MOTION for Dan Chiorean to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-22205524. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Declaration of Dan Chiorean, # 2 Exhibit Certificate of Good Standing for Dan Chiorean, # 3 Text of Proposed Order).(Chiorean, Dan) (Entered: 10/19/2020) |
10/19/2020 | 54 | MOTION for Stuart E. Des Roches to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-22205440. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Declaration of Stuart E. Des Roches, # 2 Exhibit Certificate of Good Standing for Stuart E. Des Roches, # 3 Text of Proposed Order).(Des Roches, Stuart) (Entered: 10/19/2020) |
10/19/2020 | 53 | MOTION for Chris Letter to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Declaration of Chris Letter, # 2 Exhibit Certificate of Good Standing for Chris Letter, # 3 Text of Proposed Order).(Letter, Chris) (Entered: 10/19/2020) |
10/19/2020 | 52 | MOTION for Christopher T. Stow-Serge to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Declaration of Christopher Stow-Serge, # 2 Exhibit Certificate of Good Standing for Christopher Stow-Serge, # 3 Text of Proposed Order).(Stow-Serge, Christopher) (Entered: 10/19/2020) |
10/19/2020 | 51 | MOTION for Andrew W. Kelly to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Declaration of Andrew Kelly, # 2 Exhibit Certificate of Good Standing for Andrew Kelly, # 3 Text of Proposed Order).(Kelly, Andrew) (Entered: 10/19/2020) |
10/13/2020 | | Set/Reset Hearings: Initial Conference set for 10/26/2020 at 10:00 AM before Judge Lewis J. Liman. (va) (Entered: 10/13/2020) |
10/13/2020 | 50 | OPINION & ORDER re: (35 in 1:20-cv-05826-LJL) LETTER MOTION for Extension of Time to File Case Management Plan and Scheduling Order and Request for Guidance re: End-Payor Plaintiffs' Leadership Applications addressed to Judge Lewis J. Liman from Sharon Robertson dated September 3, 2 filed by Mayor and City Council of Baltimore. For the foregoing reasons, it is hereby: ORDERED that the motion to appoint Sharon K. Robertson of Cohen Milstein and Robin van der Muelen of Labaton Sucharow as Interim Co-Lead Counsel for the putative class is GRANTED. Cohen Milstein and Labaton Sucharow will be responsible for the overall conduct of the litigation on behalf of the putative class of End-Payor Plaintiffs, including providing supervision of all class Plaintiffs' counsel in this litigation. As Interim Co-Lead Class Counsel, Cohen Milstein and Labaton Sucharow have the authority to: (As further set forth herein this Order.) It is further ORDERED that the motions by other counsel for appointment as interim class counsel for the putative End-Payor class are DENIED. It is further ORDERED that the motion to appoint interim class counsel for the putative Direct Purchaser class is DENIED. It is further ORDERED that Interim Co-Lead Class Counsel may not delegate responsibility or assign legal work to other law firms without the prior approval of the Court. No firm to which to which Interim Co-Lead Counsel delegates responsibility, when delegating with the approval of the Court, may further sub-delegate the work without the prior approval of interim co-lead counsel and the Court. It is further ORDERED that an Initial Pretrial Conference will be held on October 26, 2020 at 10:00 a.m. by TELEPHONE CONFERENCE. At that date and time, the parties are directed to dial the Court's conference line at 888-251-2909 (access code: 2123101). It is further ORDERED that, by October 22, 2020 at 5:00 p.m., interim class counsel for the End-Payor Actions and Defendants thereto, and counsel for the named plaintiff in the Direct Purchaser Actions and Defendants thereto, shall jointly file a single Case Management Plan and Scheduling Order which shall be filed in each of the Direct Purchaser Actions and in the consolidated End-Payor Action, No. 20-cv-5538, and shaLL include the following: (1) a uniform and identical date by which will be filed any amended complaint in the Direct Purchaser Actions and the consolidated amended complaint in the End-Payor Actions; (2) a uniform and identical date by which responsive papers will be due in both the Direct Purchaser and End-Payor Actions; (3) a uniform and identical briefing schedule for any motions to dismiss filed in either the Direct Purchaser or End-Payor Actions; (4) a uniform and identical schedule for discovery and post-discovery conferences and motions that will govern the Direct Purchaser and End-Payor Actions. All deadlines for filing responsive papers are adjourned pending further order of the Court. It is further ORDERED that by October 22, 2020 at 5:00 p.m., counsel in the Direct Purchaser Actions shall file a letter with the Court stating whether the two Direct Purchaser Actions should be consolidated. It is further ORDERED that the End-Payor Actions be consolidated; the Clerk of Court is respectfully directed to consolidate the following cases under No. 20-cv-5538: No. 20-cv-7580; No. 20-cv-7352; No. 20-cv-5837; No. 20-cv-5813; No. 20-cv-7492; No. 20-cv-5826; No. 20-cv-7309; No. 20-cv-5901; No. 20-cv-6769; No. 20-cv-7177; No. 20-cv-6647; No. 20-cv-7296; No. 20-cv-7304. SO ORDERED. (Signed by Judge Lewis J. Liman on 10/13/2020) (va) (Entered: 10/13/2020) |
10/12/2020 | 49 | LETTER addressed to Judge Lewis J. Liman from Dan Litvin dated October 12, 2020 re: Corrected [Proposed] Order Appointing Interim Lead Counsel and an Executive Committee. Document filed by J M Smith Corporation. (Attachments: # 1 Text of Proposed Order Exhibit A - CORRECTED [PROPOSED] ORDER APPOINTING INTERIM LEAD COUNSEL AND AN EXECUTIVE COMMITTEE).(Litvin, Dan) (Entered: 10/12/2020) |
9/29/2020 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 48 MOTION for Caitlin G. Coslett to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number BNYSDC-21898089. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) (Entered: 09/29/2020) |
9/29/2020 | 48 | MOTION for Caitlin G. Coslett to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number BNYSDC-21898089. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Declaration of Caitlin G. Coslett in Support of Plaintiff's Motion for Ms. Coslett's Admission Pro Hac Vice, # 2 Certificate of Good Standing from the Supreme Court of Pennsylvania, # 3 Certificate of Good Standing from the Supreme Court of New Jersey, # 4 Text of Proposed Order).(Coslett, Caitlin) (Entered: 09/29/2020) |
9/21/2020 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 47 MOTION for David F. Sorensen to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-21756267. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (vba) (Entered: 09/21/2020) |
9/21/2020 | 47 | MOTION for David F. Sorensen to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-21756267. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Declaration of David F. Sorensen in Support of Plaintiff's Motion for Mr. Sorensen's Admission Pro Hac Vice, # 2 Certificate of Good Standing from the Supreme Court of Pennsylvania, # 3 Text of Proposed Order).(Sorensen, David) (Entered: 09/21/2020) |
9/14/2020 | 46 | NOTICE OF APPEARANCE by Joseph Opper on behalf of J M Smith Corporation..(Opper, Joseph) (Entered: 09/14/2020) |
9/9/2020 | 45 | LETTER addressed to Judge Lewis J. Liman from Bruce E. Gerstein dated September 9, 2020 re: Application for co-lead counsel in the direct purchaser actions. Document filed by J M Smith Corporation. (Attachments: # 1 Exhibit A - Text of Proposed Order, # 2 Exhibit B - Firm Resumes, # 3 Exhibit C - Transcript - In re Loestrin 24 Fe).(Gerstein, Bruce) (Entered: 09/09/2020) |
9/4/2020 | 44 | ORDER: The Court is in receipt of motions by certain plaintiffs in these related actions informing the Court that those plaintiffs intend to seek the appointment of Interim Lead or Co-Lead Class Counsel pursuant to Federal Rule of Civil Procedure 23(g)(3) and The Manual for Complex Litigation (Fourth Edition) ("Manual") § 10.22. The Court agrees that it is more sensible to delay preparation of a case management plan and the Initial Pretrial Conference until after a decision on a motion to appoint lead counsel. Accordingly, the Initial Pretrial Conference currently scheduled for September 16, 2020 is ADJOURNED pending further order of the Court, and the parties are relieved, temporarily, of the obligation to prepare a proposed case management plan and scheduling order. IT IS FURTHER ORDERED that the End-Payor Plaintiffs shall submit leadership applications by September 9, 2020. Each applicant shall submit a single-spaced letter, not exceeding five pages, with no more than one attachment consisting of a firm or individual applicant resume. No opposition or reply to any application is permitted without permission of the Court. An initial pretrial conference will be scheduled upon a decision on the leadership applications. SO ORDERED. (Signed by Judge Lewis J. Liman on 9/4/2020) (va) (Entered: 09/04/2020) |
9/2/2020 | 43 | LETTER addressed to Judge Lewis J. Liman from Bruce E. Gerstein dated September 2, 2020 re: Complaint Against Generic Manufacturers. Document filed by J M Smith Corporation. (Attachments: # 1 Exhibit Exhibit A - Complaint).(Gerstein, Bruce) (Entered: 09/02/2020) |
9/2/2020 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 42 MOTION for Peter J. Carney to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-21435540. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) (Entered: 09/02/2020) |
9/1/2020 | 42 | MOTION for Peter J. Carney to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-21435540. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Abbvie, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC. (Attachments: # 1 Affidavit, # 2 DC - Certificate of Good Standing, # 3 VA - Certificate of Good Standing, # 4 Text of Proposed Order).(Carney, Peter) (Entered: 09/01/2020) |
8/24/2020 | 41 | LETTER addressed to Judge Lewis J. Liman from Bruce E. Gerstein dated August 24, 2020 re: Objection to Consolidation of Direct Purchaser Cases with End Payor Cases. Document filed by J M Smith Corporation..(Gerstein, Bruce) (Entered: 08/24/2020) |
8/20/2020 | 40 | LETTER addressed to Judge Lewis J. Liman from J. Mark Gidley dated August 20, 2020 re: Confirmation that all Defendants intend to file a timely motion to dismiss in response to the complaint. Document filed by Abbvie, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC..(Gidley, John) (Entered: 08/20/2020) |
8/17/2020 | 39 | ORDER: IT IS HEREBY ORDERED that any party objecting to consolidation shall file a letter on ECF, not to exceed two pages, by August 24, 2020. IT IS FURTHER ORDERED that counsel for all parties appear for an Initial Pretrial Conference by TELEPHONE on September 16, 2020, at 11:00 a.m. Parties are directed to dial into the Court's teleconference number at 888-251-2909, Access Code 2123101, and follow the necessary prompts. Initial Conference set for 9/16/2020 at 11:00 AM before Judge Lewis J. Liman. (Signed by Judge Lewis J. Liman on 8/17/2020) (va) (Entered: 08/17/2020) |
8/12/2020 | 38 | LETTER MOTION for Extension of Time to File Responsive Pleadings addressed to Judge Lewis J. Liman from J. Mark Gidley dated August 12, 2020. Document filed by Abbvie, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC..(Gidley, John) (Entered: 08/12/2020) |
8/12/2020 | 37 | RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent AbbVie Inc. for Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC. Document filed by Abbvie, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC..(Gidley, John) (Entered: 08/12/2020) |
8/12/2020 | 36 | NOTICE OF APPEARANCE by John Mark Gidley on behalf of Abbvie, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC..(Gidley, John) (Entered: 08/12/2020) |
8/12/2020 | | >>>NOTICE REGARDING DEFICIENT MOTION TO APPEAR PRO HAC VICE. Notice to RE-FILE Document No. 35 MOTION for Chris Letter to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-21123498. Motion and supporting papers to be reviewed by Clerk's Office staff... The filing is deficient for the following reason(s): missing Certificate of Good Standing from SUPREME COURT OF LOUISIANA; AFFIDAVIT NOT NOTARIZED;. Re-file the motion as a Corrected Motion to Appear Pro Hac Vice - attach the correct signed PDF - select the correct named filer/filers - attach valid Certificates of Good Standing issued within the past 30 days - attach Proposed Order.. (vba) (Entered: 08/12/2020) |
8/12/2020 | 35 | FILING ERROR - DEFICIENT DOCKET ENTRY - MOTION for Chris Letter to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-21123498. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Affidavit of Chris Letter, # 2 Text of Proposed Order Order for Admission).(Letter, Chris) Modified on 8/12/2020 (vba). (Entered: 08/12/2020) |
8/12/2020 | | >>>NOTICE REGARDING DEFICIENT MOTION TO APPEAR PRO HAC VICE. Notice to RE-FILE Document No. 34 MOTION for Christopher Stow-Serge to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-21122489. Motion and supporting papers to be reviewed by Clerk's Office staff... The filing is deficient for the following reason(s): missing Certificate of Good Standing from SUPREME COURT OF LOUISIANA; AFFIDAVIT NOT NOTARIZED;. Re-file the motion as a Corrected Motion to Appear Pro Hac Vice - attach the correct signed PDF - select the correct named filer/filers - attach valid Certificates of Good Standing issued within the past 30 days - attach Proposed Order.. (vba) (Entered: 08/12/2020) |
8/12/2020 | 34 | FILING ERRROR - DEFICIENT DOCKET ENTRY - MOTION for Christopher Stow-Serge to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-21122489. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Affidavit of Christopher Stow-Serge, # 2 Order for Admission).(Stow-Serge, Christopher) Modified on 8/12/2020 (vba). (Entered: 08/12/2020) |
8/12/2020 | | >>>NOTICE REGARDING DEFICIENT MOTION TO APPEAR PRO HAC VICE. Notice to RE-FILE Document No. 33 MOTION for Andrew Kelly to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-21122016. Motion and supporting papers to be reviewed by Clerk's Office staff... The filing is deficient for the following reason(s): missing Certificate of Good Standing from SUPREME COURT OF LOUISIANA; AFFIDAVIT NOT NOTARIZED;. Re-file the motion as a Corrected Motion to Appear Pro Hac Vice - attach the correct signed PDF - select the correct named filer/filers - attach valid Certificates of Good Standing issued within the past 30 days - attach Proposed Order.. (vba) (Entered: 08/12/2020) |
8/12/2020 | 33 | FILING ERROR - DEFICIENT DOCKET ENTRY - MOTION for Andrew Kelly to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-21122016. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Affidavit of Andrew Kelly, # 2 Text of Proposed Order Order for Admission).(Kelly, Andrew) Modified on 8/12/2020 (vba). (Entered: 08/12/2020) |
8/5/2020 | 32 | CLERK CERTIFICATE OF MAILING of one copy of the Summons (ECF No. 19); Complaint (ECF No. 1); Civil Cover Sheet (ECF No. 2); and Related Case Statement (ECF No. 3) mailed to Forest Laboratories Holdings, Ltd 18 Parliament Street Hamilton HM-11 Bermuda on 8/4/2020 by Federal Express tracking # 7711 4140 2590, to the individual of the foreign state, pursuant to the provisions of FRCP 4(f)2(c)(ii). (smc) (Entered: 08/05/2020) |
8/5/2020 | 31 | CLERK CERTIFICATE OF MAILING of one copy of the the Summons (ECF No. 19); Complaint (ECF No. 1); Civil Cover Sheet (ECF No. 2); and Related Case Statement (ECF No. 3), mailed to Forest Laboratories Ireland, Ltd Clonshaugh Industrial Estate Dublin 17 Ireland on 8/4/2020 by Federal Express tracking # 7711 4143 8926, to the individual of the foreign state. (smc) (Entered: 08/05/2020) |
7/29/2020 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 30 MOTION for Joseph T. Lukens to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-20909478. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (vba) (Entered: 07/29/2020) |
7/29/2020 | 30 | MOTION for Joseph T. Lukens to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-20909478. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Declaration of Joseph T. Lukens in Support of Plaintiff's Motion for Mr. Lukens' Admission Pro Hac Vice, # 2 Certificate of Good Standing from the Supreme Court of Pennsylvania, # 3 Text of Proposed Order).(Lukens, Joseph) (Entered: 07/29/2020) |
7/29/2020 | | >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. 29 MOTION for Peter Kohn to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-20909100. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (vba) (Entered: 07/29/2020) |
7/29/2020 | 29 | MOTION for Peter Kohn to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-20909100. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by J M Smith Corporation. (Attachments: # 1 Declaration of Peter Kohn in Support of Plaintiff's Motion for Mr. Kohn's Admission Pro Hac Vice, # 2 Certificate of Good Standing from the Supreme Court of Pennsylvania, # 3 Text of Proposed Order).(Kohn, Peter) (Entered: 07/29/2020) |
7/29/2020 | 28 | AFFIDAVIT OF SERVICE of Summons and Complaint,. Abbvie, Inc. served on 7/28/2020, answer due 8/18/2020. Service was accepted by Phyllis Mascio. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/29/2020) |
7/29/2020 | 27 | AFFIDAVIT OF SERVICE of Summons and Complaint,. Allergan, Inc. served on 7/28/2020, answer due 8/18/2020. Service was accepted by Robin Hutt-Banks, Agent. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/29/2020) |
7/29/2020 | 26 | AFFIDAVIT OF SERVICE of Summons and Complaint,. Allergan Sales LLC served on 7/28/2020, answer due 8/18/2020. Service was accepted by Julio Quinones, Security/Authorized Agent. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/29/2020) |
7/29/2020 | 25 | AFFIDAVIT OF SERVICE of Summons and Complaint,. Allergan USA, Inc. served on 7/28/2020, answer due 8/18/2020. Service was accepted by Julio Quinones, Security/Authorized Agent. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/29/2020) |
7/29/2020 | 24 | AFFIDAVIT OF SERVICE of Summons and Complaint,. Forest Laboratories Inc. served on 7/28/2020, answer due 8/18/2020. Service was accepted by Corporation Service Company Dropbox ("CSC") per CSC's COVID-19 Protocol. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/29/2020) |
7/29/2020 | 23 | AFFIDAVIT OF SERVICE of Summons and Complaint,. Forest Laboratories, LLC served on 7/28/2020, answer due 8/18/2020. Service was accepted by Robin Hutt-Banks, Agent. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/29/2020) |
7/27/2020 | 22 | ELECTRONIC SUMMONS ISSUED as to Allergan Sales LLC..(dnh) (Entered: 07/27/2020) |
7/24/2020 | | Magistrate Judge Gabriel W. Gorenstein is so designated. Pursuant to 28 U.S.C. Section 636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed before a United States Magistrate Judge. Parties who wish to consent may access the necessary form at the following link: https://nysd.uscourts.gov/sites/default/files/2018-06/AO-3.pdf. (wb) (Entered: 07/24/2020) |
7/24/2020 | | NOTICE OF CASE REASSIGNMENT to Judge Lewis J. Liman. Judge Unassigned is no longer assigned to the case..(wb) (Entered: 07/24/2020) |
7/24/2020 | | CASE ACCEPTED AS RELATED. Create association to 1:20-cv-05538-LJL. Notice of Assignment to follow. (wb) (Entered: 07/24/2020) |
7/24/2020 | 21 | REQUEST FOR ISSUANCE OF SUMMONS as to Allergan Sales, LLC, re: 1 Complaint,. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/24/2020) |
7/24/2020 | | ***NOTICE TO ATTORNEY REGARDING DEFICIENT REQUEST FOR ISSUANCE OF SUMMONS. Notice to Attorney Bruce E. Gerstein to RE-FILE Document No. 12 Request for Issuance of Summons,. The filing is deficient for the following reason(s): party name on the 'as to' docket entry text and the PDF 'To' section does not exactly match as it appears on the pleading caption;. Re-file the document using the event type Request for Issuance of Summons found under the event list Service of Process - select the correct filer/filers - and attach the correct summons form PDF. (jgo) (Entered: 07/24/2020) |
7/24/2020 | 20 | ELECTRONIC SUMMONS ISSUED as to Forest Laboratories, LLC..(jgo) (Entered: 07/24/2020) |
7/24/2020 | 19 | ELECTRONIC SUMMONS ISSUED as to Forest Laboratories Ireland, LTD..(jgo) (Entered: 07/24/2020) |
7/24/2020 | 18 | ELECTRONIC SUMMONS ISSUED as to Forest Laboratories Inc...(jgo) (Entered: 07/24/2020) |
7/24/2020 | 17 | ELECTRONIC SUMMONS ISSUED as to Forest Laboratories Holdings Ltd...(jgo) (Entered: 07/24/2020) |
7/24/2020 | 16 | ELECTRONIC SUMMONS ISSUED as to Allergan, Inc...(jgo) (Entered: 07/24/2020) |
7/24/2020 | 15 | ELECTRONIC SUMMONS ISSUED as to Allergan USA, Inc...(jgo) (Entered: 07/24/2020) |
7/24/2020 | 14 | ELECTRONIC SUMMONS ISSUED as to Abbvie, Inc...(jgo) (Entered: 07/24/2020) |
7/24/2020 | | CASE REFERRED TO Judge Lewis J. Liman as possibly related to 20-cv-5538. (jgo) (Entered: 07/24/2020) |
7/24/2020 | | Case Designated ECF. (jgo) (Entered: 07/24/2020) |
7/24/2020 | | CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is assigned to Judge Unassigned. .(jgo) (Entered: 07/24/2020) |
7/24/2020 | | ***NOTICE TO ATTORNEY REGARDING PARTY MODIFICATION. Notice to attorney Bruce E. Gerstein. The party information for the following party/parties has been modified: J M Smith Corporation. The information for the party/parties has been modified for the following reason/reasons: party text was omitted;. (jgo) (Entered: 07/24/2020) |
7/23/2020 | 13 | REQUEST FOR ISSUANCE OF SUMMONS as to Forest Laboratories, LLC, re: 1 Complaint,. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/23/2020) |
7/23/2020 | 12 | FILING ERROR - SUMMONS REQUEST As To AND PDF ERROR - REQUEST FOR ISSUANCE OF SUMMONS as to Allergan Sales, Inc., re: 1 Complaint,. Document filed by J M Smith Corporation..(Litvin, Dan) Modified on 7/24/2020 (jgo). (Entered: 07/23/2020) |
7/23/2020 | 11 | REQUEST FOR ISSUANCE OF SUMMONS as to Forest Laboratories, Inc.,, re: 1 Complaint,. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/23/2020) |
7/23/2020 | 10 | REQUEST FOR ISSUANCE OF SUMMONS as to Forest Laboratories Ireland, Ltd., re: 1 Complaint,. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/23/2020) |
7/23/2020 | 9 | REQUEST FOR ISSUANCE OF SUMMONS as to Forest Laboratories Holdings, Ltd, re: 1 Complaint,. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/23/2020) |
7/23/2020 | 8 | REQUEST FOR ISSUANCE OF SUMMONS as to Allergan, Inc., re: 1 Complaint,. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/23/2020) |
7/23/2020 | 7 | REQUEST FOR ISSUANCE OF SUMMONS as to Allergan USA, Inc, re: 1 Complaint,. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/23/2020) |
7/23/2020 | 6 | REQUEST FOR ISSUANCE OF SUMMONS as to AbbVie,Inc., re: 1 Complaint,. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/23/2020) |
7/23/2020 | 5 | NOTICE OF APPEARANCE by Dan Litvin on behalf of J M Smith Corporation..(Litvin, Dan) (Entered: 07/23/2020) |
7/23/2020 | 4 | RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/23/2020) |
7/23/2020 | 3 | STATEMENT OF RELATEDNESS re: that this action be filed as related to 1:20-cv-05538. Document filed by J M Smith Corporation..(Litvin, Dan) (Entered: 07/23/2020) |
7/23/2020 | 2 | CIVIL COVER SHEET filed..(Litvin, Dan) (Entered: 07/23/2020) |
7/23/2020 | 1 | COMPLAINT against Abbvie, Inc., Allergan Sales LLC, Allergan USA, Inc., Allergan, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories, LLC. (Filing Fee $ 400.00, Receipt Number ANYSDC-20819408)Document filed by J M Smith Corporation..(Gerstein, Bruce) (Entered: 07/23/2020) |